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General introduction and 
outline of the thesis
G e n e r a l Table 1. 
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The main topic of  this thesis is to elucidate 
the regulation of  peripheral vascular tone in 
spinal cord-injured (SCI) individuals. Since 
spinal cord-injured individuals have no 
sympathetic innervation below the level of  
the lesion, the regulation of  the peripheral 
circulation at rest and during postural 
changes will be disturbed. The question 
therefore is: which factors contribute to 
or compensate for the lack of  sympathetic 
innervation in the regulation of  peripheral 
vascular tone in SCI individuals? In this 
introduction the focus will be on the 
regulation of  vascular tone under baseline 
conditions in healthy humans and how the 
regulation of  peripheral vascular tone is 
affected by deconditioning and a change in 
sympathetic nerve activity as a result of  a 
spinal cord injury. The second part of  the 
introduction deals with the regulation of  
peripheral vascular tone upon orthostatic 
challenges in healthy humans and spinal 
cord-injured individuals.
Spinal cord injury
Epidemiology
A spinal cord injury is a disruption of  
the spinal cord resulting in complete or 
incomplete paralysis of  muscles, loss 
of  sensation, and dysfunction of  the 
autonomic nervous system. The severity of  
the consequences of  a spinal cord injury is 
dependent on the level and completeness 
of  the spinal lesion. Cervical lesions 
(tetraplegia) will result in paralysis of  the 
arms, legs and trunk. In high thoracic lesions, 
trunk and leg muscles are involved, whereas 
lower thoracic and lumbar lesions cause 
paralysis of  only leg muscles. The cervical 
cord is the most common site of  injury, 
occurring in 38-75% of  all cases.1-6 50-75% 
of the spinal lesions are traumatic of origin4, 7 
and common causes are traffi c accidents, 
falls, violence and sports.5, 6 Estimations 
of  the annual incidence of  spinal cord 
injury in the Netherlands vary between 
10.4 and 27 per million population.7-9 No 
reliable number is available for prevalence 
in the Netherlands, but extended from an 
overview of  literature on this topic10 it is 
estimated at ~12.000-15.000 of  persons 
suffering a spinal cord injury.
Improved medical care over the past six 
decades increased life expectancy of  people 
with a spinal cord injury, although there is no 
substantial change in either mortality or life 
expectancy since 1980.11 As a consequence 
of  the increased life expectancy SCI 
individuals are now more faced with 
secondary complications, like bladder and 
pulmonary infections, osteoporosis, and 
diseases more related to the cardiovascular 
system like, thromboembolism, pressure 
sores, and other cardiovascular diseases. In 
chronic SCI individuals (> 1 year post-injury) 
respiratory complications are nowadays the 
leading cause of  death followed by heart 
disease,12, 13 whereas in the past it was renal 
failure. The cardiovascular mortality is 
higher in SCI individuals as compared to 
the general population, especially in the 
SCI individuals aged below 55 years.14 (see 
Figure 1) 
Clinical consequences of a spinal cord 
injury
As the complications of  aging accumulate 
in SCI individuals, the risk factors for 
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cardiovascular diseases become apparent. 
Risk factors that may predispose for 
atherosclerosis15 include hypertension,16 
lipid abnormalities,17-19 glucose intolerance 
and diabetes mellitus,16, 20 increased weight21 
and smoking. Moreover the majority of  
individuals with SCI have a sedentary lifestyle 
and have limited physical activities, which 
seem to play a causal role in the onset of  
cardiovascular diseases, since several studies 
showed that regular physical exercise can 
decrease cardiovascular mortality.22, 23 SCI 
individuals are also faced with disturbances 
of  the autonomic nervous system, like 
orthostatic hypotension and autonomic 
dysrefl exia. Orthostatic hypotension occurs 
in SCI individuals because their inability to 
regulate and maintain blood pressure to 
postural stress as a consequence of  loss 
of  supraspinal sympathetic control. In 
the acute phase these patients experience 
syncopal events. However, in the chronic 
phase they exhibit an orthostatic tolerance 
comparable to able-bodied subjects.24 
Autonomic dysrefl exia is a potentially life-
threatening episodic hypertension that 
develops in up to 80% of  people with 
tetraplegia or high paraplegia (above the 6th 
thoracic spinal segment). This hypertension 
can be initiated by daily trivialities, such as 
bladder distension, catheterization and 
bowel evacuation that induce sensory input 
entering the spinal cord below the level of  
the lesion. It is characterized by exaggerated 
sympathetic refl exes below the level of  
the lesion that is unopposed by central 
inhibitatory pathways, and accompanied 
by a vagally induced bradycardia. During 
autonomic dysrefl exia, increases in arterial 
pressure causes debilitating headaches, 
sweating, seizures, strokes and even death.
Cardiovascular adaptations
In persons with a spinal cord injury, 
extensive adaptations of  the cardiovascular 
system occur as a consequence of  
a sedentary lifestyle and the loss of  
supraspinal sympathetic control below the 
level of  the spinal lesion. Previous studies 
using echocardiography found a signifi cant 
reduction in cardiac mass in subjects 
with tetraplegia,25-29 whereas in paraplegic 
individuals cardiac mass was unaffected.26, 
27 Total blood volume in high spinal cord 
lesions is decreased, which can be explained 
by both deconditioning and impairment of  
the autonomic nervous system.30 The basal 
levels of  both systolic and diastolic blood 
pressure in subjects with high (>T4) spinal 
cord lesions are lower than in able bodied 
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subjects, whereas basal heart rate does not 
differ.31, 32 
Furthermore, loss of  supraspinal control 
of  somatic efferents results in extreme 
deconditioning of  the leg muscles which 
is associated with reduced oxygen demand 
and subsequently with profound peripheral 
vascular adaptations. Diameters of  leg 
conduit arteries is approximately 20-30% 
lower than in able-bodied subjects.33-36 Using 
echo Doppler ultrasound measurements a 
30-50% decrease in common femoral artery 
blood fl ow has been reported,33, 34, 37, 38 while 
other studies did not observe any difference 
between SCI individuals and able-bodied 
healthy controls in baseline femoral artery 
blood fl ow.39, 40 Structural adaptations in 
the leg vascular bed of  SCI individuals 
occur, which is refl ected by a decrease in 
capillary density41 resulting in a ~35% 
reduction of  reactive hyperemic blood 
fl ow as measured by both echo Doppler37 
and venous occlusion plethysmography.35 
Baseline blood fl ow at the arteriolar level is 
~60% lower in SCI individuals compared 
to able-bodied subjects as determined 
by thermodilution technique32 or venous 
occlusion plethysmography.42 Indeed, 
despite the loss of  supraspinal sympathetic 
control, leg vascular resistance in spinal 
cord-injured individuals, in particular 
the paraplegic individuals,32 is more than 
doubled in comparison with control 
subjects.42
Regulation of baseline 
peripheral vascular tone
Blood fl ow in the skeletal muscle vascular 
bed is governed by perfusion pressure 
and vascular resistance. In supine position 
perfusion pressure is the pressure difference 
between the arterial and venous ends of  
the circulation. Since mean arterial pressure 
and venous pressure are maintained within 
narrow limits, the control of  skeletal 
muscle blood fl ow is accomplished in 
large part by variation of  skeletal muscle 
vascular resistance. Skeletal muscle vascular 
resistance is determined by the smooth 
muscle tone in the arterioles. These are 
the major sites of  control of  vascular 
resistance in the skeletal muscle vascular 
bed. Compared to other tissues skeletal 
muscle vascular tone in supine position is 
high and is essentially under dual control 
by systemic and local factors. The systemic 
mechanisms are predominantly aimed at 
blood pressure control and cardiovascular 
homeostasis, whereas the local systems 
maintain tissue homeostasis.
Systemic factors
Neural: the sympathetic nervous system
The sympathetic nervous system plays a 
key role in cardiovascular homeostasis. 
Hemodynamic changes provoke a 
compensatory refl ex response initiated by 
arterial baroreceptors and cardiopulmonary 
mechanoreceptors resulting in changes 
in sympathetic outfl ow and vagal-nerve 
activity. Afferent fi bers of  these receptors 
project to the nucleus tractus solitarii in 
the dorsal medulla, which in turn projects 
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to efferent cardiovascular neurons in the 
ventral medulla. From the medulla the 
efferent sympathetic preganglionic fi bers 
arise from the intermediolateral and –medial 
cell columns in the spinal cord and join the 
ventral roots at each vertebral level between 
Thoracic 1 and Lumbar 2 and terminate 
in the paravertebral ganglia, which are 
interconnected and form the sympathetic 
chain. The skeletal muscle vascular bed 
receives postganglionic sympathetic nerve 
fi bres. An increase in muscle sympathetic 
nerve activity will enhance vascular tone.
In humans, Barcroft et al 43 fi rst 
demonstrated that the sympathetic nervous 
system mediates a “tonic” vasoconstriction 
in the skeletal muscle vascular bed; surgical 
sympathectomy increases skeletal muscle 
blood fl ow by ~25% and decreases 
vascular tone.44, 45 Upon sympathetic 
stimulation noradrenaline is released 
from the postganglionic nerves.46 Binding 
Schematic representation of the most important factors that increase (+) or decrease (-) vascular Figure 2. 
resistance. Angiotensin II is one of the end products of the renin-angiotensin-aldosteron-system (RAAS) 
and binds to the AT1-receptor on the smooth muscle cell that results in vasoconstriction. When stimulated, 
the adrenal gland can release adrenaline and noradrenaline into the systemic circulation. Adrenaline in 
low concentrations dilates muscle resistance vessels (β2-adrenergic eff ect) and in high concentrations 
produces vasoconstriction (α-adrenergic eff ect). Noradrenaline is the major neurotransmitter of the 
postganglionic sympathetic nerves. Stimulation of the α-adrenergic receptors results in vasoconstriction. 
The endothelium produces local factors like for example nitric oxide (NO), prostacyclin (PGI2), endothelium 
derived hyperpolarizing factor (EDHF), and endothelin-1 (ET-1). The myogenic response is an autoregulatory 
mechanism of the smooth muscle cell that contracts in response to stretch and relaxes with a reduction in 
vessel wall tension.
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of  noradrenaline to both postjunctional 
α1- and α2-adrenoceptors results in an 
increase in vascular tone,47 whereas the 
prejunctional α2-adrenoceptor modulates 
noradrenaline release via a negative feedback 
mechanism.46, 48 Complete blockade of  the 
α-adrenergic receptor, assessed by infusion 
of  the nonselective α-adrenoceptor blocker 
phentolamine, reduces vascular tone by 
~50% in the leg49 and by ~70-80% in the 
forearm.50, 51 In addition, the sympathetic 
nerves secrete a variety of  other substances 
that are co-released with noradrenaline, 
like neuropeptide Y (NPY) and adenosine 
5-triphosphate (ATP).52, 53 NPY excites 
Y1-receptors and causes vasoconstriction 
by direct stimulation of  the receptor 
or by potentiation of  the α-adrenergic 
receptor mediated vasoconstriction.54 
ATP binds to P2x-purinoceptors to cause 
vasoconstriction.52 Apart from transmitters 
co-released with noradrenaline, animal55, 56 
and human in vivo57, 58 research has 
suggested that angiotensin II can also 
modulate sympathetic vasoconstriction 
by either increasing the release of  
noradrenaline through activation of  
presynaptic angiotensin II-receptors or by 
enhancing the postsynaptic noradrenaline 
responsiveness on vascular smooth cells. 
Humoral: renin-angiotensin-aldosterone system
Angiotensin II produces arteriolar 
vasoconstriction and is an end product 
of  the renin-angiotensin-aldosterone 
system (RAAS). The RAAS is stimulated 
under conditions of  renal hypoperfusion, 
produced by hypotension or volume 
depletion, by reduced sodium delivery 
to the macula densa and by increased 
sympathetic activity to the kidney. Under 
these conditions renin is released from 
the juxtaglomerular cells that intitiates a 
sequence of  steps that begins with cleavage 
of  angiotensin I from angiotensinogen. 
Angiotensin I is then converted into 
angiotensin II. This reaction is catalyzed 
by angiotensin converting enzyme (ACE), 
which is mainly located in the lungs, but 
is also present at the luminal membrane 
of  vascular endothelial cells, the kidney, 
adrenal gland and the brain.59-62 Angiotensin 
binds to specifi c angiotensine II receptors: 
AT1- en AT2-receptoren.
63 Binding to AT1-
receptors results in an increase in vascular 
tone by a direct effect on the smooth 
muscle cell mediated primarily by protein 
kinase C generation.64 As was explained in 
the previous paragraph angiotensin II can 
also infl uence vascular tone indirectly by 
mediating sympathetic vascular tone.55-58 
From human in vivo research we know that 
angiotensin II has a minor contribution to 
baseline forearm vascular tone in healthy 
human.65-68 However, under conditions of  
RAAS activation, endogenous angiotensin 
II contributes to the acute local maintenance 
of  basal peripheral vascular tone. 
Intrabrachial administration of  losartan, a 
specifi c AT1-receptor antagonist, in sodium 
depleted healthy individuals increases 
forearm blood fl ow 60%.67 In patients 
with heart failure and liver cirrhosis, where 
plasma renin activity is increased, losartan 
causes local peripheral vasodilatation.69-71
Local factors
Endothelium derived factors
The endothelial cells control the tone of  
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the underlying vascular smooth muscle 
by releasing various relaxing factors, from 
which nitric oxide (NO), prostacyclin (PGI2) 
and endothelium-derived hyperpolarizing 
factor (EDHF) are the most signifi cant, 
and vasoconstrictor mediators, such as 
endothelin (ET), angiotensin II, and 
vasoconstrictor prostanoids.72, 73
Furchgot et al 74 demonstrated that 
the relaxation of  the vascular smooth 
muscle cells in response to acetylcholine 
was dependent on the integrity of  the 
endothelium that released a vasorelaxing 
factor that was later identifi ed as NO.75 NO 
is synthesized in the endothelial cell from 
oxygen and L-arginine by endothelial NO 
synthase (NOS). It diffuses to the vascular 
smooth muscle cell where it stimulates 
soluble guanylate cyclase, resulting in an 
increased formation of  cyclic guanosine 
monophosphate and subsequent relaxation 
of  the vascular smooth muscle cell.76 
The likely physiological stimulus for 
NO production is increased shear stress 
by increased blood fl ow. Shear stress 
is the frictional force of  blood on the 
endothelium. Stimulated NO production 
or endothelium-dependent vasodilatation 
can be measured by ultrasound at the 
level of  the conduit artery during reactive 
hyperemia. This fl ow-mediated dilatation 
(FMD) provides an index of  conduit artery 
endothelium dependent NO function, 
whereas pharmacological stimulation of  
NO production by intraarterial infusion 
of  acetylcholine is used as measure of  
endothelial function at arteriolar level. 
Apart from stimulated production of  
NO, NO is also released basally and is 
involved in the regulation of  baseline 
arteriolar vascular tone since infusion of  
the L-arginine analogue and NOS inhibitor 
NG-monomethyl-L-arginine (L-NMMA) 
into the brachial artery reduced forearm 
blood fl ow by 30-50%.77, 78 Contribution 
of  NO to baseline vascular tone in the 
leg vascular bed is unknown, and will be a 
topic of  the present thesis. Although NO 
is a predominant endothelium derived 
vasodilator in the regulation of  vascular 
smooth muscle tone, the contribution of  
the other endothelium derived vasoactive 
factors will also be discussed. PGI2 is 
synthesized by cyclooxygenase-1 (COX-
1), which is expressed in the vascular 
endothelium. Inhibition of  COX-1 by 
intraarterial administration of  aspirin 
or indomethacin in the human forearm 
reduced blood fl ow by 22-32% suggesting 
that prostanoids also play a role in 
maintaining smooth muscle vascular tone 
in humans.79, 80 Debate surrounds the 
identity of  EDHF and its mechanism 
of  action, with the consensus being that 
there is no universal EDHF. Two primary 
mechanistic pathways are implicated: (i) 
myoendothelial gap junctions mediating the 
spread of  endothelial cell hyperpolarization 
or small signaling molecules (or both) 
to the smooth muscle; and (ii) diffusible 
mediators released from the endothelium, 
including potassium ions (K+), hydrogen 
peroxide (H2O2), epoxyeicosatrienoic acid 
(EET), C-type natriuretic peptide (CNP), 
but also PGI2 and NO. (For review see
81-83) 
In vivo studies indicate that EDHF seems 
to contribute little to basal blood fl ow 
and vascular tone, but makes a signifi cant 
contribution to evoked blood fl ow. (For 
review see84)
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Among the vasoconstrictor factors released 
by the endothelium, endothelin-1 is the 
most potent. In humans endothelin-1 
infused into the brachial artery results 
in a decrease in forearm blood fl ow.85, 86 
Endothelin-1 binding to ETA-receptor and 
ETB-receptor on the smooth muscle cell 
results in vasoconstriction.87 ETB-receptors 
are also located on the endothelium.88 In 
contrast, activation of  these ETB-receptors 
mediates vasodilatation by the release 
of  endothelium-dependent vasodilator 
substances such as NO and PGI2.
89 
Contribution of  endothelin-1 to baseline 
vascular tone is not uniform in the human 
skeletal muscle vascular bed. Forearm 
blood fl ow increased by 35-60% during 
intraarterial infusion of  ETA/B-receptor 
antagonists,90, 91 whereas in the leg blockade 
of  the ETA/B-receptor hardly infl uenced leg 
blood fl ow.92
In addition to their own distinct profi le 
of  activity, there is clear evidence that all 
these endothelial mediators are interacting 
with each other in a complex but integrated 
manner to maintain baseline vascular tone 
and the health of  the vasculature. 
Myogenic tone
The myogenic response was fi rst described 
by Bayliss93 in 1902 and has been proposed 
to participate in the establishment of  basal 
vascular tone and autoregulation of  blood 
fl ow.94 It is characterized by an inherent 
ability of  arterioles to contract to an increase 
in transmural pressure. The stimulus 
for the myogenic response is a pressure 
induced alteration of  vessel wall tension95 
that produces depolarization of  smooth 
muscle cell membranes with a subsequent 
depolarization-induced Ca2+ entry being 
necessary for myogenic contraction.94 
However, the exact mechanism linking the 
increase in transmural pressure and vascular 
smooth muscle constriction remains 
unclear.
Animal in vitro studies have revealed that, 
in particular, skeletal muscle vessels exhibit 
a strong myogenic tone.96-98 Under baseline 
physiological levels of  transmural pressure, 
the active myogenic tone, which is defi ned 
as the percentage of  passive vessel diameter, 
in the rat muscle vascular bed is 50%.97, 99 
In vivo the muscle vascular bed is not only 
under the infl uence of  transmural pressure, 
but is also exposed to the pulsatility of  blood 
pressure, neurotransmitters and endothelial 
infl uences. It is known from animal research 
that the myogenic response is modulated by 
α-adrenergic stimulation by increasing the 
strength of  the myogenic response.100 Flow 
and factors released from the endothelium, 
like NO, can also infl uence the strength of  
the myogenic response.101
Regulation of baseline 
peripheral vascular tone in 
SCI individuals 
In this section the focus will be on the 
role of  the sympathetic nervous system, 
endothelial factors, in particular NO, and 
the myogenic tone in the regulation of  
basal vascular tone in SCI individuals.
Sympathetic vascular tone
The initial phase after a spinal cord injury 
is characterized by “spinal shock”, which 
is described as the sudden and transient 
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suppression of  neural function below the 
level of  the spinal cord lesion. During this 
state, a fl accid paralysis of  skeletal muscle 
occurs and all tendon, cutaneous, and 
(para)sympathetic refl exes integrated in the 
spinal cord below the lesion are abolished 
or greatly reduced. As a consequence 
of  reduced sympathetic activity, one can 
imagine that the contribution of  the 
sympathetic nervous system, in maintaining 
vascular tone is diminished in the spinal 
shock phase, which will clinically result in 
hypotension. In humans, the spinal shock 
phase persists for days to weeks. Recovery 
is refl ected by emergence of  spinal 
(sympathetic) refl exes. The role of  these 
refl exes in the regulation of  vascular tone, 
and whether they contribute to the high 
vascular tone in the paralyzed legs, in the 
chronic phase after a spinal cord-injured 
individuals is not known. Animal research 
has focused on whether the deafferented 
spinal cord can generate signifi cant basal 
sympathetic activity. In anaesthetized 
rats, sympathetic outfl ow to renal and 
splenogastric, but not lumbar, sympathetic 
activities after spinal transaction was 
reported to be well maintained.102 However, 
in awake cervical spinal rats there was no 
evidence for functionally signifi cant spinally 
generated sympathetic nerve activity.103, 104 
In humans, microneurographic recordings 
have also reported decreased activity in the 
cutaneous and muscle postganglionic axons 
situated below the level of  the lesion.105, 106 
Therefore, despite the return of  spinal 
sympathetic refl exes, there is no convincing 
animal or human data to demonstrate that 
the deafferented spinal cord can generate 
signifi cant basal sympathetic activity that 
could contribute to baseline vascular tone.
Average sympathetic outfl ow can be 
estimated by determination of  venous 
plasma noradrenaline.107 Plasma 
noradrenaline levels depend on the level 
of  the spinal lesion. In individuals with a 
cervical lesion, plasma noradrenaline is 
lower than in control subjects at rest.108, 109 
Individuals with high (T1-T4) thoracic 
lesions show low110 to normal plasma 
noradrenaline levels,111 whereas individuals 
with the spinal lesion below T5 have 
normal108 to high111 plasma noradrenaline 
levels as compared with able-bodied 
subjects. So, in individuals with cervical 
lesions, where overall sympathetic activity 
is reduced, circulating plasma noradrenaline 
has a minor contribution to baseline vascular 
tone, whereas in individuals with thoracic 
lesions circulating normal to high plasma 
noradrenaline levels could contribute to 
baseline vascular tone.
RAAS system
In the absence of  adequate sympathetic 
innervation the renin-angiotensin-
aldosteron system helps to maintain blood 
pressure, especially in SCI individuals 
with high thoracic or cervical lesions, 
indicated by elevated resting plasma renin 
levels,31, 112-114 probably in response to 
low perfusion pressure of  the kidneys. 
Whether angiotensin II levels are raised 
and will subsequently contribute to the 
high leg vascular tone in SCI individuals is 
unknown.
Endothelium
Deconditioning
Studies on the effect of  deconditioning on 
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NO pathway are controversial. Previous 
animal studies have mimicked physical 
inactivity by hindlimb unloading and they 
report inconsistent results. Some studies 
demonstrate a decreased endothelial 
NO synthase (eNOS) expression in the 
endothelial cells of  both conductance 
and resistance vessels, and an attenuated 
vasodilatation to acetylcholine, suggesting 
that the endothelial release of  NO was 
attenuated by rat hindlimb unloading.115-117 
In contrast, another study demonstrated no 
alterations of  eNOS expression following 
rat hindlimb unloading, but an upregulation 
of  aortic inducible NOS.118 In humans, 
evidence for an attenuated endothelial NO 
release in both conductance and resistance 
arteries following deconditioning is sparse. 
Kamiya et al 119 showed a decrease in plasma 
nitrite/nitrate concentration, an indicator 
of  endogenous nitric oxide production, 
after head-down bed rest suggesting a 
diminished release of  endothelial NO. This 
was not confi rmed by Bonnin et al 120 who 
did not fi nd a signifi cant change in urinary 
nitrite excretion during 7 days of  head-
down tilt bed rest. In one study, the effect 
of  immobilization of  a forearm, by forearm 
casting for treatment of  fractures, on NO 
availability was investigated by infusion of  
L-NMMA to block the NO production.121 
The response to L-NMMA was similar in 
the casted subjects and their controls. The 
results of  this study could be explained by 
methodological considerations, like casting 
for fractures as a model for deconditioning, 
and the dosage of  L-NMMA used, which 
is not likely to produce maximal NOS 
inhibition.
Flow-mediated dilatation (FMD) in 
the superfi cial femoral artery, which is 
endothelium dependent and an indicator 
of  shear stress-induced endothelial nitric 
oxide production, is, surprisingly, increased 
after deconditioning due to unilateral 
lower limb suspension122 and bed rest.123 
In these studies, endothelium-independent 
dilatation increased simultaneously 
suggesting that vascular adaptations to 
deconditioning occur not only in the 
endothelium, but also at the level of  the 
smooth muscle. Similarly, in the brachial 
artery an increased FMD was reported 
after 7 days of  bed rest deconditioning, but 
endothelium independent vasodilatation 
was not affected.
Due to hindlimb unloading circulating 
plasma ET-1 levels are increased.124 
In humans, deconditioning caused by 
microgravity, tended to increase plasma 
ET-1 levels.125
Sympathectomy
Some animal studies have shown decreased 
NO availability, in terms of  decreased 
eNOS or blunted vasorelaxation to 
endothelial stimulation, due to surgical 
or chemical sympathectomy.126-128 Data 
of  human in vivo research are confl icting. 
Lepori et al 129 examined vasoconstrictor 
responses to systemic doses of  L-NMMA 
in innervated calfs and denervated forearms. 
Sympathectomy markedly potentiated 
the vasoconstrictor response effect of  
L-NMMA infusion and they concluded 
that this could be related to an augmented 
contribution of  NO to the regulation of  
local vascular resistance after denervation. 
However, local infusion of  L-NMMA into 
the brachial artery of  the sympathectomized 
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forearm resulted in similar vasoconstrictor 
responses as in non-sympathectomized 
limb130 suggesting endothelial function was 
not changed by sympathectomy.131
Spinal cord-injured individuals
No studies have examined the role of  
baseline NO production in the increased 
leg vascular tone in SCI individuals. Plasma 
levels of  the most important endothelial 
derived vasoconstrictor factor, ET-1, have 
been reported to be very high in SCI 
individuals,132 which may be suggestive 
for an upregulation of  the ET-1 pathway. 
Although in a recent study plasma ET-1 
levels do not differ between the SCI 
individuals and control subjects, the 
contribution of  ET-1 to baseline vascular 
tone in SCI individuals is increased.92 
As such, ET-receptor sensitivity and/
or receptor signaling may explain the 
upregulated ET-pathway, which is rather 
mediated by the ETA-receptor than the 
ETB-receptor.
Superfi cial femoral artery FMD is increased 
in SCI individuals as compared with control 
subjects.37, 133 If  FMD is corrected for its 
eliciting stimulus shear rate, this difference 
is no longer statistically signifi cant. 
However, per delta shear rate the response 
is still greater in SCI individuals than in 
controls. These results are in contrast with 
the posterior tibial artery FMD, which was 
lower in SCI individuals than in controls,134 
that could be explained by placement of  
the cuff  proximal or distal to the measuring 
site. In the studies by De Groot et al,37, 133 
the ultrasound probe was proximal to the 
cuff, whereas in the study described by 
Stoner et al,134 the site of  measurement 
was in the ischaemic area distal to the cuff. 
Under these circumstances FMD is affected 
by vasodilators other than NO which are 
released in response to ischaemia, and may 
also be complicated by myogenic responses 
as a result of  the pressure fall inside the 
artery during occlusion.135 Endothelium 
independent vasodilatation of  the 
superfi cial femoral artery is not altered after 
spinal cord injury, indicating no change in 
vascular smooth muscle function37 In the 
non-paralyzed upper extremity, FMD does 
not differ between SCI individuals and 
control subjects.37, 134
Myogenic tone
Whether an increase in myogenic tone 
is responsible for the increase in leg 
vascular tone in SCI individuals has 
never been investigated. Results of  
animal research investigating effects of  
sympathetic stimulation or denervation, 
and deconditioning on myogenic tone or 
response are unequicoval. In the rat skeletal 
muscle vascular bed, it was demonstrated 
that α-adrenergic stimulation increases 
the strength of  the myogenic response.100, 
136 In line with these results, one might 
expect that myogenic tone is attenuated 
in SCI individuals, who lack sympathetic 
activity below the level of  the lesion. In 
contrast, chronic sympathetic denervation 
on resistance arteries in the rabbit ear 
vasculature showed that the denervated 
artery developed greater stretch dependent 
myogenic tone. It was concluded that this 
phenomenon may partially account for 
the return of  vascular tone after an initial 
decrease in vascular tone due to sympathetic 
denervation.137 After rat hindlimb 
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unloading, myogenic tone is attenuated in 
both arterioles of  fast twitch fi bers in the 
gastrocnemius muscle138 and in mesenteric 
resistance arteries.139 However, in these 
studies the myogenic response may be 
affected by chronic changes in transmural 
pressure rather than by deconditioning. 
Regulation of peripheral 
vascular tone during 
orthostatic challenges
Regulation of peripheral vascular tone 
under normal physiological conditions
Assumption of  the upright posture results 
in pooling of  500-1000 ml of  blood in 
the lower extremities and the splanchnic 
circulation. This initiates an acute rapid 
decrease in venous return to the heart. 
The ensuing reduction in ventricular 
fi lling pressure results in diminished 
cardiac output and blood pressure. The 
fall in blood pressure and thoracic volume 
provokes the compensatory barorefl ex 
to increase sympathetic and to reduce 
parasympathetic outfl ow. The increase in 
sympathetic outfl ow will rise peripheral 
vascular resistance, venous return and 
cardiac output. The prompt increase in 
peripheral vascular resistance, mediated 
by sympathetic α-adrenergic stimulation, 
is the key event in blood pressure control 
during postural stress.140 Apart from 
barorefl ex control, local sympathetic 
mechanisms, such as the venoarteriolar 
refl ex, have been reported to contribute 
to the hemodynamic response to postural 
stress. The venoarteriolar refl ex is triggered 
when venous pressure is elevated above 25 
mmHg or more.141 It has been suggested 
that during orthostasis as much as 45% of  
the increase in systemic vascular tone is due 
to the venoarteriolar refl ex.141-146 Several 
studies have been performed to unravel the 
mechanism of  the venoarteriolar refl ex.141, 
143, 147, 148 From these studies, it can be 
concluded that the venoarteriolar refl ex 
concerns a local α-adrenergic sympathetic 
axon refl ex, although a recent study makes 
the α-adrenergic origin of  the venoarteriolar 
refl ex uncertain.149
Except for α-adrenergic stimulation, 
non-adrenergic mechanisms, such as 
purinoceptor stimulation and release of  
neuropeptide Y, seem to contribute to the 
vasoconstrictor response after sympathetic 
stimulation.150, 151
In addition, the leg vasoconstrictor 
response to postural stress may in part 
be myogenic,152 and as such not related 
to the sympathetic nervous system. This 
support from this concept comes from 
a human study where both arm and leg 
vascular resistance were measured during 
40° head-up tilt, with the arm kept at heart 
level.153 Despite similar increases in muscle 
sympathetic nerve activity in the arm and 
leg, the increase in vascular tone in the leg 
was ~2 times higher, which may be caused 
by an increase in leg transmural pressure 
evoking the myogenic response.
Postural vasoconstriction in spinal 
cord-injured individuals
In SCI individuals, sympathetic brainstem 
control of  the vascular bed below the level of  
the spinal cord lesion is defi cient. Especially 
in the early stages of  rehabilitation, SCI 
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individuals are prone to orthostatic 
hypotension. However, chronically injured 
individuals show, despite the absence of  
central sympathetic control,154 a remarkable 
orthostatic tolerance during postural stress 
and, in particular the paraplegic individuals, 
maintain blood pressure during orthostatic 
challenges.155 Moreover, preservation of  
tilt-induced leg vasoconstriction in these 
individuals has been reported.144, 156, 157
Activation of  spinal sympathetic refl exes 
may be one of  the mechanisms contributing 
to the tilt-induced vasoconstriction and 
recovery of  blood pressure upon head-
up tilt.158 These spinal refl exes function 
independent of  brainstem control and 
may evoke an increase in muscle and skin 
vascular tone.106 It has been suggested that 
spinal sympathetic refl exes contribute to 
the head-up tilt induced vasoconstriction 
in muscle144 and subcutaneous tissue157 in 
individuals with cervical spinal lesions. 
However, the importance of  these refl exes 
in maintaining blood pressure upon postural 
change remains doubtful since the head-up 
tilt induced plasma noradrenaline response 
was almost completely absent in individuals 
with a cervical spinal lesion.113
During head-up tilt, plasma renin levels 
increase more in cervical spinal cord-
injured individuals than in controls or in 
individuals with a thoracic spinal lesion.113, 
114 The renin release seem to be independent 
of  sympathetic stimulation and is probably 
dependent on the fall in renal perfusion 
pressure upon head-up tilt.159 The 
subsequent production of  angiotensin II is 
likely to play a role in the head-up tilt induced 
vasoconstriction in spinal cord-injured 
individuals, in particular in individuals with 
cervical spinal lesions, which is supported 
by the observation that administration of  
captopril, which prevents angiotensin II 
formation, considerably enhances postural 
hypotension. (unpublished results by 
Mathias et al 159) 
Local mechanisms, like the (sympathetic) 
venoarteriolar refl ex and the myogenic 
response has been proposed to contribute 
to the leg vasoconstriction in SCI individuals 
in response to head-up tilt.36, 144, 160, 161
Aim and outline of the thesis
Regulation of  skeletal muscle vascular tone 
in humans relies on systemic and local 
regulatory mechanisms. Systemic control 
consists of  both sympathetic and humoral 
control, in particular the renin-angiotensin-
aldosterone system. Myogenic regulation, 
which is an intrinsic mechanism of  the 
vascular smooth muscle, and vasoactive 
substances derived by the endothelium, are 
local regulatory mechanisms. Apart from 
the sympathetic nervous system, which 
is the dominant determinant of  baseline 
vascular tone and the increase in vascular 
tone upon postural stress, endothelium 
derived factors, like nitric oxide (NO), are 
important modulators of  baseline vascular 
tone.
Individuals with a complete spinal cord 
injury lack sympathetic barorefl ex control 
of  the leg vascular bed. However, despite 
sympathetic denervation in the paralyzed 
legs, (1) leg vascular tone is almost twice 
as high as compared with able-bodied 
subjects, and (2) SCI individuals show 
head-up tilt induced increase in leg vascular 
tone to withstand orthostatic stress. The 
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aim of  the present thesis is to elucidate the 
role of  the sympathetic nervous system, 
and endothelial derived substances, in 
particular NO, in the regulation of  baseline 
vascular tone in SCI individuals and able-
bodied subjects. Furthermore, we tried 
to unravel the regulatory mechanisms 
behind the preserved head-up tilt induced 
vasoconstriction in SCI individuals. The 
studies described in this thesis are aimed to 
improve our understanding of  the (patho)
physiologic regulation of  vascular tone in 
order to provide tools to prevent secondary 
complications, like pressure sores and 
atherosclerosis, in SCI individuals.
Chapter 2 focuses on the contribution of  
the sympathetic nervous system to baseline 
leg vascular tone in SCI individuals and 
controls. We hypothesized that blockade of  
the α-adrenergic receptor in the leg vascular 
bed of  SCI individuals, with central loss of  
sympathetic control of  the leg vascular bed, 
affects baseline vascular tone to a lesser 
extent than in able-bodied subjects
In Chapter 3, the effect of  deconditioning 
on baseline endothelial NO production was 
investigated. The hypothesis was that the 
contribution of  NO to baseline vascular 
tone is reduced in deconditioned skeletal 
muscle. Therefore, the purpose of  this 
study was to assess the effect of  extreme, 
long-term deconditioning, by means of  a 
spinal cord injury, and moderate, short-
term deconditioning by unilateral lower 
limb suspension, on the contribution of  
NO to baseline vascular tone in human leg 
skeletal muscle vascular bed.
Flow-mediated dilatation (FMD) is a 
valuable and non-invasive tool to evaluate 
conduit artery endothelial function in 
humans. Decreased endothelial function, 
characterized by a reduced bioavailability 
of  nitric oxide (NO), has been proposed 
as an important early event in the 
pathogenesis of  atherosclerosis, since NO 
is an important anti-atherogenic molecule. 
Inactivity is an independent risk factor for 
atherosclerosis, but surprisingly the FMD 
in the paralyzed and thus inactive legs of  
SCI individuals is preserved. Therefore, in 
Chapter 4, we examined whether superfi cial 
femoral artery FMD in healthy subjects and 
in SCI individuals is NO-mediated.
The applicability and reproducibility of  
venous occlusion plethysmography for 
blood fl ow measurements in the calf  
during head-up tilt at different tilt angles 
was assessed in Chapter 5.
In Chapter 6, the role of  α-adrenergic 
receptor stimulation in the leg 
vasoconstrictor response to orthostatic 
stress was elucidated in able-bodied 
subjects, with intact sympathetic barorefl ex 
control of  the leg vascular bed, and in 
spinal cord-injured individuals, who lack 
barorefl ex control of  the leg vascular bed. 
Since α-adrenergic stimulation is the most 
important determinant of  leg vascular tone 
during head-up tilt in able bodied subjects, 
we hypothesized that blockade of  the 
α-adrenergic receptor in the leg vascular 
bed will result in a substantial blunting of  
the leg vasoconstrictor response to head-up 
tilt. This response will be larger in subjects 
with an intact barorefl ex than in subjects 
who fail barorefl ex control over the leg 
vascular bed, and therefore depend on local 
mechanisms of  vasoconstriction.
The different local vasoconstriction 
mechanisms in SCI individuals were aimed to 
be unraveled in Chapter 7. In SCI individuals 
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and able-bodied subjects, changes in blood 
fl ow were measured in response to both 
limb dependency and cuff  infl ation above 
(forearm) and below (calf) the level of  
the spinal lesion, without interference 
of  the barorefl ex in SCI individuals. We 
hypothesized that these local mechanisms 
contribute more to vasoregulation in SCI 
individuals than in controls.
Methods applied in this 
thesis
Perfused upper leg model
The technique of  leg blood fl ow 
measurements in combination with 
drug infusions into the femoral artery is 
developed collectively by the department 
of  Physiology and Pharmacology-
Toxicology. A cannula (Angiocath 16 gauge, 
Becton Dickinson, Sandy, Utah, USA) is 
introduced into the femoral artery of  the 
leg using a modifi ed Seldinger technique. 
The intra-arterial cannula is used for drug 
administration and for blood pressure 
measurement. Local anesthesia (4 ml 
lidocaine 20 mg⋅ml-1) is used. 
Bilateral upper leg blood fl ow is measured 
by electrocardiography-triggered venous 
occlusion plethysmography using 
mercury-in-silastic strain gauges placed 
approximately 10 cm proximal to the 
patella. The thigh cuffs are simultaneously 
infl ated to 50 mmHg using a rapid cuff  
infl ator (Hokanson E-20, D.E. Hokanson, 
Bellevue, Washington, USA).162 Cuffs below 
the knee were infl ated to suprasystolic 
levels (> 200 mmHg) in order to occlude 
the calf  circulation. This way the use of  
high doses of  drugs was abolished reducing 
subsequent systemic effects. To prevent 
discomfort, infusions were interrupted 
every ten minutes and the calf  circulation 
restored for 5 minutes.
Ultrasound measurements
Baseline red blood cell velocity and diameter 
of  the superfi cial femoral artery were 
measured using an echo Doppler device 
(Megas, ESAOTE Firenze, Italy) with a 5-7.5 
MHz broadband linear array transducer.33, 
37 Increased shear stress in the femoral 
artery, as induced by reactive hyperemia 
elicits an endothelium-dependent dilatation 
(fl ow-mediated dilatation, FMD) of  the 
superfi cial femoral artery. For this purpose, 
a cuff  is placed around the upper thigh 
distal to the imaging site of  the superfi cial 
femoral artery. The cuff  is infl ated to 
a supra-systolic pressure of  220 for 5 
minutes to produce local ischemia. After 
cuff  defl ation, hyperemic fl ow velocity in 
the superfi cial femoral artery is recorded on 
videotape for the fi rst 25 seconds, followed 
by a continuous registration of  the vessel 
diameter for 5 minutes to determine 
FMD. The reproducibility for the resting 
measurements in the superfi cial femoral 
artery was reported as 1.5% for diameter, 
and 14% for blood fl ow. The reproducibility 
for the relative FMD change was 15%.37
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Abstract
Background – Supraspinal sympathetic control 
of leg vascular tone is lost in spinal cord-injured 
individuals but this does not result in a reduced 
leg vascular tone: leg vascular resistance is even 
increased. The aim of this study is to assess the 
α-adrenergic contribution to the increased vascular 
tone in the lower extremity in patients without 
central sympathetic control of leg circulation.
Methods – Upper leg vascular resistance responses to 
local infusion of incremental doses of phentolamine 
(a competitive antagonist of the α-adrenoceptor) 
into the femoral artery were determined in 10 
spinal cord-injured individuals (SCI) and 8 healthy 
age-matched controls during local β-adrenergic 
receptor blockade with propranolol.
Results – Basal leg vascular resistance was higher 
in SCI than in controls (41 ± 6 AU versus 24 ± 4 AU; 
P=0.034). The same accounts for minimal leg vascular 
resistance, assessed during reactive hyperemia, 
which was higher in SCI compared with controls (6.9 
± 1.0 AU versus 2.5 ± 0.2 AU; P<0.01). The maximal 
phentolamine-induced reduction in leg vascular 
resistance normalized to each individual’s minimal 
resistance did not diff er between the groups (68 ± 
17% and 51 ± 4% for SCI and controls, respectively; 
P>0.1). A decline in mean arterial pressure was 
observed in both groups with increasing dosage of 
phentolamine. In response, baroreceptor-mediated 
vasoconstriction was observed in the non-infused 
leg of the controls, whereas in SCI individuals this 
reaction was absent.
Conclusion – These results indicate that the 
α-adrenoceptor-mediated vascular tone in the leg is 
preserved in spinal cord-injured individuals without 
sympathetic supraspinal control.
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Introduction
In healthy humans, the sympathetic nervous 
system contributes importantly to basal 
vascular tone as assessed by pharmacological 
blockade of  the α-adrenoceptor1-3 or 
acute denervation in sympathectomized 
patients.4 In spinal cord-injured individuals 
the supraspinal sympathetic control of  leg 
vascular tone is lost. One would expect 
a low leg vascular tone and orthostatic 
intolerance in these individuals. However, 
the opposite holds true: leg vascular 
resistance is increased in spinal cord-injured 
individuals5, 6 and orthostatic tolerance 
seems not to be affected.7
In both animal8-10 and human research,4 
sympathectomy results in a dramatic 
increase in blood fl ow to the denervated 
part of  the body. However, this effect is 
short lasting and presympathectomy levels 
of  blood fl ow are reached within days in 
animals11 to a few months in humans.12-14 
The underlying mechanism for this biphasic 
response has not yet been clarifi ed. Apart 
from partial denervation or reinnervation 
of  sympathetic nerves,12 circulating 
catecholamines, other systems regulating 
vascular resistance such as endothelial 
factors,12, 13, 15, 16 the renin angiotensin 
system,17, 18 or denervation-induced 
upregulation of  α-adrenoceptors19, 20 may 
substitute for the reduced sympathetic 
input to vascular tone. In spinal cord-
injured individuals, the situation is even 
more complex since spinal sympathetic 
refl exes may still be intact. Furthermore, 
loss of  supraspinal control of  somatic 
efferents results in extreme deconditioning 
of  the leg muscles which is associated with 
reduced oxygen demand and subsequently 
with profound functional and structural 
vascular adaptations.5, 6 Indeed, leg vascular 
resistance in spinal cord-injured individuals 
is even increased in comparison with control 
subjects, despite the loss of  supraspinal 
sympathetic control.21
The purpose of  this study was to assess 
the contribution of  α-adrenoceptor-
mediated vasoconstriction to the vascular 
tone in the lower extremity of  individuals 
with central loss of  sympathetic control 
of  the leg circulation due to a spinal cord 
injury. We hypothesize that the sympathetic 
contribution to basal vascular tone in 
spinal cord-injured individuals is reduced 
in comparison to control subjects.
Methods
Subjects
Eight healthy controls (C), seven men and 
one woman, and ten spinal cord-injured 
individuals (SCI), eight men and two 
women, participated in the study. Baseline 
characteristics of  the SCI and controls are 
shown in Table 1 and Table 2. The SCI 
continued their medication throughout 
the study. The control group was similar 
with respect to age, gender and smoking 
habits. The spinal cord-injured individuals 
had complete motor and sensor spinal cord 
lesions of  traumatic origin varying from 
Thoracic 4 – Thoracic 12 (American Spinal 
Injury Association ASIA A). The level of  
the spinal lesion was assessed by clinical 
examination. After the completion of  the 
study, eight SCI (six men and two women) 
were willing to return to the laboratory to 
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assess the completeness of  the sympathetic 
lesion by use of  a cold pressor test of  the 
hand. For interpretation of  the cold pressor 
test a separate control group was assembled 
with similar age and gender profi le (n=9; 
age: 39 ± 2 years; gender profi le: seven men 
and two women).
The study was approved by the Hospital 
Ethics Committee. All subjects gave their 
written informed consent prior to the 
study.
Experimental procedures and protocol
All subjects refrained from caffeine, alcohol 
and nicotine for at least twelve hours and 
did not eat three hours prior to testing. 
All subjects had emptied their bladder 
in the hour before the test to minimize 
the infl uence of  any refl ex sympathetic 
activation on peripheral vascular tone.
All tests were performed in the afternoon 
with the subjects in supine position in 
a quiet temperature-controlled room 
(22°C-24°C). Each subject was studied on 
two different occasions, separated by at 
least three days. On the fi rst day maximal 
upper leg blood fl ow was determined after a 
12-minute arterial occlusion period22 (non-
invasive study day). On the second day 
phentolamine, a non-selective competitive 
antagonist of  α-adrenergic receptors, was 
infused into the femoral artery (invasive 
study day). On both study days bilateral 
upper leg blood fl ow was measured by 
electrocardiography-triggered venous 
occlusion plethysmography using mercury-
in-silastic strain gauges (Hokanson EC4, 
D.E. Hokanson, Washington D.C., USA). 
Strain gauges were placed 10 cm above the 
patella. The thigh collecting cuffs (12 cm 
width) were simultaneously infl ated using a 
rapid cuff  infl ator (Hokanson E-20) to a 
pressure of  50 mmHg during 8 heart cycles, 
with a 10-heart cycles interval between the 
venous occlusions. The lower legs were 
supported approximately 10 cm above 
Specifi c characteristics of spinal cord-injured individuals.Table 1. 
Subject Age 
(yr)
Sex Level of 
spinal 
lesion
Time since 
injury (years)
Sweating 
under 
lesion
Smoking Medication
1 38 M T12 16 + - -
2 34 M T4 5 - - -
3 34 M T4 5 - - tolterodine bid 2 mg 
baclofen tid 10 mg
4 (excluded) 31 F T10 8 - - -
5 33 M T6 10 - - -
6 49 M T6 17 - + nitrofurantoїne
7 40 M T4 18 - - -
8 45 M T5 13 + - levothyroxine
9 41 M T5 23 + - -
10 41 F T12 9 + + baclofen tid 40 mg
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heart level, to facilitate venous outfl ow 
between the venous occlusions.23 At least 
one minute before upper leg blood fl ow 
measurements were performed, the calf  
circulation was occluded by infl ating cuffs 
below the knee to suprasystolic values (> 
200 mmHg). Calf  circulation was excluded 
from the experimental preparation by a 
suprasystolic cuff  in order to avoid the use 
of  high dosages with subsequent systemic 
effects of  these drugs (see below). In nine 
controls, a pilot experiment was performed 
using an identical experimental set-up 
except for the intra-arterial cannulation. 
Upper leg vascular resistance appeared 
stable over time and was not affected by 
the repeated arterial occlusions (data not 
shown).
Non-invasive study days
Reactive Hyperemia
Maximal upper leg blood fl ow using venous 
occlusion plethysmography was determined 
after a 12-minute arterial occlusion period.22 
A cuff  around the left thigh was infl ated 
to > 200 mmHg. Flow measurements 
were immediately commenced after cuff  
pressure release. In accordance with 
previous studies24, 25 the highest value of  
upper leg blood fl ow was obtained within 
30 seconds after cuff  release (by the fi rst 
or second measurement). Simultaneously, 
arterial blood pressure measurements were 
performed continuously, at the left third 
fi nger using Finapress (Finapress, Ohmeda 
2300, BP Monitor BOC Health Care), 
in order to calculate minimal vascular 
resistance.
Cold pressor test
In order to determine the completeness 
of  the sympathetic lesion, the hand was 
immersed into water of  4°C during three 
minutes. Calf  blood fl ow was measured 
using venous occlusion plethysmography 
by placing a strain gauge around the thickest 
part of  the calf  at baseline and during the 
three minutes cold pressor test. Arterial 
pressure was continuously monitored 
using Finapress. Calf  vascular resistance 
was calculated by dividing mean arterial 
pressure by calf  blood fl ow. The mean of  
the three highest values of  calf  vascular 
resistance during the cold pressor test 
was used to calculate the percent change 
in vascular resistance compared with the 
mean vascular resistance of  the baseline.
Invasive study day
Using a modifi ed Seldinger technique, an 
intra-arterial cannula (Angiocath 16 gauge, 
Becton Dickinson, Sandy, Utah, USA) was 
introduced into the femoral artery of  the 
left leg at the level of  the inguinal ligament 
for blood pressure measurement (Hewlett 
Packard monitor type 78353B, Hewlett 
Packard GmbH, Böblingen, Germany), and 
for intra-arterial administration of  drugs by 
an automatic syringe infusion pump (Type 
STC-521, Terumo Corporation, Tokyo, 
Japan). In SCI individuals, the femoral 
artery was cannulated without anesthesia 
because of  the lack of  sensibility under 
the level of  the spinal cord injury. In two 
SCI subjects, we failed to cannulate the left 
femoral artery so we had to use the right 
femoral artery. In controls, the left femoral 
artery was cannulated after local anesthesia 
(0.4 ml lidocaine 20 mg·ml-1). Heart rate 
Preserved α-adrenergic tone
37
was recorded from the electrocardiogram. 
The schedule of  the protocol is shown in 
Figure 1. After complete instrumentation 
and at least 30 minutes after cannulation of  
the femoral artery an arterial blood sample 
was taken to determine norepinephrine and 
epinephrine concentration. First, baseline 
leg blood fl ow was measured, during a 
5-minute NaCl 0.9% infusion period, 
followed by infusion of  propranolol 
during 5 minutes in a dose of  2 μg·min-1 
per 100ml of  upper leg volume. Upper leg 
volume was determined by anthropometry 
as described and validated by Jones et al.26 
Subsequently, phentolamine was infused 
at incremental doses of  0.375–0.75–1.5–
3.0–6.0–12.0–24.0 μg·min-1·100ml-1 of  
upper leg volume. Previous studies showed 
complete α-adrenergic blockade in the 
leg of  healthy volunteers at a dose of  12 
μg·min-1·100ml-1.2 Each dose was given for 
5 minutes. During the entire phentolamine 
infusion, propranolol was coinfused at 
a dose of  2 μg·min-1·100ml-1 to prevent 
unopposed β-adrenergic vasodilatation 
during α-adrenergic blockade. Every ten 
minutes infusions were interrupted and 
the circulation to the calf  was restored by 
defl ating the arterial occlusion cuffs for 
fi ve minutes to prevent discomfort. At the 
end of  the highest dose of  phentolamine 
and propranolol, isoproterenol (15 
ng·min-1·100ml-1) was co-infused, in the 
controls only, to verify β-adrenoceptor 
blockade. The vasodilator action of  this 
dose of  isoproterenol was confi rmed in 
one experiment with a healthy volunteer. 
In addition, in this pilot study the used 
propranolol dose appeared to abolish 
the vasodilator action of  isoproterenol, 
confi rming adequate β-adrenoceptor 
blockade. During the whole protocol, 
0.75 
1.5 
3.0 
6.0 
12.0 
55 
Time (min) 
-30 0 5 10 15 20 25 30 35 40 45 50 
ca
nn
ul
at
io
n 
Pleth Pleth Pleth Pleth 
bl
oo
d 
sa
m
pl
e 
Infusion of NaCl 0.9% 
Propranolol infusion (2μg·min-1·100ml-1) 
Phentolamine infusion, dose in μg·min-1·100ml-1 
0.375 
24.0 
60 65 
Pleth 
12.0 
Schematic representation of the experimental protocol. Knee cuff s for arterial occlusion were Figure 1. 
only infl ated during venous occlusion plethysmography (Pleth).
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infusion rate was kept constant at a rate of  
20 μl·100ml-1·min-1.
Drugs and solutions
Phentolamine (Regitine®, 10 mg·ml-1, 
Novartis Pharma BV, Arnhem, The 
Netherlands), propranolol (Inderal®, 1 
mg·ml-1, Zeneca Farma BV, Ridderkerk, 
The Netherlands), and isoproterenol 
(Isoprenaline sulfaat, 1 mg·ml-1, Fresenius 
Kabi Nederland BV, The Netherlands) were 
dissolved in NaCl 0.9% at the beginning of  
each experiment.
Data analysis
Upper leg blood fl ow in ml·min-1·100ml-1 
was calculated as the slope of  the volume 
change curve. Because of  a cuff  infl ation 
artifact during the fi rst second, the slope 
from 2 – 6 seconds after cuff  infl ation 
was used. Upper leg blood fl ow values of  
the last 2 minutes of  each infusion were 
averaged to calculate upper leg blood fl ow.
Blood pressure signifi cantly changed 
during the course of  the intra-arterial 
phentolamine infusions. Therefore, upper 
leg vascular resistance was calculated as 
mean arterial pressure in mmHg divided 
by upper leg blood fl ow in ml·min-
1·100ml-1 and expressed in arbitrary units 
(AU=mmHg·min·100ml·ml-1). For these 
calculations, we assumed that central 
venous pressure was low and remained 
constant throughout the protocol.
Since structural differences in the vascular 
bed of  SCI individuals could non-
specifi cally affect the vasodilator response 
to phentolamine, the individual responses 
in vascular resistance to infusion of  
phentolamine were normalized to each 
subject’s minimal vascular resistance as 
assessed during reactive hyperemia. The 
maximal response (Emax) for each individual 
was determined using the maximal observed 
response to infusion of  phentolamine.
Statistics
Results are expressed as mean ± SEM. 
Differences in baseline characteristics and 
in the maximal effect of  phentolamine 
(Emax) between the groups were tested 
using the Mann-Whitney-U-test. The effect 
of  propranolol and differences between 
the last two doses of  phentolamine were 
tested with the Wilcoxon-test. Between 
group differences in response to infusion 
of  phentolamine were analyzed using two 
factor repeated measures ANOVA with 
the phentolamine dose as within subject 
factor and the presence of  a spinal cord 
lesion as between subject factor (Statistical 
Package for Social Sciences (SPSS) version 
10.0). The null hypothesis was formulated, 
as there were no differences between the 
groups in response to intra-arterial infusion 
of  phentolamine in upper leg vascular 
resistance.
A two-sided p-value of  less than 0.05 was 
considered to be statistically signifi cant.
Results
Confi rmation of the lack of supraspi-
nal sympathetic control
Individual responses in calf  vascular 
resistance of  8 spinal cord-injured 
individuals (SCI) and 9 controls are shown 
in Figure 2. The increase in calf  vascular 
resistance was signifi cantly less in SCI than 
in controls.
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In one spinal cord-injured individual (subject 
4, T10 spinal lesion), an obvious increase 
in vascular resistance was observed during 
the cold pressor test. For this reason, we 
excluded this individual from the analysis. 
Exclusion of  this subject did not have any 
effect on overall results.
Two spinal cord-injured individuals (subject 
8 and subject 9) could not participate in the 
cold pressor test. However, they both had 
complete spinal lesions at level Thoracic 
5, which makes an intact sympathetic 
innervation of  the legs unlikely.27
Baseline characteristics
The two groups did not differ with respect 
to age, systolic blood pressure, diastolic 
blood pressure, mean arterial pressure, 
heart rate, norepinephrine and epinephrine 
serum concentration. Body weight and thigh 
volume were signifi cantly lower in SCI than 
in controls.
Baseline upper leg blood fl ow was 
signifi cantly lower and leg vascular resistance 
was signifi cantly higher in SCI as compared 
with controls.
Maximal leg blood fl ow was lower and 
minimal leg vascular resistance were higher in 
SCI than in controls (Table 2).
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Individual responses of relative calf vascular resistance to the cold pressor test of the hand. Figure 2. 
Subject 8 and subject 9 did not participate in this part of the experiment. The dotted line represents 
subject 4, who is excluded from the analysis.
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Response to drug infusions in the 
infused leg
Propranolol infusion alone did not affect 
any of  the hemodynamic parameters 
(Table 3). Isoproterenol, co-infused with 
phentolamine and propranolol at the end 
of  the protocol in the control group, did 
not further change upper leg vascular 
resistance (15 ± 4 AU to 15 ± 5).
Upper leg blood fl ow increased signifi cantly 
and upper leg vascular resistance decreased 
signifi cantly in both groups in response to 
phentolamine infusion. No difference in 
upper leg vascular resistance was observed 
between the doses 12 and 24 μg·min-
1·100ml-1 of  phentolamine in both groups, 
indicating that in both groups a maximal 
effect of  phentolamine was observed 
(P>0.1 for both groups; see Table 3).
The increase in upper leg blood fl ow in 
response to infusion of  phentolamine was 
signifi cantly less in SCI compared with 
controls (P<0.001 for the effect of  dose 
in both groups, P<0.05 for the between 
group effect; see Table 3). However, the 
relative decrease in vascular resistance 
did not signifi cantly differ in response to 
phentolamine infusion between the SCI 
and controls in the infused leg (P>0.1 for 
the effect of  group and the dose by group 
interaction; see Figure 3a). The maximal 
responses in vascular resistance, expressed 
as percent change of  baseline, normalized 
to each individual’s minimal resistance 
(Emax) did not signifi cantly differ between 
the two groups (68 ± 17% and 51 ± 4% for 
the SCI group and controls, respectively; 
P>0.1; see Figure 4).
A signifi cant, and dose-dependent, decline 
Baseline characteristics. (Mean ± SEM)Table 2. 
SCI (N=9) C (N=8) p-value
Age (yr) 39 ± 2 36 ± 3 0.36
Body mass (kg) 71 ± 4 81 ± 4 0.13
Thigh volume (L) 4.9 ± 0.2 7.6 ± 0.4 <0.001
Systolic blood pressure (mmHg) 125 ± 5 132 ± 5 0.18
Diastolic blood pressure (mmHg) 73 ± 4 68 ± 2 0.50
Mean arterial pressure (mmHg) 92 ± 3 90 ± 2 0.63
Heart rate (min-1) 67 ± 4 60 ± 4 0.44
Upper leg blood fl ow (ml·min-1·100ml-1) 2.7 ± 0.5 4.3 ± 0.6 0.027
Upper leg vascular resistance (AU) 41 ± 6 24 ± 4 0.034
Maximal upper leg fl ow (ml·min-1·100ml-1) 14 ± 2 32 ± 3 0.001
Minimal upper leg vascular resistance (AU) 6.9 ± 1.0 2.5 ± 0.2 0.001
Epinephrine (nmol/l) 0.10 ± 0.01 0.29 ± 0.09 0.17
Norepinephrine (nmol/l) 1.51 ± 0.26 1.34 ± 0.20 0.91
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Mean percent change (± SEM) in upper leg vascular resistance (ULVR) ± SEM in response to Figure 3. 
infusion of incremental doses of phentolamine during local β-adrenergic blockade in the infused leg (A) 
and the non-infused leg (B). No diff erence in percent change between the groups was observed in the 
infused leg. ULVR of the non-infused leg in the controls increased during the fi rst doses, which was diff erent 
from the spinal cord-injured individuals, where ULVR decreased throughout the whole protocol (P<0.01 for 
the eff ect of group). Prop = propranolol infusion; ● = Spinal cord-injured individuals; ○ = Controls
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Eff ect of increasing dose of phentolamine on blood pressure, heart rate, and vascular tone of Table 3. 
the infused leg in SCI and controls.
SCI subjects (N=9) Controls (N=8)
Drug ULBF MAP ULVR HR ULBF MAP ULVR HR
NaCl 0.9% 2.7 ± 0.5 92 ± 3 41 ± 6 66 ± 4 4.3 ± 0.6 90 ± 2 24 ± 4 60 ± 4
Prop 2.8 ± 0.5 90 ± 3 40 ± 6 67 ± 4 4.2 ± 0.6 93 ± 3 24 ± 3 61 ± 4
Phe 0.375 3.5 ± 0.6 90 ± 3 31 ± 4 64 ± 4 4.7 ± 0.6 91 ± 3 21 ± 3 63 ± 5
Phe 0.75 3.7 ± 0.6 89 ± 3 29 ± 4 65 ± 4 5.4 ± 0.6 91 ± 2 19 ± 2 61 ± 4
Phe 1.5 4.0 ± 0.6 90 ± 3 27 ± 4 63 ± 3 5.6 ± 0.6 90 ± 2 18 ± 3 58 ± 4
Phe 3.0 4.2 ± 0.6 87 ± 3 25 ± 3 65 ± 3 6.1 ± 0.7 89 ± 2 16 ± 2 59 ± 4
Phe 6.0 4.4 ± 0.6 87 ± 3 23 ± 3 65 ± 3 6.7 ± 0.8 88 ± 2 15 ± 2 60 ± 4
Phe 12.0 4.3 ± 0.6 85 ± 3 23 ± 4 66 ± 3 6.8 ± 0.9 88 ± 2 15 ± 2 61 ± 4
Phe 24.0 4.2 ± 0.6 85 ± 3 24 ± 3 66 ± 3 6.8 ± 0.8 87 ± 2 14 ± 2 60 ± 4
   P<0.05 P<0.05 P<0.05 NS P<0.05 P<0.05 P<0.05 NS
ULBF: upper leg blood fl ow (ml·min-1·100ml-1); MAP: mean arterial pressure (mmHg); ULVR: upper leg 
vascular resistance (AU); HR: heart rate (beats/min); Prop: propranolol in a dose of 2 μg·min-1·100ml-1; 
Phe: phentolamine (dose in μg·min-1·100ml-1). P-values indicate the level of signifi cance for the eff ect of 
phentolamine dose on baseline values during propranolol infusion (repeated measures ANOVA)
Δ  N
or
m
al
iz
ed
 U
L
V
R
 (
%
)
-80
-60
-40
-20
0
20
Mean percent change (± SEM) of upper leg vascular resistance (ULVR) ± SEM in the infused leg, Figure 4. 
normalized to each individual’s minimal vascular resistance. Prop = propranolol infusion; ● = Spinal cord-
injured individuals; ○ = Controls
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in mean arterial pressure (MAP) was 
observed in both groups (P<0.01 for the 
effect of  phentolamine dose; see Table 3). 
Heart rate (HR) did not change in either 
group during the protocol.
Response to drug infusions in the non-
infused leg
In the non-infused leg, the controls showed 
a maximal increase in upper leg vascular 
resistance of  23.8 ± 5.1% at a dose of  1.5 
μg·min-1·100ml-1, which decreased slightly 
to 10.2 ± 5.4% at a dose of  24 μg·100ml-
1·min-1. In contrast, in the SCI group upper 
leg vascular resistance decreased with 22.8 
± 6.2 % throughout the incremental doses 
of  phentolamine. (P<0.01 for the effect of  
group; see Figure 3b).
Discussion
The major observation of  the present study 
is that α-adrenoceptor blockade in the legs 
of  spinal cord-injured individuals decreases 
the vascular resistance by 68% when 
normalized to each individual’s maximal 
vasodilator capacity. The decrease in 
vascular resistance is of  the same magnitude 
as in controls. To our knowledge, this is the 
fi rst observation that α-adrenergic tone 
of  the leg skeletal muscle vascular bed is 
preserved in individuals without supraspinal 
sympathetic control.
Upper leg blood fl ow is lower and upper 
leg vascular resistance is higher in SCI 
than in controls. This is in accordance with 
previous observations in an independent 
sample of  SCI and controls, using a different 
technique to measure leg blood fl ow.21 As 
previously discussed,21 this is most likely 
due to structural (a decrease in number of  
arterioles and capillaries and/or a decrease 
in diameter of  the resistance vessels) 
as well as functional changes. Indeed, 
previous research,6, 25 and the present 
observation that maximal vasodilatation 
during post-ischemic hyperemia is reduced 
in SCI, supports the concept that structural 
changes in SCI contribute to the reduced 
baseline leg blood fl ow. 
Phentolamine-induced upper leg 
vasodilatation in SCI, regardless the 
method of  expressing the results (relative 
or normalized), indicates preserved 
α-adrenergic vascular tone in these 
individuals. The absolute upper leg 
blood fl ow in response to infusion of  
phentolamine was less in SCI as compared 
with controls. This is due to structural 
changes in the leg vascular bed of  SCI 
since this apparent difference disappeared 
when results were normalized to the 
individual maximal vasodilator capacity of  
the upper leg vascular bed. In controls, the 
vasodilator response to phentolamine was 
very similar to the response observed by 
others in a similar group of  volunteers.2 
Therefore, methodological problems are 
not likely to explain the lack of  difference 
between the groups in vasodilator response 
to phentolamine in the present study. 
Since upper leg blood fl ow was lower in 
SCI than in controls, the same dose of  
phentolamine resulted in higher local plasma 
concentration of  phentolamine in the 
infused leg in SCI compared with controls. 
However, in both groups, a maximal 
vasodilator response to phentolamine was 
achieved. This is supported by the observed 
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plateau in upper leg vascular resistance in 
response to infusion of  the two highest 
doses of  phentolamine. Therefore, possible 
differences in plasma phentolamine 
concentration (these concentrations 
were not measured) cannot explain the 
similarity between the two groups in their 
maximal response in vascular resistance to 
phentolamine infusion. 
In addition, in both groups, blood 
pressure decreased during the course of  
the phentolamine infusions to a similar 
extent. This refl ects a systemic effect of  
local vasodilatation in a large vascular bed 
(infused leg). During the course of  the 
experiment, a spill of  phentolamine into the 
systemic circulation must have occurred, as 
refl ected by a decrease in upper leg vascular 
resistance in the non-infused leg in SCI. 
The drop in blood pressure will engage 
the barorefl ex, resulting in an increase in 
sympathetic tone to the heart and peripheral 
circulation. In theory, the barorefl ex-
mediated increase in sympathetic tone 
could have limited the vasodilator response 
to phentolamine in the infused leg of  the 
controls. However, this is very unlikely, 
since a possible refl ex vasoconstriction in 
the infused leg was prevented by the local 
infusion of  phentolamine.
The lack of  a barorefl ex-mediated increase 
in heart rate in both groups of  volunteers 
is explained by spill of  propranolol into 
the systemic circulation. Pilot studies 
clearly showed an increase in heart rate 
during infusion of  phentolamine without 
simultaneous infusion of  propranolol (data 
not shown). In the present study, subsequent 
blockade of  cardiac β-adrenergic receptors 
by propranolol prevented the barorefl ex-
mediated increase in heart rate.
The results observed in this study reject 
our hypothesis that α-adrenergic tone is 
reduced in SCI as compared to controls. 
However, the elevated upper leg vascular 
resistance in spinal cord-injured individuals 
cannot be explained completely by the 
preserved α-adrenergic tone since in both 
SCI as well as controls the contribution of  
α-adrenergic stimulation to the leg vascular 
tone is of  the same magnitude. In theory, 
several mechanisms may be responsible for 
the preserved α-adrenergic contribution 
in basal vascular tone in SCI. First, in the 
studied subjects, the spinal cord injury 
may have been incomplete or supraspinal 
control of  sympathetic outfl ow to the leg 
may have been restored. This explanation is 
excluded for several reasons. In fi ve of  the 
SCI, sweating was disturbed under the level 
of  the lesion, indicating loss of  autonomic 
control of  the skin. Furthermore, the lack 
of  a barorefl ex-mediated vasoconstriction 
in the non-infused leg in SCI as opposed to 
the controls, and the lack of  vasoconstriction 
in the calf  during the cold pressor test, 
indicates a lack of  supraspinal control of  
sympathetic outfl ow to the leg vasculature 
in SCI. A second reason for the preserved 
α-adrenergic tone in SCI may be related to 
the spinal sympathetic refl ex and the local 
venoarteriolar refl ex. A previous study 
reported that both spinal sympathetic refl ex 
activity and the venoarteriolar refl ex may 
contribute to leg muscle vasoconstriction 
during tilt in tetraplegic subjects,28 but 
very low sympathetic activity in cutaneous 
and muscle postganglionic axons situated 
below the level of  the spinal cord injury 
was measured in basal supine position.29, 
30 The venoarteriolar refl ex is elicited by 
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an increase in venous transmural pressure 
of  more than 25 mmHg31 and may be 
mediated by α-adrenoceptors,32 which 
has not been confi rmed by others.33 Thus, 
although spinal refl exes and venoarteriolar 
refl ex do not likely explain the preserved 
α-adrenergic tone, their role cannot 
completely be excluded.
Finally, α-adrenergic receptor 
hypersensitivity to circulating 
catecholamines, the serum concentration 
of  which was similar in both groups, 
could have preserved the α-adrenergic 
infl uence on basal vascular tone. Reduced 
local release of  norepinephrine may have 
induced a compensatory increase in either 
the sensitivity or number of  α-adrenergic 
receptors or the effi cacy of  post-receptor 
signaling.19, 20, 34 From the presenting data, 
it is not possible to assess α-adrenergic 
sensitivity since an α-adrenergic antagonist 
was used, which affi nity to the α-receptor is 
different from the affi nity of  α-adrenoceptor 
agonists, like norepinephrine. Further 
research should address the question of  
altered α-adrenoreceptor sensitivity in 
SCI.
A limitation of  this study is that we only 
used α-adrenergic blockade to assess the 
contribution of  the sympathetic nervous 
system in the control of  basal vascular 
tone below the level of  spinal cord injury. 
Other neurotransmitters, like adenosine 
triphosphate and neuropeptide Y, are 
released simultaneously with norepinephrine 
by the sympathetic nerve endings and cause 
vasoconstriction by activating P2x receptors 
and Y1 receptors, respectively.
35 Due to this 
limitation, we may have underestimated the 
contribution of  the sympathetic nervous 
system in the regulation of  basal vascular 
tone in controls and in individuals with a 
spinal cord lesion.
In conclusion, α-adrenergic contribution 
to basal vascular tone is preserved below 
the level of  the lesion in spinal cord-
injured individuals, and is of  the same 
magnitude as in controls. As such, the 
sympathetic nervous system is still a 
target for pharmacological intervention to 
improve the perfusion of  the leg in SCI. 
However, our results do not completely 
explain the elevated leg vascular resistance 
in SCI since the contribution of  the 
sympathetic nervous system to leg vascular 
tone in SCI is of  the same magnitude as in 
controls. Therefore, other factors, like for 
example impaired endothelium-mediated 
vasodilatation, could be responsible for the 
observed elevation of  leg vascular tone in 
SCI and should be subject of  investigation 
to further unravel the mechanisms behind 
the observed increase in leg vascular 
resistance in SCI.
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Abstract
Background – Deconditioning is a risk factor for 
cardiovascular disease. Exercise reduces this risk, 
possibly by improving the vascular endothelial nitric 
oxide (NO) pathway. The eff ect of deconditioning 
on the NO pathway is largely unknown. This study 
was designed to assess baseline NO availability 
in the leg vascular bed after extreme, long-term 
deconditioning (spinal cord-injured individuals, SCI) 
as well as after moderate, short-term deconditioning 
(4 weeks of unilateral lower limb suspension, ULLS).
Methods – For this purpose, seven SCI were 
compared with 7 matched controls. Additionally, 7 
healthy subjects were studied Pre- and Post-ULLS. 
Leg blood fl ow was measured by venous occlusion 
plethysmography at baseline and during infusion 
of 5 incremental dosages of NG-monomethyl-L-
arginine (L-NMMA) into the femoral artery. Sodium 
nitroprusside (SNP) was infused to test vascular 
responsiveness to NO.
Results – Baseline leg vascular resistance tended to be 
higher in SCI compared with controls (37 ± 4 versus 
31 ± 2 AU, P=0.06). Deconditioning did neither alter 
the vasoconstrictor response to L-NMMA (increase 
in resistance in SCI versus controls: 102 ± 33% versus 
69 ± 9%; Pre- versus Post-ULLS: 95 ± 18% versus 119 
± 15%), nor the vascular responsiveness to NO.
Conclusion – Two human in vivo models of 
deconditioning show a preserved baseline NO 
availability in the leg skeletal muscle vascular bed.
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Introduction
The endothelium plays a crucial role in 
the regulation of  vascular function and 
structure. Among the various mediators 
released by the endothelium, nitric oxide 
(NO) may be considered the most important 
vasodilator substance. The importance of  
the NO pathway is demonstrated by the 
strong link between endothelial dysfunction 
and cardiovascular disease.1 Various risk 
factors for cardiovascular disease, such as 
arterial hypertension, diabetes, smoking 
and hypercholesterolemia, are associated 
with defects in the NO pathway.1 
Reduced baseline NO production has been 
demonstrated in patients with hypertension 
and their offspring,2 in smokers,3 and in 
chronic heart failure patients.4 Exercise 
training enhances baseline NO production 
in healthy subjects,5 in patients with 
hypercholesterolemia,6 and in chronic 
heart failure patients.7 As such, the positive 
effect of  exercise on these conditions may 
be partly explained by augmentation of  
baseline NO availability.
A sedentary lifestyle is an independent risk 
factor for atherosclerosis and cardiovascular 
disease.8 Baseline blood fl ow to the 
deconditioned skeletal muscles is reduced.9-11 
In response to a reduction in blood fl ow, 
baseline NO synthesis may be attenuated, 
which triggers vascular remodelling and 
atherosclerosis.12, 13 Accordingly, Kamiya 
et al 9 showed a decrease in plasma nitrite/
nitrate concentration, an indicator of  
endogenous NO production, after head-
down bed rest, suggesting a diminished 
release of  endothelial NO. Therefore, we 
hypothesize that the contribution of  NO 
to baseline vascular tone is reduced in 
deconditioned skeletal muscle. We tested 
this hypothesis in two human in vivo models 
of  inactivity. The fi rst model concerns 
spinal cord-injured individuals (SCI). SCI 
offer a unique model of  nature to assess 
peripheral vascular adaptations to inactivity. 
In these individuals, the part of  the body 
below the level of  the lesion is subject to 
extreme and long-term deconditioning. 
Extensive vascular adaptations, including a 
reduction in baseline blood fl ow, occur in 
the leg vascular bed in SCI.11, 14 However, 
the legs of  SCI are not only subject to 
extreme deconditioning, but also to 
denervation. Therefore, a second model 
was used: unilateral lower limb suspension 
(ULLS). This model of  deconditioning is 
less extreme and limited in duration, but is 
not confounded by denervation. The ULLS 
model15 is based on the avoidance of  all 
weight bearing activities of  one leg, while 
the subject uses crutches for locomotion. 
The ULLS model induces muscle atrophy 
and a decrease in muscle strength.15-18
The purpose of  this study was to assess 
the effect of  extreme, long-term (SCI) and 
moderate short-term (ULLS) deconditioning 
on the contribution of  NO to baseline 
vascular tone in the human leg skeletal 
muscle vascular bed. To address this issue 
increasing dosages of  NG-monomethyl-
L-arginine (L-NMMA, a blocker of  NO-
synthase) and sodium nitroprusside (SNP, 
a NO donor) were infused into the femoral 
artery in spinal cord-injured individuals and 
matched controls, and in subjects before 
and after 4 weeks of  ULLS.
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Methods
Subjects
In total, 19 subjects participated and 
underwent the same tests to assess the 
contribution of  NO to baseline vascular 
tone. In a fi rst study, 7 male SCI, with 
extreme, long-term deconditioning, were 
compared with 7 controls, matched for 
gender and age. In a second study, 7 healthy 
subjects (3 males, 4 females) were measured 
twice, once before and once 4 weeks after 
short-term deconditioning by ULLS. Two 
of  these subjects also served as controls for 
the SCI.
SCI suffered from a complete motor and 
sensor spinal cord lesion of  traumatic 
origin varying from Cervical 5 – Thoracic 
12 (American Spinal Injury Association 
ASIA A). The level of  the spinal lesion was 
assessed by clinical examination. One of  the 
SCI used baclofen (10 mg daily) throughout 
the study. Three females in the ULLS study 
used oral contraceptives. During their Pre-
ULLS and Post-ULLS measurements, all 
females were in the same phase of  their 
menstrual or contraceptive pill cycle.
All subjects met the inclusion criteria: age 
18-50 years; non-smokers; diastolic blood 
pressure below 90 mmHg; normal fasting 
glucose, cholesterol, and triglyceride values. 
Thus, individuals with the most important 
risk factors that could affect endothelial 
function, in particular baseline NO 
production, were excluded from the study. 
Baseline characteristics are shown in Table 
1. In the ULLS study, subjects exercised 2.1 
± 0.7 hours per week. Exercise in the SCI 
(4.9 ± 0.8 hours per week) consisted of  
voluntary arm exercise. This type of  upper 
body exercise is limited by the amount of  
active muscle mass19 and does not affect 
the leg vasculature.20 The Hospital Ethics 
Committee approved the study. All subjects 
gave their written informed consent prior 
to the study. The study conforms with the 
principles outlined in the Declaration of  
Helsinki.
Experimental procedures
Leg blood flow measurement
All subjects fasted overnight, and refrained 
from caffeine and alcohol for 24 hours. 
All subjects emptied their bladder before 
testing to minimize the infl uence of  refl ex 
sympathetic activation on vascular tone. All 
tests were performed in the morning with 
the subjects in supine position in a quiet 
temperature-controlled room (23-24°C).
The technique of  leg blood fl ow 
measurements in combination with drug 
infusions into the femoral artery has been 
described previously.14 A cannula (Angiocath 
16 gauge, Becton Dickinson, Sandy, Utah, 
USA) was introduced into the femoral 
artery of  the leg using a modifi ed Seldinger 
technique. The intra-arterial cannula was 
used for drug administration and for 
blood pressure measurement. Heart rate 
was derived from the electrocardiogram. 
In control and ULLS subjects, local 
anaesthesia (4 ml lidocaine 20 mg/ml) was 
applied. Because of  the lack of  sensibility 
no anaesthesia was used in SCI. 
Bilateral upper leg blood fl ow was measured 
by electrocardiography-triggered venous 
occlusion plethysmography, using mercury-
in-silastic strain gauges placed approximately 
Chapter 3
52
10 cm proximal to the patella. We have 
previously shown that the reproducibility 
of  upper leg blood fl ow measurements is 
good.21 The thigh cuffs were simultaneously 
infl ated to 50 mmHg using a rapid cuff  
infl ator (Hokanson E-20, D.E. Hokanson, 
Bellevue, Washington, USA).22 Cuffs below 
the knee were infl ated to suprasystolic levels 
(> 200 mmHg) in order to occlude the 
calf  circulation. This way, the use of  high 
doses of  drugs, with subsequent systemic 
effects, could be minimized. To prevent 
discomfort, infusions were interrupted 
every ten minutes and the calf  circulation 
was restored for 5 minutes.
Drug infusion protocol
The drug infusion protocol is represented at 
the bottom of  Figure 1. The measurements 
started at least 30 minutes after cannulation 
of  the femoral artery. Each drug dose was 
administered for 5 minutes. First, baseline 
leg blood fl ow was measured during saline 
(NaCl 0.9%) infusion. Subsequently, 
L-NMMA was infused into the femoral 
artery at incremental doses of  0.025–
0.05–0.1–0.2–0.4 mg/min per decilitre 
(dl) of  upper leg volume. In a pilot study 
with doses up to 0.8 mg/min/dl maximal 
vasoconstriction was already achieved at 0.2 
and 0.4 mg/min/dl. Subsequently, glucose 
5% was infused followed by infusion of  
increasing dosages of  the NO donor 
sodium nitroprusside (SNP, 0.06–0.2–0.6 
μg/min/dl). Sodium nitroprusside was 
infused to explore differences in smooth 
muscle sensitivity to exogenous NO. A 
one-hour washout period was scheduled 
before angiotensin II infusion. Angiotensin 
II (0.25–0.5–2.0 ng/min/dl) served 
as a control vasoconstrictor to detect 
differences in vasoconstrictor capacity due 
to structural vascular changes induced by 
deconditioning. During the whole protocol, 
infusion rate was kept constant at a volume 
rate of  10 μl/min/dl.
Drugs and solutions
NG-monomethyl-L-arginine and angiotensin 
II (both from Clinalfa, Läufl ingen, 
Switzerland) were dissolved in saline at 
the beginning of  each experiment. Sodium 
nitroprusside (department of  Clinical 
Pharmacy, Radboud University Nijmegen 
Medical Centre) was dissolved in glucose 
5% and protected against light.
Upper leg volume measurement
Upper leg volume was determined by 
anthropometry as described by Jones et 
al.23
ULLS protocol
In seven subjects, the right leg was exposed 
to deconditioning induced by 4 weeks of  
ULLS. We used a ULLS model very similar 
to the original description by Berg.15 The 
right leg was suspended by attachment of  
a sling to a non-rigid ankle brace and to a 
harness on the upper body and unloaded 
from all weight bearing. Sole elevation 
of  the contra-lateral foot was not used, 
because it produced instability of  the leg. 
The harness was used during all locomotor 
activity, and the subjects used crutches for 
walking. Instructions were provided to 
minimize muscle activity of  the suspended 
leg. Compliance was monitored with a diary, 
weekly interviews, and leg skin temperature. 
Skin temperature was consistently 1-2ºC 
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lower in the unloaded thigh and calf  versus 
the control leg.
Strength measurement
In order to test the effectiveness of  ULLS 
to induce deconditioning, the strength 
of  the quadriceps muscle was quantifi ed. 
Maximum voluntary contraction (Newton) 
of  the quadriceps muscle of  both legs 
was assessed with an isometric quadriceps 
dynamometer24 before and after 4 weeks of  
ULLS. The hips and knees were positioned 
at 90º and 60º of  fl exion, respectively. The 
highest obtained result of  three consecutive 
measurements represented the maximum 
voluntary contraction. This method has an 
acceptable reproducibility with a coeffi cient 
of  variance of  10.2%.
Data analysis
Upper leg blood fl ow in ml/min/
dl was calculated as the slope of  the 
plethysmographic volume curve, as 
described previously.14 Leg blood fl ow 
values of  the fi nal 2 minutes of  each 
5-minute infusion period were averaged.
Blood pressure signifi cantly changed during 
the course of  the experiment. Therefore, 
upper leg vascular resistance (LVR) was 
calculated as mean arterial pressure (MAP, 
in mmHg) divided by leg blood fl ow in 
ml/min/dl and expressed in arbitrary 
units (AU=mmHg·min/ml/dl). For these 
calculations, we assumed that central 
venous pressure was low and remained 
constant throughout the protocol.
We used the fi rst baseline measurement 
(during saline infusion) to calculate the 
percentage change in outcome parameters 
during infusion of  L-NMMA and SNP. 
Glucose 5% and SNP were infused 
immediately after infusion of  L-NMMA. 
The NO donor SNP directly affects the 
vascular smooth muscle cell and overrules 
the effect of  L-NMMA, so the effect of  
L-NMMA during infusion of  SNP can be 
ignored. To calculate the percentage change 
during angiotensin II infusion, the baseline 
measurement directly prior to angiotensin 
II infusion was used. In order to control 
for changes in vasoconstrictor capacity 
by deconditioning, the vasoconstrictor 
response to L-NMMA was normalized to 
the average vasoconstrictor response to 
angiotensin II.
Statistics
Results represent means ± SEM. Differences 
in baseline characteristics between SCI 
and controls were tested using the Mann-
Whitney-U-test. Changes in strength, leg 
volume, and body mass after ULLS were 
tested with Wilcoxon signed rank test. For 
SCI and matched controls, differences in the 
response to infusion of  drugs were analyzed 
using two-way repeated measures ANOVA 
with the drug dose as within subject factor 
and the presence of  a spinal cord lesion 
as between group factor. For ULLS, a two 
factor repeated measures ANOVA was 
used with the drug dose and Pre- or Post-
ULLS as within subject factors. Differences 
in response between drug doses were tested 
with the least signifi cant difference post-hoc 
test (Statistical Package for Social Sciences 
(SPSS) 11.0). Differences were considered 
to be statistically signifi cant at a two-sided 
P-value of  less than 0.05. 
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Results
Eff ects of extreme, long-term decondi-
tioning (SCI) on baseline parameters
SCI and matched controls did not differ 
with respect to age and blood pressure. 
Related to their spinal cord lesion, thigh 
volume and body mass were lower in SCI 
compared with controls (Table 1). Baseline 
leg blood fl ow tended to be lower (2.8 ± 0.5 
versus 3.3 ± 0.2 ml/min/dl, P=0.064) and 
LVR tended to be higher (37 ± 4 versus 31 
± 2 AU, P=0.064) in SCI compared with 
controls.
Eff ects of moderate, short-term 
deconditioning (ULLS) on baseline 
parameters
Body mass and thigh volume did not 
change after ULLS (Pre versus Post: 71.8 
± 4.6 versus 72.1 ± 4.6 kg, and 6.7 ± 0.5 
versus 6.7 ± 0.5 litre, respectively). After 4 
weeks of  ULLS, strength of  the quadriceps 
muscle decreased by 22.2 ± 8.3% (P<0.05). 
Strength of  the control leg quadriceps 
muscle did not change (-1.8 ± 14.0%). 
ULLS did neither alter baseline leg blood 
fl ow, nor LVR (Pre versus Post: 3.9 ± 0.7 
versus 4.5 ± 0.9 ml/min/dl and 26 ± 3 
versus 23 ± 3 AU, respectively).
Response to L-NMMA
Leg vascular resistance (LVR) increased 
signifi cantly in all groups during L-NMMA 
infusion (P<0.01). The responses of  LVR 
to L-NMMA, expressed as percentage of  
baseline LVR, were not different between 
SCI (extreme, long-term deconditioning) 
and matched controls (Figure 1A). The 
response of  LVR to L-NMMA in SCI 
was also compared to the data of  all 12 
controls (including 5 additional control 
subjects from the Pre-ULLS study), 
Baseline characteristics.Table 1. 
Extreme deconditioning Moderate 
deconditioning
SCI (n=7) Controls (n=7) ULLS-subjects (n=7)
Age (years) 38 ± 2 32 ± 5 24 ± 2
Body mass (kg) 71.1 ± 5.4 81.4 ± 3.6* 71.8 ± 4.6
Upper leg volume (L) 5.0 ± 0.3 7.1 ± 0.4† 6.7 ± 0.5
Systolic blood pressure (mmHg) 123 ± 6 124 ± 4 114 ± 2
Diastolic blood pressure (mmHg) 76 ± 2 83 ± 3 77 ± 3
Triglycerides (mmol /l) 1.3 ± 0.3‡ 1.4 ± 0.3 1.2 ± 0.2
Cholesterol (mmol /l) 4.6 ± 0.4‡ 4.5 ± 0.3 4.4 ± 0.2
Glucose (mmol /l) 4.5 ± 0.3 4.7 ± 0.1 4.9 ± 0.1
Exercise (hours per week) 4.9 ± 0.8 3.9 ± 0.8 2.1 ± 0.7
Values represent means ± SEM. * P = 0.047 versus SCI. † P = 0.006 versus SCI. ‡ Data are from 6 subjects.
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but again no difference in response was 
detected. Likewise, moderate short-term 
deconditioning (ULLS) did not affect the 
response of  LVR to infusion of  L-NMMA 
(Figure 1B). All these observations were 
similar when the absolute instead of  the 
relative (%) changes in the LVR were 
analyzed. After normalizing the response to 
L-NMMA to the individual mean response 
to angiotensin II (for data of  angiotensin 
II response see next paragraph), again no 
differences were observed between SCI 
and controls, nor between Pre- and Post-
ULLS. 
Eff ect of L-NMMA, SNP and angiotensin II on blood pressure, heart rate, and vascular tone in Table 2. 
SCI and controls.
Drug dose SCI (n=7) Controls (n=7)
(dose/
min/dl)
MAP HR LBF LVR MAP HR LBF LVR
Infusion Control Infusion Control
L-NMMA
Saline 91 ± 4 57 ± 4 2.8 ± 0.5 37 ± 4 34 ± 5 98 ± 4 57 ± 3 3.3 ± 0.2 31 ± 2 33 ± 2
0.025 mg 91 ± 4 58 ± 5 2.4 ± 0.4 43 ± 5 36 ± 4 100 ± 5 56 ± 3 2.6 ± 0.2 40 ± 3 35 ± 2
0.05 mg 94 ± 4 56 ± 5 2.2 ± 0.4 47 ± 5 33 ± 4 99 ± 4 58 ± 3 2.6 ± 0.1 40 ± 3 35 ± 2
0.1 mg 95 ± 5 55 ± 6 1.9 ± 0.3 56 ± 7 36 ± 5 100 ± 4 57 ± 3 2.3 ± 0.2 47 ± 4 33 ± 3
0.2 mg 96 ± 4 53 ± 4 1.8 ± 0.3 71 ± 16 37 ± 6 102 ± 4 55 ± 3 2.2 ± 0.1 49 ± 3 33 ± 3
0.4 mg 101 ± 4 54 ± 4 1.6 ± 0.2 71 ± 11 39 ± 5 105 ± 4 57 ± 3 2.1 ± 0.1 52 ± 3 30 ± 2
* * * * † * * * * ‡
SNP
Glucose 104 ± 4 53 ± 4 2.0 ± 0.2 54 ± 5 40 ± 7 109 ± 3 55 ± 5 2.9 ± 0.2 39 ± 2 30 ± 3
0.06 μg 105 ± 4 52 ± 5 3.1 ± 0.5 37 ± 4 42 ± 5 106 ± 4 58 ± 4 4.9 ± 0.6 25 ± 4 34 ± 3
0.2 μg 92 ± 4 56 ± 5 4.4 ± 0.8 25 ± 3 35 ± 5 101 ± 5 58 ± 4 5.3 ± 0.6 21 ± 3 39 ± 6
0.6 μg 83 ± 4 64 ± 5 5.5 ± 1.0 18 ± 2 33 ± 7 96 ± 5 67 ± 5 7.7 ± 0.9 15 ± 3 35 ± 6
* * * * * * * *
ANG II
Saline 103 ± 4 56 ± 5 2.2 ± 0.4 56 ± 12 43 ± 7 105 ± 4 60 ± 5 3.1 ± 0.4 37 ± 5 34 ± 3
0.25 ng 106 ± 3 56 ± 5 1.7 ± 0.3 80 ± 18 46 ± 9 109 ± 5 61 ± 6 2.4 ± 0.3 51 ± 6 34 ± 3
0.5 ng 106 ± 4 55 ± 5 1.5 ± 0.3 105 ± 32 55 ± 20 109 ± 5 63 ± 6 2.3 ± 0.2 53 ± 6 33 ± 3
2.0 ng 112 ± 5 57 ± 6 1.4 ± 0.3 124 ± 36 55 ± 17 112 ± 5 62 ± 5 1.8 ± 0.2 73 ± 12 32 ± 4
* * * * * *
Values represent means ± SEM. MAP, mean arterial pressure (mmHg); HR, heart 
rate (beats/min); LBF, leg blood fl ow (ml/min/dl); LVR, leg vascular resistance 
(AU); Infusion, the infused leg; Control, the non-infused leg. Ang II, angiotensin II.
signifi cant dose eff ect for both groups (P<0.05, two-way-ANOVA). † trend to signifi cant interaction for 
dose x group (P=0.069). ‡ signifi cant dose eff ect (P<0.05, one-way-ANOVA).
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In SCI, the matched controls and in the Pre-
ULLS-tests, the maximal vasoconstrictor 
response to L-NMMA was already 
achieved at the dose of  0.2 mg/min/dl. 
As a consequence, doubling of  the dose 
to 0.4 mg/min/dl did not induce a further 
vasoconstrictor response, indicating that 
maximal NO inhibition was achieved. In 
the Post-ULLS-tests, LVR increased further 
at the dose of  0.4 mg/min/dl (P=0.031). 
However, pilot studies in healthy volunteers 
showed that increasing the L-NMMA-dose 
to 0.8 mg/min/dl did not further increase 
LVR (LVR 46 ± 4, 45 ± 5, and 48 ± 4 AU 
during 0.2, 0.4 and 0.8 mg L-NMMA/min/
dl, respectively, n=3). 
Eff ect of L-NMMA, SNP and angiotensin II on blood pressure, heart rate, and vascular tone Table 3. 
Pre- and Post-ULLS
Drug 
dose
Pre-ULLS (n=7) Post-ULLS (n=7)
(dose/
min/dl)
MAP HR LBF LVR MAP HR LBF LVR
Infusion Control Infusion Control
L-NMMA
Saline 90 ± 2 62 ± 3 3.9 ± 0.7 26 ± 3 29 ± 4 90 ± 2 67 ± 4 4.5 ± 0.9 23 ± 3 26 ± 3
0.025 mg 92 ± 2 62 ± 3 3.3 ± 0.6 32 ± 4 30 ± 4 91 ± 2 67 ± 4 4.2 ± 0.9 27 ± 4 28 ± 4
0.05 mg 92 ± 2 60 ± 3 2.8 ± 0.4 37 ± 4 30 ± 4 93 ± 2 65 ± 3 3.3 ± 0.7 34 ± 5 30 ± 5
0.1 mg 94 ± 2 63 ± 3 2.5 ± 0.3 41 ± 4 28 ± 4 95 ± 3 66 ± 4 2.8 ± 0.5 40 ± 6 29 ± 4
0.2 mg 97 ± 2 60 ± 3 2.2 ± 0.2 46 ± 4 30 ± 4 96 ± 2 63 ± 4 2.6 ± 0.4 43 ± 6 30 ± 5
0.4 mg 99 ± 2 60 ± 3 2.1 ± 0.2 49 ± 4 28 ± 3 99 ± 3 64 ± 3 2.3 ± 0.3 51 ± 7 29 ± 5
* * * * * * * *
SNP
Glucose 101 ± 2 61 ± 4 3.0 ± 0.3 36 ± 3 27 ± 4 98 ± 2 59 ± 3 2.9 ± 0.4 37 ± 4 28 ± 4
0.06 μg 100 ± 1 62 ± 4 5.7 ± 0.9 21 ± 3 28 ± 4 98 ± 2 65 ± 4 5.3 ± 0.9 22 ± 3 29 ± 4
0.2 μg 95 ± 2 62 ± 3 6.3 ± 1.4 19 ± 3 30 ± 3 93 ± 2 66 ± 4 6.4 ± 1.5 18 ± 3 31 ± 4
0.6 μg 90 ± 1 72 ± 4 8.0 ± 1.5 14 ± 3 34 ± 5 90 ± 3 72 ± 3 8.3 ± 1.7 13 ± 2 35 ± 6
* * * * * * * * * *
ANG II
Saline 97 ± 2 65 ± 4 3.5 ± 0.6 32 ± 4 31 ± 4 97 ± 2 66 ± 5 4.4 ± 1.1 31 ± 6 32 ± 7
0.25 ng 101 ± 2 67 ± 3 2.9 ± 0.5 41 ± 5 28 ± 5 101 ± 3 71 ± 4 3.5 ± 0.8 40 ± 8 29 ± 6
0.5 ng 100 ± 2 66 ± 4 2.6 ± 0.4 44 ± 5 26 ± 4 99 ± 2 69 ± 4 2.9 ± 0.8 46 ± 8 29 ± 6
2.0 ng 106 ± 3 68 ± 4 2.1 ± 0.2 55 ± 5 27 ± 5 105 ± 2 72 ± 5 2.0 ± 0.4 63 ± 10 28 ± 6
* * * * * * * *
Values represent means ± SEM. MAP, mean arterial pressure (mmHg); HR, heart rate (beats/min); LBF, 
leg blood fl ow (ml/min/dl); LVR, leg vascular resistance (AU); Infusion, the infused leg; Control, the non-
infused leg. Ang II, angiotensin II.
* signifi cant dose eff ect for both groups (P<0.05, two-way-ANOVA).
Preserved NO contribution
57
L-NMMA induced a signifi cant and dose-
dependent increase in MAP (P<0.001), 
which did not signifi cantly differ between 
SCI and controls, and between Pre- and 
Post-ULLS tests (Table 2 and Table 3). SCI 
and their controls and the ULLS-subjects 
showed a decrease in HR during L-NMMA 
infusion (Table 2 and 3).
Response to SNP
Neither the absolute nor the relative (%) 
response of  LVR to SNP differed between 
SCI and controls (Table 2, Figure 1A). This 
also holds for the Pre- versus Post-ULLS 
response to SNP (Table 3, Figure 1B). MAP 
decreased in all groups during the higher 
dosages of  SNP (P<0.001, Table 2 and 3). 
Response to angiotensin II
The absolute and relative (%) responses of  
LVR to angiotensin II (Table 2, Figure 1) 
were not different in SCI compared with 
controls. The absolute responses of  LVR 
to angiotensin II (Table 3) was not different 
in Pre- versus Post-ULLS. In all groups, 
MAP increased signifi cantly during the 
higher dosages of  angiotensin II (P<0.001, 
Table 2 and 3). This increase in MAP was 
not different in SCI versus controls nor in 
Pre-ULLS versus Post-ULLS. HR did not 
change signifi cantly in either group.
 Adverse eff ect of ULLS
Originally 8 subjects participated in the 
ULLS-protocol. One subject developed a 
deep venous thrombosis of  the suspended 
leg during ULLS and was excluded from 
the study. We have reported separately on 
this serious adverse effect of  ULLS and 
have proposed precautionary measures.25 
Change in leg vascular resistance in response to L-NMMA (0.025-0.05-0.1–0.2–0.4 mg/Figure 1. 
min/dl of leg tissue), SNP (0.06–0.2–0.6 μg/min/dl), and angiotensin II (Ang II 0.25–0.5–2.0 ng/min/
dl). A Spinal cord-injured individuals versus matched controls (closed and open circles, respectively). 
B Healthy subjects before and after ULLS (open and closed circles, respectively). Data represent 
means and SEM.
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Discussion
The present study showed that, in contrast 
to our hypothesis, the contribution of  NO 
to baseline vascular tone is not affected 
by deconditioning of  human skeletal 
muscle. This is remarkable since exercise 
increases the contribution of  NO to 
baseline vascular tone.5 Therefore, effects 
of  deconditioning are not the inverse of  
effects of  exercise training. Preserved 
contribution of  NO to baseline vascular 
tone was confi rmed in both extreme, 
long-term (SCI) and moderate, short-
term (ULLS) deconditioning. Infusion of  
L-NMMA into the femoral artery increased 
basal LVR to a similar extent in SCI versus 
matched controls, as well as in Pre- versus 
Post-ULLS. Second, the response to the 
NO donor sodium nitroprusside was 
similar in SCI versus controls, and in Pre- 
versus Post-ULLS, indicating equal smooth 
muscle responsiveness to NO. Third, the 
vasoconstrictor response to angiotensin II 
did not differ between SCI and controls or 
between Pre- and Post-ULLS, indicating 
that there were no non-specifi c changes 
in vasoconstrictive capacity in both 
models. The latter observation is further 
strengthened by the fact that the response 
to L-NMMA normalized to the individual 
mean angiotensin II response did not differ 
in SCI versus controls, nor in Pre- versus 
Post-ULLS. 
Deconditioning below the spinal cord lesion 
is an important consequence in SCI. In the 
SCI subjects in this study, leg volume was 
lower, indicating muscle atrophy, leg blood 
fl ow tended to be lower and LVR tended to 
be higher compared with controls. This is in 
accordance with previous observations of  a 
signifi cantly higher leg vascular resistance in 
SCI as compared with controls.26 While in 
our study, ULLS did not lower baseline leg 
blood fl ow, as assessed by plethysmography, 
we are confi dent that deconditioning did 
occur. Using echo Doppler ultrasound, 
we demonstrated that the diameter of  the 
common and superfi cial femoral artery 
signifi cantly decreased after ULLS in the 
same group of  subjects, while overall blood 
fl ow in these arteries was unchanged.27 
This corresponds with ultrasound data on 
diameter and blood fl ow in SCI.28 Changes 
in diameter without alterations in baseline 
blood fl ow have also been shown in training 
studies, where an increase in femoral artery 
diameter occurred without changes in 
baseline blood fl ow.29 Finally, since there was 
a signifi cant decrease of  22% in strength 
of  the quadriceps muscle, the ULLS 
model evidently caused deconditioning 
of  the leg. This decrease in maximum 
voluntary contraction closely agrees with 
previous reports of  a 13-21% reduction 
after 10 days to 6 weeks of  unloading, 
which was invariably accompanied by 
muscular atrophy as assessed by MRI or 
CT measurements.16-18, 30, 31
We assessed the contribution of  NO to 
baseline vascular tone by quantifying the 
vasoconstrictor response to L-NMMA. 
Fundamental to this technique is 
achievement of  maximal inhibition of  
NO-synthase. In our SCI, their matched 
controls, and in the Pre-ULLS-tests, LVR 
did not further increase during the fi nal 
L-NMMA dose, which indicates that 
a maximal vasoconstrictor effect was 
achieved. This maximal vasoconstrictor 
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response to L-NMMA (L-NMMA caused 
a 35-40% decrease in leg blood fl ow in the 
controls of  the SCI-study and before ULLS) 
is very similar to a 31% decrease in forearm 
blood fl ow when L-NMMA is infused into 
the brachial artery of  healthy subjects.32 
So, despite the dependent position of  
the leg to the heart during standing, the 
contribution of  NO to baseline vascular 
tone seems comparable in the vascular 
beds of  the leg and arm. The maximal dose 
of  L-NMMA used in previous studies was 
comparable to our 0.1 mg/min/dl dose.5, 33 
If, in analogy with these studies, we limited 
the analysis to the lower three doses, our 
results and conclusion did not change. 
After ULLS, the vasoconstrictor response 
to the fi nal L-NMMA dose (0.4 mg/min/
dl) was higher than with the previous 
dose (0.2 mg/min/dl). Although this may 
indicate that maximal vasoconstriction 
was not achieved, data from a pilot study 
showed that the higher dose of  0.8 mg/
min/dl of  L-NMMA did not cause further 
vasoconstriction in the leg of  healthy 
volunteers. Finally, if  the vasoconstrictor 
response to L-NMMA was not maximal in 
the Post-ULLS test, then this would point 
towards augmented NO-mediated effects 
by moderate deconditoning. Augmented 
NO-mediated effects by deconditioning 
would be a strong argument against our 
hypothesis. 
The results of  the present study indicate that 
short-term and long-term deconditioning 
of  skeletal muscle does not reduce the 
contribution of  NO to baseline vascular 
tone in humans. Therefore, the observed 
increase in vascular resistance after 
deconditioning9, 10, 26 cannot be explained 
by a reduced role of  NO in baseline 
vascular tone. Training, i.e. the opposite of  
deconditioning, caused an increased basal 
NO production in the forearm vascular 
bed of  both healthy individuals5 and 
hypercholesterolemic patients,6, 34 and an 
increase in nitrite-nitrate level after 8 weeks 
of  cycle training.35 Since these studies 
suggest that exercise can improve baseline 
NO availability in humans, the results 
of  the present study were unexpected. 
Data on the effects of  long-term training 
(months-years) on endothelial function are 
limited. However, baseline NO production 
was similar in endurance trained athletes 
and controls.36 It has been proposed that 
changes in endothelial function represent 
short-term adaptations to training and are 
eventually replaced by structural or other 
adaptations.37 This is illustrated by the 
observation that the endothelial function 
in forearm vessels of  long-term tennis 
players was similar in the dominant and 
non-dominant arm.38 One should take 
notice that these subjects played tennis for 
13 hours per week and that this may have 
resulted in concomitant training of  the 
non-dominant arm. 
Data on the effects of  deconditioning on 
the NO pathway are scarce. In agreement 
with our results, deconditioning induced 
by casting for arm fractures, does not 
change the vasoconstrictor response to 
infusion of  L-NMMA in the forearm in a 
cross-sectional study after cast removal.33 
Our data provide additional information, 
since they are derived from both a cross-
sectional and a longitudinal intervention 
study, and are not biased by the effects 
of  trauma and fracture healing on 
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baseline blood fl ow. Plasma nitrite-nitrate 
concentration decreased in one bed rest 
study,9 suggesting an impaired endothelial 
NO production, while in another bed rest 
study, no changes in urinary nitrite-nitrate 
excretion occurred.39 As compared with the 
nitrite-nitrate method, which refl ects total 
body NO metabolism, our approach more 
specifi cally quantifi es the role of  NO in 
baseline vascular tone after deconditioning. 
Previous animal studies have mimicked 
physical inactivity by hindlimb unloading 
and report confl icting results. Some studies 
demonstrate a decreased eNOS expression 
in the endothelial cells of  both conductance 
and resistance vessels, and an attenuated 
maximal vasodilatation to acetylcholine 
suggesting a decrease of  endothelial NO 
release by hindlimb unloading.40-42 In 
contrast, another study demonstrated no 
alterations of  endothelial NOS expression, 
but an increase in aortic inducible NOS 
content following hindlimb unloading.43
After reduction of  blood fl ow in animals by 
partial ligation of  conduit arteries, baseline 
NO synthesis is reduced, which may trigger 
arterial remodelling and atherosclerosis.12, 13 
However, the present study suggests that 
a reduction in blood fl ow or increase in 
vascular tone in humans is not explained 
by a diminished endogenous NO release 
under baseline conditions. Although, in the 
present study baseline NO synthesis is not 
affected, the NO release upon different 
stimuli may still play a role in arterial 
remodelling and in the vulnerability to 
atherosclerosis. Nevertheless, application 
of  a stimulus is an artifi cial setting, since it 
is highly unlikely that the leg vascular bed 
of  SCI is exposed to triggers that increase 
NO release. In this regard, it is interesting 
to realize that fl ow-mediated dilatation of  
the superfi cial femoral artery, based on 
endothelial NO release in response to a 
shear stress stimulus, is preserved and seems 
to be enhanced in the chronically inactive 
legs of  SCI28 and after 4 weeks of  ULLS.27 
However, these data are derived from a 
conduit artery in response to a shear stress 
stimulus and cannot predict the response 
to acetylcholine or comparable drugs on 
the arteriolar level.44 Moreover, in animals 
the short-term and long-term effects of  
exercise training on the NO pathway differ 
between conduit and resistance arteries.45
 
In the SCI and the ULLS model, the physical 
inactivity is most prominent in the part of  
the body below the spinal cord lesion and 
in the suspended leg, respectively. One 
might argue that increased activity of  the 
upper body and of  the non-suspended leg 
could have systemic effects on endothelial 
function, masking the effect of  inactivity 
on endothelial NO release. However, in the 
ULLS subjects the physical activity score 
tended to be lower after ULLS arguing 
against a training effect of  walking with 
crutches. It has been debated whether the 
effects of  training on endothelial function 
are localized or systemic in nature. Leg 
training causes changes in baseline NO 
production5 and improves endothelial 
function46 in the arms. However, evidence 
exists that changes in endothelial 
function occur predominantly locally in 
the exercised limbs.47-49 In SCI, neither 
systemic cardiovascular effects50 nor local 
vascular effects of  deconditioning20 can 
be normalized with upper body training. 
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Recently, Thijssen et al 51 demonstrated 
that the adaptation to leg exercise is a 
local phenomenon and only occurs in the 
stimulated leg muscles. Collectively these 
data provide evidence that upper arm 
exercise and even exercise of  adjacent 
muscle by electrical stimulation does not 
affect the vasculature in the non-exercised 
leg muscles in SCI. Based on the previous 
arguments we believe that our results are 
not confounded by systemic effects of  
increased upper body physical activity. 
In the present study, we used spinal cord 
injury as a unique model of  nature to 
investigate adaptations in the peripheral 
circulation in response to extreme 
deconditioning. As valuable as information 
is from this patient population, one 
should be cautious to extrapolate this 
information to the general population, 
since other conditions unique to spinal 
cord injury can infl uence the results, 
such as impaired supraspinal sympathetic 
control. However, recent human studies 
have shown that endothelial function does 
not change after chronic sympathectomy.52 
In addition, adaptations in the circulatory 
system in SCI are reversible by functional 
electrostimulation training,26, 53 providing 
more evidence that these adaptations 
primarily result from deconditioning. 
We used ULLS as a second model of  
deconditioning. Since healthy subjects 
participated in this part of  the study, loss of  
supraspinal control was not a confounder. 
The observations on the NO pathway in 
the ULLS-studies are in close agreement 
with the observations in the SCI-study. 
In conclusion, the results of  the present 
study demonstrate a preserved contribution 
of  NO to baseline vascular tone in 
deconditioned leg skeletal muscle in man.
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Abstract 
Background – Flow-mediated dilatation (FMD) of the 
brachial and radial arteries is an important research 
tool for assessment of endothelial function in vivo, and 
is nitric oxide (NO)-dependent. The leg skeletal muscle 
vascular bed is an important territory for studies in 
exercise physiology. However, the role of endothelial 
NO in the FMD response of lower limb arteries has 
never been investigated. The purpose of this study 
was to examine the contribution of NO to FMD in the 
superfi cial femoral artery in healthy subjects. Since 
physical inactivity may aff ect endothelial function, 
and therefore NO availability, spinal cord-injured (SCI) 
individuals were included as a model of extreme 
deconditioning.
Methods – In 8 healthy men (34 ± 13 years) and 6 SCI 
individuals (37 ± 10 years), the 5-minute FMD response 
in the superfi cial femoral artery was assessed by echo-
Doppler, both during infusion of saline and during 
infusion of the NO-synthase-blocker NG-monomethyl-
L-arginine (L-NMMA). In a subset of the controls (n=6), 
the 10-minute FMD response was also examined using 
the same procedure.
Results – The 5-minute FMD response in controls (4.2 
± 0.3%) was signifi cantly diminished during L-NMMA 
infusion (1.0 ± 0.2%, P<0.001). In SCI, L-NMMA also 
signifi cantly decreased the FMD response (from 8.2 ± 
0.4% during saline to 2.4 ± 0.5% during L-NMMA). The 
hyperaemic fl ow response during the fi rst 45 seconds 
after cuff  defl ation was lower in both groups during 
infusion of L-NMMA, but the eff ect of L-NMMA on FMD 
persisted in both groups after correction for the shear 
stress stimulus. The 10-minute FMD was not aff ected 
by L-NMMA (saline: 5.4 ± 1.6 %, L-NMMA: 5.6 ± 1.5 %).
Conclusion – Superfi cial femoral artery FMD in response 
to distal arterial occlusion for a period of 5 minutes is 
predominantly mediated by NO in healthy men and in 
the extremely deconditioned legs of SCI individuals. 
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Introduction
Flow-mediated dilatation (FMD) refers to 
the vasodilatation observed in a conduit 
artery in response to elevations in shear 
stress during reactive hyperaemia. FMD 
is a valuable non-invasive tool to evaluate 
endothelial function in humans.1 It is 
reduced in patients with risk factors 
for cardiovascular diseases such as 
hypercholesterolemia, hypertension, 
diabetes, and smoking,2-4 as well as in the 
elderly.5, 6 Decreased endothelial function, 
characterized by a reduced bioactivity of  
nitric oxide (NO), has been proposed 
as an important early event in the 
pathogenesis of  atherosclerosis,7 since NO 
is an important anti-atherogenic molecule. 
Indeed, decreased FMD is an independent 
predictor for cardiovascular morbidity and 
mortality.8-11
It has been shown that the FMD response 
in the brachial and radial arteries, under 
specifi c conditions, is mediated by 
endothelial NO, since selective blockade of  
NO production with NG-monomethyl-L-
arginine (L-NMMA) largely abolishes the 
response.12-14 NO dependency of  FMD in 
other arteries has not been examined.
The effect of  regular aerobic exercise on 
FMD in healthy men15-17 and in subjects 
with cardiovascular disease18, 19 has been 
examined primarily in the brachial artery. 
Since exercise-induced vascular adaptations 
mainly occur in the trained areas,20 
assessment of  lower limb FMD may provide 
more direct and sensitive information about 
local vascular endothelial function changes. 
This is particularly relevant since we know 
that leg and arm vascular beds respond 
differently to endothelium-dependent 
and -independent vasodilator agents.21 In 
parallel to this, heterogeneity in the conduit 
vessels in the upper and lower limbs is 
present regarding vessel dilatation for a 
given change in shear rate.22, 23 Consequently, 
FMD responses observed in the brachial 
artery cannot necessarily be extrapolated 
to the leg vascular bed. Therefore, the aim 
of  this study was to examine whether the 
FMD observed in the superfi cial femoral 
artery in healthy subjects is NO-mediated. 
Physical inactivity is a common risk 
factor for cardiovascular diseases and 
for atherosclerosis. It has recently been 
demonstrated that conduit artery function 
in the extremely inactive legs deteriorates 
at a greater rate than in the arms of  spinal 
cord-injured (SCI) individuals.24 To examine 
the applicability of  superfi cial femoral 
artery FMD as a marker of  NO-mediated 
vasodilatation in a muscle vascular bed 
subject to extreme inactivity, SCI individuals 
were included. Endothelial NO production 
during reactive hyperaemia was blocked by 
infusion of  L-NMMA into the common 
femoral artery. We hypothesize that the 
superfi cial femoral artery FMD in normal 
(healthy subjects) as well as in abnormal 
conditions (SCI individuals) is mediated 
through endothelial NO production. 
Methods
Subjects
Eight healthy male controls (C, 34 ± 4 years, 
185 ± 2 cm, 82 ± 7 kg) and 6 male spinal cord-
injured individuals (SCI, 37 ± 4 years, 179 ± 
1 cm, 72 ± 3 kg) participated in this study. 
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Subjects with a history of  cardiovascular 
diseases, diabetes, hypercholesterolemia, 
or hypertension were excluded from the 
study. Control subjects were non-smokers 
who used no medication. The SCI subjects 
continued their medication, which did not 
interfere with the cardiovascular system, 
throughout the study. Two spinal cord-
injured individuals smoked, but refrained 
from smoking 3 days prior to testing. 
The spinal cord-injured individuals had 
complete motor and sensory spinal cord 
lesions of  traumatic origin varying from 
Thoracic 1 to 12 (American Spinal Injury 
Association A). The level of  the spinal 
lesion was assessed by clinical examination. 
The Hospital Ethics Committee approved 
the study. All subjects gave their written 
informed consent prior to the study. The 
study conformed to the principles outlined 
in the Declaration of  Helsinki.
Protocol
Measurements were carried out in the 
morning after an overnight fast. Subjects 
were asked to empty their bladder before 
examination and they refrained from 
alcohol, caffeine, vitamin C, and exercise 
at least 18 hours prior to the test. Room 
temperature was controlled at 23-24°C.
FMD with NO blockade (5-minute)
A cannula (Angiocath 16 gauge, Becton 
Dickinson, Sandy, Utah, USA) was 
introduced into the femoral artery under 
local anaesthesia (4 ml lidocaine 20 mg/ml) 
using a modifi ed Seldinger technique. The 
intra-arterial cannula was used for drug 
administration and for continuous blood 
pressure monitoring. Heart rate was also 
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Schematic overview of the invasive study protocol (RH: reactive hyperaemia).Figure 1. 
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continuously monitored using lead II from 
an electrocardiogram. The measurements 
started at least 30 minutes after cannulation 
of  the femoral artery (Figure 1). First, 
measurements of  vessel diameter and 
red blood cell velocity of  the superfi cial 
femoral artery (SFA) were performed 
during saline (NaCl 0.9%) infusion. FMD 
was assessed after a cuff  was infl ated 
around the upper thigh for 5 minutes to 
suprasystolic pressure of  220 mmHg. The 
5-minute occlusion period was based on 
the current knowledge of  NO dependency 
of  the brachial artery FMD,13 and on the 
frequent use of  this protocol in previous 
studies examining the lower leg conduit 
artery FMD.23-25 The cuff  placement was 
distal to the arterial cannulation site, with 
the artery insonated between the site of  the 
cannulation and the placement of  the cuff. 
After cuff  defl ation, hyperaemic blood 
fl ow velocity in the SFA was recorded on 
videotape for the fi rst 45 seconds, followed 
by registration of  the vessel diameter for 5 
minutes.26, 27 
Twenty minutes after cuff  release, baseline 
measurements were repeated during 
infusion of  saline in order to verify that 
haemodynamic parameters had returned 
to pre-occlusion levels. Subsequently, 
L-NMMA was infused into the femoral 
artery at a dose of  0.1 mg/min per decilitre 
(dl) of  leg volume. Using a similar dose in 
the forearm, Mullen13 abolished FMD of  
the brachial artery. In addition, a previous 
study that infused this dose into the femoral 
artery showed minimal systemic effects.28 
Resting echo Doppler measurements 
of  SFA were performed between 8 and 
10 minutes during the 10-minute pre-
infusion period of  L-NMMA. Infusion 
of  L-NMMA was continued during the 
5-minute arterial occlusion and 5 minutes 
after cuff  release. During the whole 
protocol, infusion rate was kept constant 
at a volume rate of  10 μl/min/dl. In a 
subgroup of  the healthy controls (n=3, 34 
± 9 years), no effect of  the infusate was 
found on blood fl ow measurement or 
blood fl ow of  the superfi cial femoral artery 
(without infusate: 64 ± 15, with infusate 61 
± 12 ml/min).
FMD with NO blockade (10-minute)
To examine whether the period of  arterial 
occlusion infl uences the nature of  the FMD 
response in the superfi cial femoral artery, we 
repeated the above stated experiments after 
an arterial occlusion period of  10 minutes. 
The results of  the 5-minute occlusion 
were compared with the 10-minute arterial 
occlusion. 
Measurements and analyses
Red blood cell velocities and vessel diameter 
of  superfi cial femoral artery were measured 
with an echo Doppler device (Megas Esaote, 
Firenze, Italy) with a 5-7.5 MHz broadband 
linear array transducer. The sample volume 
was placed in the centre of  the artery and 
images were made approximately 3 cm 
distal to the bifurcation into the deep and 
the superfi cial femoral artery. The angle 
of  insonation during velocity assessments 
was consistently below 60 degrees. Arterial 
diameter measures were assessed from 
arterial B-mode images where the vessel 
is parallel to the transducer. For baseline 
diameter measurements, two consecutive 
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images in the longitudinal view were frozen 
at the peak systolic (Ds) and end-diastolic 
phase (Dd). Off  line, 3 measurements 
were performed per diameter image, and 
the mean diameter (D) was calculated by 
using the formula: 1/3 · systolic diameter 
+ 2/3 · diastolic diameter. For baseline 
velocity measurements, four images with 
a total of  10-12 velocity profi les were 
obtained and manually traced afterwards by 
a single investigator. The average of  these 
10-12 Doppler spectra waveforms was 
used to calculate mean velocity (Vmean). 
Subsequently, mean blood fl ow in ml/min 
was calculated as π(radius)2 · Vmean(cm/s) 
· 60 and mean wall shear rate (MWSR) was 
calculated as 4 · Vmean/D(s–1).
Hyperaemic velocity was recorded on 
videotape for the fi rst 45 seconds after 
cuff  release. After 45 seconds, superfi cial 
femoral artery diameter was recorded 
continuously until 5 minutes after cuff  
release for assessment of  the FMD. Reactive 
hyperaemic blood velocity was calculated 
from the fl ow velocity integral (FVI) every 
5 seconds, from 15 to 45 seconds after 
cuff  release, which was manually traced by 
a single investigator. Subsequently, mean 
blood fl ow in ml/min was calculated as 
π(radius)2 · Vmean(cm/s) · 60 and mean 
wall shear rate (MWSR) was calculated as 4 
· Vmean/D (s–1). 
Vessel diameters of  the SFA after reactive 
hyperaemia were measured off  line from 
videotape at 50, 60, 90, 120, 240, and 
300 seconds after cuff  release to measure 
FMD. All diameters were measured at 
the end-diastolic phase of  the cardiac 
cycle, corresponding to the R wave of  a 
simultaneous ECG signal. FMD in the 
SFA was expressed as both the maximal 
absolute and relative diameter change in 
end-diastolic baseline diameter. MWSR 
area-under-the-curve (MWSR-AUC) was 
calculated from 15-45 seconds after cuff  
release.29 To correct for the shear stress 
stimulus, the ratio between the relative 
FMD response (%FMD) and the primary 
stimulus for vessel dilatation (MWSR-
AUC) was calculated. Reproducibility of  
the measurements in the superfi cial femoral 
artery in our lab are reported to be 1.5% 
for baseline diameter, 14% for blood fl ow 
and 15% for FMD.30
Statistical analysis
The primary end point of  this study was 
the superfi cial femoral artery FMD. We 
decided that with an estimated SD of  35% 
of  the baseline value, a mean relevant effect 
of  the L-NMMA infusion should be at least 
50% (for the control and SCI comparison) 
and calculated that with an alpha of  0.05, 
6 subjects per group would be needed 
to achieve a power of  90%. Statistical 
analyses were performed using SPSS 12.0 
computer software (SPSS Inc., Chicago, 
Illinois, USA). Kolmogorov-Smirnov test 
indicated a normal (Gaussian) distribution 
of  data. Results are expressed as mean ± 
SEM. Differences during the whole period 
of  reactive hyperemia in blood fl ow, mean 
wall shear rate and diameter between 
the two experimental conditions (saline 
versus L-NMMA) were examined using a 
two-way repeated measures ANOVA. To 
assess differences in FMD response during 
saline and L-NMMA infusion in controls 
and SCI individuals (for the 5-minute as 
well as 10-minute ischaemic stimulus), 
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a Student’s t-test for paired groups was 
used. To examine differences between 
groups, an unpaired Student’s t-test was 
used. Differences were considered to 
be statistically signifi cant at a two-sided 
probability value of  ≤0.05. 
Results 
Baseline vascular characteristics
Resting superfi cial femoral artery diameters 
were signifi cantly lower in spinal cord 
injured (SCI) individuals compared with 
controls (0.55 ± 0.04 and 0.78 ± 0.02 
cm, respectively), while mean wall shear 
rate (MWSR) was higher in SCI than in 
controls (50 ± 4 and 13 ± 1 s, respectively). 
Resting blood fl ow through the superfi cial 
femoral artery (SFA) did not differ between 
controls and SCI (75 ± 12 and 98 ± 18 
ml/min, respectively). Controls showed 
a signifi cantly larger leg volume than SCI 
(11.1 ± 0.7 and 7.9 ± 0.3 L, respectively). 
After correction for leg volume, SCI 
individuals demonstrated a higher blood 
fl ow compared with controls (13 ± 2 and 7 
± 1 ml/min/L, respectively).
Before administration of  L-NMMA, the 
superfi cial femoral artery blood fl ow and 
diameter had returned to baseline values in 
both groups (Table 1). Superfi cial femoral 
artery blood fl ow decreased signifi cantly 
in both groups during L-NMMA infusion 
(P<0.05). Infusion of  L-NMMA did not 
have any effect on baseline diameter of  the 
superfi cial femoral artery nor did it affect 
mean arterial blood pressure or heart rate 
in either group (Table 1).
 Table 1. 
Baseline 1
(Saline)
Baseline 2
(Saline)
L-NMMA
Diameter (cm)
Controls 0.78 ± 0.02 0.79 ± 0.02 0.77 ± 0.02
SCI 0.55 ± 0.02 0.55 ± 0.02 0.55 ± 0.02
Superfi cial femoral artery blood fl ow (ml/min)
Controls 75 ± 12 82 ± 12 46 ± 7 *
SCI 98 ± 18 85 ± 14 59 ± 14 *
Heart rate (bpm)
Controls (n=7) 55 ± 2 57 ± 3 55 ± 3
SCI 58 ± 4 57 ± 3 58 ± 3
Mean arterial pressure (mmHg)
Controls (n=7) 90 ± 3 93 ± 3 95 ± 3
SCI 98 ± 3 101 ± 3 103 ± 3
* P<0.05:  Signifi cantly diff erent from baseline 2. Due to technical problems, no registration is present of 
the heart rate and mean arterial pressure of 1 control subject.
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FMD and hyperaemic responses
Controls After the 5-minute period of  distal 
leg ischaemia, peak blood fl ow was maximal 
within 15 seconds with a subsequent decay 
in blood fl ow thereafter (Figure 2A). At 45 
seconds post-cuff  defl ation, blood fl ow had 
decreased but not fully returned to baseline 
(Saline: 281 ± 133 versus 75 ± 34 mL/
min, L-NMMA: 190 ± 74 versus 46 ± 21 
mL/min). Post-ischaemic fl ow and MWSR 
were lower during L-NMMA infusion than 
during saline infusion (Figure 2A and Figure 
2B, P=0.023 for post-ischaemic blood fl ow, 
and P=0.024 for MWSR). During reactive 
hyperaemia, the area-under-the-curve for 
MWSR during saline infusion (488 ± 33) 
was larger than during L-NMMA infusion 
(413 ± 40, P=0.02).
After cuff  release, FMD in the SFA of  
controls was 4.2 ± 0.3% during saline 
infusion (Figure 3). Infusion of  L-NMMA 
almost completely abolished the FMD 
response (1.0 ± 0.2%, P<0.001) (Figure 3). 
Analysing the overall course of  the FMD, 
the change in diameter during reactive 
hyperaemia was completely abolished 
during L-NMMA infusion (Figure 2C). 
After correction for its stimulus (area-
under-the-curve for MWSR), a marked 
difference in FMD response between 
saline (0.0089 ± 0.0009 AU) and L-NMMA 
infusion (0.0026 ± 0.0006 AU, P<0.001) 
was still observed (Figure 3).
SCI individuals Post-ischaemic fl ow and 
MWSR were lower during L-NMMA 
infusion than during saline infusion 
(Figure 2, P=0.006 for post-ischaemic 
blood fl ow, and P=0.003 for MWSR). At 
45 seconds post-cuff  defl ation, blood fl ow 
had decreased but was not yet returned to 
baseline (Saline: 216 ± 91 versus 98 ± 43 
mL/min, L-NMMA: 223 ± 91 versus 59 ± 
33 mL/min).  During reactive hyperaemia, 
the area-under-the-curve for MWSR during 
saline infusion (803 ± 100) was larger 
compared with the area-under-the-curve 
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for MWSR during L-NMMA infusion (744 
± 99, P=0.047). FMD response in the SFA 
in SCI was 8.2 ± 0.4% under saline infusion, 
while infusion of  L-NMMA signifi cantly 
reduced the FMD response (2.4 ± 0.5%, 
P<0.001, Figure 3). By correcting the FMD 
response for its stimulus (area-under-the-
curve for MWSR), a reduced FMD was 
still observed (saline: 0.0113 ± 0.0020 AU, 
L-NMMA: 0.0037 ± 0.0009 AU).
FMD response in SCI was signifi cantly 
larger than in controls during saline (SCI: 
8.2 ± 0.4%; controls: 4.2 ± 0.3%; P<0.001) 
as well as during infusion of  L-NMMA 
(SCI: 2.4 ± 0.5%, controls: 1.0 ± 0.2, 
P=0.03). However, after correction for the 
eliciting stimulus (area-under-the-curve 
for MWSR), no difference was observed 
between SCI and controls, either during 
saline (SCI: 0.0113 ± 0.0020 AU; controls: 
0.0089 ± 0.0009 AU; P=0.35) or during 
L-NMMA infusion (SCI: 0.0037 ± 0.0009 
AU; controls 0.0026 ± 0.0006 AU, P=0.31) 
(Figure 3). 
FMD with NO blockade (10-minute)
These experiments were performed in 
a subset of  the original group of  healthy 
controls (n=6). The subpopulation of  
healthy controls is representative for the 
original population regarding age (40 
± 4 versus 34 ± 4 years, respectively), 
body weight (86 ± 6 versus 82 ± 7 kg, 
respectively), systolic blood pressure (124 
± 3 versus 128 ± 3 mmHg, respectively) 
and diastolic blood pressure (70 ± 4 versus 
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76 ± 4 mmHg, respectively). Baseline 
femoral artery did not differ between both 
experiments (5-minute: 7.9 ± 0.2, 10-minute: 
7.9 ± 0.2 mm). The 5-minute as well as 
the 10-minute FMD procedure resulted 
in a dilatation of  the superfi cial femoral 
artery (Figure 4). After 5-minute occlusion, 
the superfi cial femoral artery dilatation 
was signifi cantly reduced during infusion 
of  L-NMMA, whereas no difference in 
artery dilatation is observed during the 
10-minute FMD procedure between saline 
and L-NMMA (Figure 4). During reactive 
hyperaemia after the 10-minute occlusion, 
the area-under-the-curve for MWSR 
during saline infusion (1270 ± 345) was 
not different from L-NMMA infusion 
(1447 ± 318, P=0.42). Also correcting the 
superfi cial femoral artery dilatation after 10-
min ischemia for the area-under-the-curve 
for MWSR, no difference was observed 
between saline (0.0071 ± 0.0028 AU) and 
L-NMMA infusion (0.0047 ± 0.0009 AU; 
P=0.34). 
Discussion
In the present study, we demonstrate that the 
FMD response of  the superfi cial femoral 
artery in healthy men and in spinal cord-
injured (SCI) individuals predominantly 
refl ects NO-mediated endothelium-
dependent vasodilatation. FMD of  the 
superfi cial femoral artery in response to a 
5-minute period of  ischaemia induced by 
a cuff  placed distal to the site of  artery 
insonation therefore represents a suitable 
method to examine NO bioavailability and 
endothelial function in the lower limbs.
Contribution of NO to FMD in controls
Previous reports utilising L-NMMA as a 
competitive antagonist have demonstrated 
a crucial role for NO in radial13, 14 and 
brachial artery12 dilatation in response to 
brief  periods of  reactive hyperaemia. In 
the present study, the increase in superfi cial 
femoral artery diameter in healthy men, 
after a brief  episode of  reactive hyperaemia, 
was almost completely abolished during 
infusion of  L-NMMA. Thus, in accordance 
with data in the upper limbs, our data 
demonstrate that the FMD response of  
the superfi cial femoral artery in healthy 
men refl ects NO-mediated endothelium-
dependent vasodilatation. One may 
argue that the impact of  L-NMMA on 
arterial diameter may be due, in part, to a 
diminished fl ow stimulus. Indeed, blood 
fl ow, MWSR and area-under-the-curve for 
MWSR during reactive hyperaemia were 
slightly lower during infusion of  L-NMMA 
than during saline infusion. Nevertheless, 
when the FMD response was corrected 
for its stimulus (area-under-the-curve for 
MWSR), a marked difference between 
saline and L-NMMA infusion was still 
observed.
The FMD of  the superfi cial femoral artery 
after blockade of  NO production was 
~1% in the controls in the present study. 
Lieberman et al 31 observed a 7% FMD of  
the brachial artery during administration 
of  L-NMMA. The discrepancy with 
the present results can be explained by 
placement of  the occlusion cuff  relative to 
the ultrasound probe. In the present study, 
the ultrasound probe was proximal to the 
cuff, whereas Lieberman et al 31 placed the 
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cuff  on the upper arm with the site of  
measurement in the ischaemic area distal to 
the cuff. Under these circumstances FMD 
is affected by vasodilators other than NO 
which are released in response to ischaemia, 
and may also be complicated by myogenic 
responses as a result of  the pressure fall 
inside the artery during occlusion.12 In 
other studies where the arterial measuring 
site was proximal to the cuff, L-NMMA 
reduced radial artery vasodilatation to 0.7 
– 2%13 or converted radial dilatation to 
vasoconstriction,14 whilst brachial artery 
FMD was completely abolished.12 In all 
studies, the FMD response was investigated 
after a 5-minute occlusion period causing a 
brief  shear stress stimulus. The nature of  
the shear stress stimulus is critical to the 
NO-dependency, since the FMD response 
to more sustained stimuli (caused by release 
of  15 minutes ischaemia, skin warming, 
or distal infusion of  acetylcholine) is 
unaffected by L-NMMA.13 Parallel to this, 
we could demonstrated in a subset of  the 
control subjects that a 10-minute period 
of  ischaemia results in a dilatation of  the 
superfi cial femoral artery that is unlikely the 
result of  an endothelium-dependent NO-
mediated mechanism only. This suggests 
that, similar to the brachial artery, the 
duration of  the ischaemic period is critical 
for the NO-dependency of  the superfi cial 
femoral artery.
During a 5-minute occlusion, FMD may be 
partially dependent upon other vasodilator 
agents such as EDHF or prostacyclin. In 
addition, an increase in shear stress can also 
stimulate endothelin production; blockade 
of  endothelin-A receptors improves FMD 
in chronic heart failure patients.32 Although 
these NO-independent mechanisms could 
explain the residual FMD during NO-
blockade in the present study, we argue 
they play a relatively minor role in the 
superfi cial femoral artery FMD, since 
L-NMMA blunted the dilatation up to 
about 70% and the increase in diameter 
observed during infusion of  saline was 
inhibited throughout L-NMMA infusion 
(Figure 2C). Nonetheless, our fi nding of  
NO dependency of  FMD in the lower limb 
is limited to the superfi cial femoral artery in 
response to a 5-minute distal occlusion.  
Contribution of NO to FMD in SCI
In keeping with recent reports after 
prolonged (spinal cord injury30) and short-
term (unilateral lower limb suspension33 
deconditioning or deconditioning by bed 
rest34, 35), our fi ndings demonstrate an 
enhanced FMD response in SCI. Recently, 
Stoner et al 24 demonstrated an attenuated 
posterior tibial artery FMD response in SCI 
individuals, measuring the artery diameter 
in the ischaemic area distal to the cuff. As 
discussed previously, one may speculate 
whether this response is NO-mediated or 
infl uenced by other metabolic vasoactive 
substances. Since deconditioning leads to 
marked changes in vascular function,36-38 
we considered the possibility that other 
mechanisms than NO might mediate FMD 
under these conditions. Indeed, during 
blockade of  NO production by L-NMMA, 
the FMD response was attenuated but 
not abolished in SCI and was more 
preserved than in controls (~2.4% versus 
~1%, respectively). However, it has been 
proposed that the FMD response should 
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be corrected for the eliciting stimulus by 
taking the post-occlusive area-under-the-
curve of  the mean wall shear rate.29 After 
such correction was applied, no differences 
in FMD response between SCI and controls 
were evident. Although the contribution of  
other vasodilating agents cannot be ruled 
out in explaining the remaining FMD 
response during L-NMMA infusion in SCI, 
the FMD of  the superfi cial femoral artery 
following a 5-minute ischaemic stimulus 
in the deconditioned legs of  SCI depends 
predominantly on NO.
Administration of  L-NMMA decreased 
superfi cial femoral artery blood fl ow but did 
not affect basal superfi cial femoral artery 
diameter, and no systemic effects were 
observed since mean arterial blood pressure 
and heart rate were not changed during 
infusion of  L-NMMA in both groups. The 
decrease in blood fl ow is consistent with 
the existence of  basal release of  NO in the 
leg resistance vessels, which is in agreement 
with previous observations.28 The apparent 
lack of  effect of  L-NMMA on basal 
superfi cial femoral artery diameter suggests 
that, consistent with the observations in the 
radial and brachial artery,12-14 NO does not 
contribute markedly to basal vascular tone 
in large conduit arteries. 
Limitations
A recent study demonstrated that the 
shear stimulus area-under-the-curve, but 
not the peak shear stimulus, is the critical 
determinant of  the peak fl ow-mediated 
dilatation.29 Although we examined the AUC 
during a large time window, a limitation in 
this study is that we could not examine 
the superfi cial femoral artery blood fl ow 
beyond 45 s after cuff  release. After 45 s 
of  cuff  release, we found that superfi cial 
femoral artery blood fl ow was markedly 
reduced, yet did not return to baseline 
values. In a group of  healthy men (n=6, 
33 ± 7 years), we performed additional 
experiments and examined the fl ow 
response for 5 minutes after cuff  release 
(unpublished data). We found that blood 
fl ow returned to baseline values between 
90-120 s post defl ation, while blood fl ow 
was 2-fold higher than baseline values at 
45 s after cuff  release. The latter fi nding 
was also present in the data set of  controls 
and SCI subjects presented in this paper. 
In addition, based on previously reported 
limb differences in vascular control21 and 
conduit vessel responsiveness to a certain 
change in shear,22 one may argue whether 
correction methods for the brachial artery 
are equally applicable to superfi cial femoral 
artery FMD. Indeed, markedly different 
time-courses of  post-occlusive brachial 
artery dilator response29 (a peak within 50-
80 s) exist compared with the superfi cial 
femoral artery change after cuff  release as 
described in this study (peak between 1-4 
minutes). Further studies will be required 
to fully ascertain the appropriate correction 
for stimulus for lower limb arteries.
Clinical relevance
The non-invasive measurement of  the 
FMD in the brachial artery is a widely 
accepted and frequently used method to 
examine endothelial function. Based on 
the results of  this study, we advocate the 
use of  superfi cial femoral artery FMD in 
disease states that specifi cally affect the 
lower extremities (such as peripheral artery 
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disease) or to examine the effects of  exercise 
training programs in the legs. Moreover, 
changes in leg conduit arteries are clinically 
relevant since the peripheral atherosclerotic 
process occurs more often in arteries of  the 
lower limbs than in the upper limbs.39 Taken 
together, we believe that the assessment of  
the superfi cial femoral artery FMD provides 
a relatively unexplored and interesting fi eld 
of  cardiovascular physiology in health and 
(cardiovascular) disease.  
In conclusion, we have demonstrated that 
superfi cial femoral artery dilatation to a 
transient period of  increased fl ow after 
5 minutes of  arterial occlusion of  the leg 
represents predominantly NO-dependent 
dilatation in healthy men and in spinal 
cord-injured individuals. Consequently, 
superfi cial femoral artery FMD can be 
used as a valid and novel explorative tool to 
examine endothelial function in the lower 
limbs in humans. 
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Abstract 
Background – We tested whether venous occlusion 
plethysmography (VOP) is an appropriate method 
to measure calf blood fl ow (CBF) during head-up tilt 
(HUT).
Methods – CBF measured with VOP was compared 
with superfi cial femoral artery blood fl ow 
as measured by Doppler ultrasound during 
incremental tilt angles.
Results – Measurements of both methods correlated 
well (r=0.86). Reproducibility of VOP was fair in 
supine position and 30°  HUT (CV: 11% to 15%).
Conclusion – This indicates that VOP is an applicable 
tool to measure leg blood fl ow during HUT, 
especially up to 30° HUT.
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Introduction
The main mechanism responsible 
for maintaining blood pressure 
during orthostatic stress is arteriolar 
vasoconstriction.1 In order to quantify the 
response in vascular resistance to postural 
stress, in particular in the leg, it is necessary 
to measure leg blood fl ow accurately.
Venous occlusion plethysmography (VOP) 
is a well-established method to measure 
calf  blood fl ow, which has been used in 
a variety of  conditions, i.e. exercise2 and 
reactive hyperaemia.3 However, its use 
for measuring leg blood fl ow in standing 
or head-up tilt (HUT) position remains 
controversial, since an empty venous 
system has been suggested to be requisite 
for this method.4-6 Since in the upright 
posture veins are already distended, due 
to an increase in hydrostatic pressure, 
further collection of  blood may be defi ned 
by venous compliance rather than arterial 
infl ow. This may question the validity 
of  measuring blood fl ow using VOP in 
dependent limbs or in the upright posture. 
Although VOP has been used during HUT, 
accuracy or reproducibility of  this method 
has not been reported.7-9
Therefore, the purpose of  this study was to 
assess the applicability and reproducibility 
of  VOP for blood fl ow measurements in 
the calf  (CBF) during HUT at different 
tilt angles (0°, 30°, 45°, and 70°). In a 
subgroup, CBF measurements by VOP were 
compared with blood fl ow measurements 
using Doppler ultrasound. To assess 
reproducibility of  VOP, measurements 
were performed twice.
Methods
Subjects
In total eighteen healthy, normotensive 
subjects aged 21 to 30 years volunteered to 
participate in this study. In eight subjects, 
blood fl ow measurements using VOP were 
compared with blood fl ow measurements 
using Doppler ultrasound (DU). In ten 
other subjects, the VOP measurements 
were repeated within two weeks to assess 
reproducibility.
Baseline subject characteristics are 
illustrated in Table 1. None of  the subjects 
used cardiovascular medication or suffered 
from cardiovascular disease. All were non-
smokers and had no history of  syncope. 
All volunteers refrained from caffeine and 
alcohol for at least eighteen hours and from 
food intake for three hours prior to testing. 
The Hospital Ethics Committee approved 
the study. All subjects gave their written 
informed consent.
Measurements
The subjects lay in supine position on a 
manually driven tilt table and were supported 
Subject characteristics.Table 1. 
Mean ± SD
Age, yrs 25 ± 4
Length, cm 187 ± 9
Body mass, kg 80 ± 11
Calf circumference, cm 38 ± 2
Systolic blood pressure, mmHg 125 ± 12
Diastolic blood pressure, mmHg 74 ± 5
Heart rate, bpm 64 ± 10
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 Absolute values Figure 1. 
of calf blood fl ow (CBF) 
measured with venous 
occlusion plethysmography 
and superfi cial femoral artery 
blood fl ow (BF SFA), heart 
rate (HR) and mean arterial 
pressure (MAP) during supine 
position, 30°, 45°, and 70° HUT. 
One-way repeated measures 
ANOVA showed a signifi cant 
eff ect of tilt for all parameters. 
* = P<0.05 and indicates 
signifi cantly diff erent from the 
position before.
          =  supine;
          = 30° HUT;  
          =  45° HUT;
          = 70° HUT
by a saddle. The venous occlusion cuff  was 
placed around the right thigh and connected 
to a rapid cuff  infl ator (Hokanson Stopler 
E-20, Bellevue, WA 98005, USA). The 
mercury-in-silastic strain gauge was placed 
around the thickest part of  the calf  and 
was connected to the plethysmograph. Red 
blood cell velocities and systolic and diastolic 
vessel diameter of  the right superfi cial 
femoral artery were measured with a pulsed-
colour Doppler device, which is described in 
detail elsewhere.10 Reproducibility of  DU in 
the superfi cial femoral artery was 1.5% for 
diameter, 14% for blood fl ow.11 
Protocol
Supine blood fl ow measurements using DU 
and VOP were performed after subjects 
were 30 minutes quietly in supine position. 
When the subject was 2 minutes into 30° 
HUT, DU measurements started until 3.5 
minutes where after CBF continued for 
another 3.5 minutes. The venous occlusion 
pressure was adjusted to the hydrostatic 
pressure column, which is derived from 
the vertical distance heart level – thigh level 
and was calculated as the sinus of  the tilt 
angle * actual distance heart – thigh, and 
was 75 mmHg during 30° HUT. The same 
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procedure was repeated for 45°, and 70° 
HUT using a venous occlusion pressure of  
87, and 105 mmHg, respectively.
Data analysis
CBF in ml·100ml-1·min-1 was calculated 
as described previously12 and values from 
minute 3.5 until 7 were averaged to calculate 
CBF for each HUT position. Doppler 
ultrasound was analyzed as described 
before10 to obtain superfi cial femoral artery 
blood fl ow. To compare CBF measurements 
with superfi cial femoral artery blood fl ow, 
CBF measurements in ml·100ml-1·min-1 
were multiplied by lower leg volume (ml) as 
measured by water displacement.
Statistics
Data are expressed as mean ± standard 
deviation (SD).
The results of  each method were correlated 
and agreement evaluated according to the 
method described by Bland and Altman.13 
The limits of  agreement are defi ned as the 
mean of  the relative differences between 
the two methods ± 2 SD. Student’s t-test 
was used to test for systemic differences 
between the two methods.
Reproducibility of  the CBF was assessed 
by calculating the coeffi cient of  variance 
(CV) from two measurements.12
To determine whether hemodynamic 
responses were dependent on the angle of  
tilt, one-way repeated measures ANOVA’s 
were applied. If  signifi cant effects of  tilt 
were observed, post-hoc paired t-tests 
with Bonferroni correction for multiple 
testing were used. A P-value of  <0.05 was 
considered to indicate signifi cance. 
Results
In 5 volunteers, CBF could not be 
measured during 70° head-up tilt (HUT), 
due to a poor plethysmography signal or 
near fainting of  the subject. One subject 
was not available for the  second VOP 
measurements. Therefore, reproducibility 
data were analysed over nine subjects. 
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Blood fl ow in the Figure 2. 
superfi cial femoral artery 
(BF SFA) measured by 
Doppler ultrasound during 
different angles of head-up 
tilt versus calf blood fl ow 
(CBF) measured by venous 
occlusion plethysmography 
corrected for lower leg 
volume. Pearson correlation 
coeffi cient is 0.86.
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Hemodynamic responses to HUT 
(Figure 1)
CBF and superfi cial femoral artery blood 
fl ow (BF SFA) decreased signifi cantly from 
supine to 30° with no further decrease with 
increasing tilt angle (Figure 1). The relative 
decrease in CBF (46% ± 11%) from supine to 
30° was signifi cantly larger than the decrease 
in BF SFA (40% ± 12%) (P<0.001).
Agreement VOP and DU 
The Pearson correlation between the two 
methods was 0.86 (P<0.001) for all data 
points (Figure 2).
The agreement between the two methods 
was evaluated by plotting the relative 
difference in each measurement against 
the mean for all data points and separated 
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Relative diff erence between Figure 3. 
the blood fl ow measured by venous 
occlusion plethysmography (VOP) and 
the superfi cial femoral artery blood 
fl ow measured by Doppler ultrasound 
(DU) versus the mean of both fl ow for 
each individual subject at diff erent tilt 
angles.
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for the different tilt angles (Figure 3). The 
relative mean difference ((VOP – DU)/
DU) was –14% ± 22 for all data points in 
supine position and HUT indicating that 
overall CBF (VOP) is lower than BF SFA 
(DU); for supine position the relative mean 
difference between VOP and DU was 1.5% 
± 24; for 30°: -13% ± 23; for 45°: -23% ± 
19; for 70°: -23% ± 15. Limits of  agreement 
for all data points in supine position 
and during HUT were -58% to 31% and 
became smaller during HUT. The limits of  
agreement are reasonable, although CBF 
during HUT is lower than BF SFA.
Reproducibility of VOP during head-
up tilt
The coeffi cient of  variation (CV) of  CBF 
ranged between 8.7 and 15.0% (Table 2). In 
70° HUT, the CV for both parameters was 
calculated over 4 subjects only.
Discussion
Calf  blood fl ow (CBF) measured with VOP 
correlates well with superfi cial femoral 
artery blood fl ow (BF SFA) measured with 
DU, and can be measured reproducibly 
during HUT. Since the most profound 
changes in blood fl ow with both techniques 
were already measured in 30° HUT, and the 
increase in hydrostatic and venous pressure, 
and concomitant technical diffi culties 
are smallest from supine to 30° HUT, we 
recommend to use VOP for leg blood fl ow 
measurements during HUT up to 30°.
The decrease in leg blood fl ow assessed 
with VOP and DU is comparable to tilt-
induced blood fl ow changes in other studies 
using DU (33%-59%).14-17 The strong 
relationship between VOP and DU blood 
fl ow measurements in the present study 
is in line with previous studies reporting 
correlation coeffi cients varying from 0.57 
to 0.99 at rest and during exercise.18-20 
Head-up tilt affects muscle blood fl ow 
more than skin blood fl ow.21, 22 Since skin 
blood fl ow contributes more to superfi cial 
femoral blood fl ow than to calf  blood fl ow, 
this may explain the observed discrepancy 
between the decrease in CBF (-48%) versus 
the decrease in superfi cial femoral artery 
blood fl ow (∼40%) in response to HUT.
Reproducibility of  baseline CBF (15.0%) 
Values of calf blood fl ow (n=9).Table 2. 
Supine 30° HUT 45° HUT 70° HUT (n=4)
Subject test 1 test 2 test 1 test 2 test 1 test 2 test 1 test 2
Mean ± SD 2.6±0.6 2.6±0.8 1.3±0.3 1.3±0.3 1.1±0.3 1.1±0.2 1.1±0.2 1.2±0.2
%change± SD -45±11 -49±12 -54±11 -57±13 -44±17 -44±14
CV 15.0%(CI 10.1 – 29.1) 11.0%(CI 7.4 – 21.3) 14.9%(CI 10.0 – 28.9) 8.7%(CI 4.9 – 33.2)
Values of calf blood fl ow in ml·100ml-1·min-1 and mean absolute and relative data ± SD in supine 
position, 30°, 45°, and 70° head-up tilt (HUT) for the fi rst and second test. Coeffi cients of Variation 
(CV). Missing data in 70° HUT are due to near fainting or a poor plethysmography signal.
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(A) Pressure-Volume curve and (B) Pressure-Compliance curve based on data of a similar Figure 4. 
group of volunteers measured by venous occlusion plethysmography at different cuff occlusion 
pressures (for method and protocol see25). The increases in calf volume in response to 30°, 45°, and 
70° HUT are marked by the dotted lines in the pressure volume curve (A). The different tilting angles 
correspond with different venous pressures (X-axis). Transferring these venous pressures into the 
pressure-compliance curve (B) clearly demonstrate that during 30° HUT venous compliance is still 
on the steep linear part of the curve, whereas during 45°, and 70° HUT the venous compliance is 
compromised.
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is in range with other studies using similar 
techniques to measure leg blood fl ow.12, 23, 24 
The coeffi cient of  variation of  CBF during 
HUT was even better (11.0-17.9%), which 
indicates that VOP is a reproducible tool 
to measure tilt-induced vasoconstriction 
repetitively. The low coeffi cients of  
variation of  CBF during 70° (8.7-8.9%) are 
not representative since these coeffi cients 
of  variation were calculated over no more 
than 4 subjects. Not all subjects were able 
to abstain from moving their legs in 70° 
HUT position, and some subjects fainted in 
this position. Moreover, the quality of  the 
plethysmographic tracing became worse at 
70° HUT whereas at the lower tilt angles the 
plethysmography signal is of  good quality 
indicated by the volume pulsations in the 
plethysmographic tracing for the period of  
venous occlusion.
Our data and previous studies26-29 show 
that at 30° HUT peripheral vascular 
responses are accomplished to a large 
extent. The increase in hydrostatic pressure 
and concomitant increase in venous 
pressure is low at 30°. From Figure 4B it 
can be concluded that at 30° HUT venous 
compliance is still at the steep portion of  the 
venous compliance curve whereas during 
45°, and 70° HUT the venous compliance 
has shifted to the non-linear part. At 30° 
HUT increase of  the plethysmography 
Typical plethysmographic tracing of one individual subject during a complete experiment. Figure 5. 
Blood fl ow measurements at 30° HUT start when the plethysmography signal does not change anymore, 
meaning that venous volume reached a steady state situation. Besides, looking at a typical VOP tracing 
at 30° HUT, the increase in venous volume is linear during the fi rst 5 seconds of cuff  infl ation, indicating 
that blood fl ow measurements using VOP during 30° HUT are not compromised by a decrease in venous 
compliance.
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signal during venous occlusion is linear 
while at 45° and 70° HUT, however, venous 
distensibility is reduced and consequently 
results in a non-linear increase in leg volume 
during infl ation of  the venous occlusion 
cuffs, which is illustrated in Figure 5. We 
therefore recommend using VOP at 30° 
HUT. For studies focussing on syncope at 
the endpoint of  HUT, which requires larger 
tilt angles, other techniques to measure leg 
blood fl ow should be used.
Limitation
Using VOP, blood fl ow is defi ned as limb 
volume changes over time. During HUT, 
when the leg is below heart level, volume 
changes can still be measured using VOP, 
however, the physiological determinants of  
these volume changes are complex and it is 
no longer possible to say with reasonable 
certainty that a change in volume over 
time, which most likely refl ects fl ow, is 
determined by resistance vessel tone. For 
example, limb blood fl ow measured using 
VOP in HUT position can decrease due to 
an increase in venous pressure, as a result 
of  venous congestion and the associated 
fall in arterio-venous pressure gradient, 
without any increase in resistance at the 
arteriolar level. 
In conclusion, this study demonstrates 
that CBF measured by VOP during HUT 
is suitable and reproducible. The method 
is easy applicable and recommended in tilt 
angles equal to 30° to avoid high hydrostatic 
and leg venous pressures. 
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Abstract
Background - The prompt increase in peripheral 
vascular resistance, mediated by sympathetic 
α-adrenergic stimulation, is believed to be the key 
event in blood pressure control during postural 
stress. However, despite the absence of central 
sympathetic control of the leg vasculature, 
postural leg vasoconstriction is preserved in spinal 
cord-injured individuals (SCI). This study aimed 
to assess the contribution of both central and 
local sympathetically induced α-adrenergic leg 
vasoconstriction to head-up tilt (HUT) by including 
healthy individuals and SCI, who lack central 
sympathetic barorefl ex control over the leg vascular 
bed.
Methods - In 10 controls and 9 SCI the femoral artery 
was cannulated for drug infusion. Upper leg blood 
fl ow (LBF) was measured bilaterally using venous 
occlusion strain gauge plethysmography before and 
during 30° HUT throughout intra-arterial infusion of 
saline or the non-selective α-adrenergic receptor 
antagonist phentolamine, respectively. Additionally, 
in six controls the leg vascular response to the cold 
pressor test was assessed during continued infusion 
of phentolamine, in order to confi rm complete 
α-adrenergic blockade by phentolamine.
Results - During infusion of phentolamine HUT 
still caused vasoconstriction in both groups: leg 
vascular resistance (mean arterial pressure/LBF) 
increased by 10 ± 2 AU (compared to 12 ± 2 AU 
during saline infusion), and 13 ± 3 AU (compared to 
7 ± 3 AU during saline infusion) in controls and SCI, 
respectively.
Conclusion - Eff ective α-adrenergic blockade did not 
reduce HUT-induced vasoconstriction, regardless 
intact barorefl ex control of the leg vasculature. 
Apparently, redundant mechanisms compensate 
for the absence of sympathetic α-adrenoceptor leg 
vasoconstriction in response to postural stress.
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Introduction
The prompt increase in peripheral vascular 
resistance, mediated by sympathetic 
α-adrenergic stimulation, is believed to be 
the key event in blood pressure control 
during postural stress1. In individuals 
who fail arterial and cardiopulmonary 
barorefl ex-mediated control over the legs, 
for instance individuals with a complete 
spinal cord injury (SCI), leg vasoconstriction 
upon postural change is preserved.2-7 In 
SCI individuals preservation of  postural 
vasoconstriction may, apart from structural 
vascular adaptations, such as vascular 
atrophy, explain their remarkable orthostatic 
tolerance and suggests the importance 
of  local mechanisms in the regulation of  
vascular tone during postural challenges. 
So, apart from central sympathetic control, 
local sympathetic mechanisms, such as the 
venoarteriolar refl ex, contribute to the 
hemodynamic response to postural stress. 
The venoarteriolar refl ex is triggered when 
venous pressure is elevated above 25 mmHg 
or more.8 During orthostasis as much as 45% 
of  the increase in systemic vascular tone is 
due to the venoarteriolar refl ex.9 Several 
studies have been performed to unravel the 
mechanism of  the venoarteriolar refl ex.4, 
8-10 From these studies, it can be concluded 
that the venoarteriolar refl ex concerns a 
local α-adrenergic sympathetic axon refl ex.
Apart from α-adrenergic stimulation, 
non-adrenergic mechanisms, such as 
purinoceptor stimulation and release of  
neuropeptide Y, seem to contribute to the 
vasoconstrictor response after sympathetic 
stimulation.11, 12 In addition, the leg 
vasoconstrictor response to postural stress 
may in part be myogenic,13 and as such not 
related to the sympathetic nervous system.
Nevertheless, the importance of  the 
sympathetic nervous system during 
orthostasis is supported by the fact that 
patients who fail an adequate increase in 
sympathetic activity during postural stress, 
such as patients with autonomic failure, 
are not able to maintain blood pressure. In 
spite of  this, in humans the sympathetic 
contribution to leg vascular tone in response 
to orthostasis has not been quantifi ed. 
Therefore, the present study aimed to 
quantify the involvement of  sympathetic 
α-adrenergic vasoconstriction to head-up 
tilt-induced increase in leg vascular tone by 
including healthy individuals and individuals 
who lack barorefl ex control over the leg 
vascular bed, due to a spinal cord injury. 
We hypothesize that blockade of  the 
α-adrenergic receptor in the leg vascular 
bed will result in a substantial blunting 
of  the leg vasoconstrictor response to 
head-up tilt (HUT), which will be larger in 
subjects with an intact barorefl ex than in 
subjects who fail barorefl ex control over 
the leg vascular bed and therefore depend 
on local vasoconstriction mechanisms. To 
address this hypothesis, the vasoconstrictor 
response to HUT was quantifi ed, both 
during infusion of  saline and during 
infusion of  phentolamine (an α-adrenergic 
blocking agent) into the femoral artery in 
controls and spinal cord-injured individuals. 
Appropriate control experiments were 
performed for relevant confounding 
mechanisms.
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Methods
Subjects
Nine male spinal cord-injured individuals 
(SCI) and ten healthy male controls 
participated in the study (Table 1). All 
subjects were normotensive (auscultatory 
blood pressure measurement) and the 
controls used no medication. The SCI 
continued their medication throughout the 
study. The control group was similar with 
respect to smoking habits (one subject in 
each group smoked). All subjects had no 
history of  syncope. The two groups did 
not differ with respect to age, systolic 
and diastolic blood pressure, and heart 
rate. Body weight and thigh volume were 
signifi cantly lower in SCI than in controls. 
The SCI had complete spinal cord lesions 
of  traumatic origin varying from Cervical 
5 – Thoracic 12 (American Spinal Injury 
Association ASIA A14). The motor and 
sensor level of  the spinal lesion was assessed 
by clinical examination. The completeness 
of  the sympathetic lesion was confi rmed by 
the cold pressor test by immersing the hand 
into ice water and assessing the effect on 
leg vascular tone, except for one individual 
suffering from a cervical 5 spinal lesion 
Subject characteristics.Table 1. 
Subject Level of 
spinal 
lesion
Time 
since 
injury
(years)
Smoking Medication Age 
(yr)
Body 
weight
(kg)
Upper 
leg 
volume
(L)
Syst/Diast
blood 
pressure
(mmHg)
Heart 
rate
(bpm)
1 C5 22 + Baclofen 
10 mg tid, 
Bisacodyl, 
Brindley 
stimulator
43 60 5.6 110/74 48
2 T6 11 - 34 71 5.7 128/68 47
3 T4 20 - 42 74 5.9 115/75 59
4 T5 6 - 35 68 5.0 102/64 63
5 T5 20 - 49 67 5.1 110/70 64
6 T12 12 - 38 73 4.3 150/90 56
7 T6 3 - Detrusitol 23 74 6.5 122/78 41
8 T8 10 - 45 77 4.9 110/72 70
9 T8 7 - Intrathecal 
Baclofen
35 85 5.6 134/84 62
SCI
Mean±SD
38±8 72±7 5.4±0.6 120±15/75±8 57±9
C
Mean±SD
36±9 88±12 8.2±1.2 127±9/80±5 58±6
SD - standard deviation
Chapter 6
98
who lacked sensibility of  the hand15. The 
study was approved by the Hospital Ethics 
Committee. All subjects gave their written 
informed consent prior to the study.
Experimental procedures and protocol
Instrumentation and measurements
All subjects refrained from caffeine and 
alcohol for at least twelve hours, from 
nicotine for at least 48 hours, and from food 
for three hours prior to testing. All subjects 
had emptied their bladder in the hour before 
the test to minimize the infl uence of  any 
refl ex sympathetic activation on peripheral 
vascular tone. All tests were performed in 
the afternoon with the subjects in supine 
position in a quiet temperature-controlled 
room (22°C - 24°C). The subjects lay in 
supine position on a manually driven tilt 
table and were supported by a saddle to 
prevent gliding down during HUT.
Using a modifi ed Seldinger technique, 
an intra-arterial cannula (Angiocath 16 
gauge, Becton Dickinson, Sandy, Utah, 
USA) was introduced into the femoral 
artery of  the right leg at the level of  
the inguinal ligament for intra-arterial 
administration of  drugs by an automatic 
syringe infusion pump. The right femoral 
artery was cannulated after local anesthesia 
(0.4 ml lidocaine 20 mg/ml). Heart rate 
was recorded from the electrocardiogram. 
Blood pressure measurements were 
performed continuously using a portable 
blood pressure device (Portapres, TNO, 
The Netherlands). This device corrects for 
hydrostatic pressure changes. A fi nger cuff  
was attached to the middle phalanx of  the 
left third fi nger. Data were collected beat to 
beat during the experiment at a sampling rate 
of  200 Hz. Finger arterial blood pressure 
measurements during HUT accurately 
refl ect intra-arterial blood pressure changes 
in young healthy volunteers.16
Bilateral upper leg blood fl ow was measured 
by electrocardiography-triggered venous 
occlusion plethysmography using mercury-
in-silastic strain gauges (Hokanson EC4, 
D.E. Hokanson, Washington D.C., USA), 
which is a valid method to measure upper 
leg blood fl ow.17 In supine position the 
thigh collecting cuffs (12 cm width) were 
simultaneously infl ated using a rapid cuff  
infl ator (Hokanson E-20) to a pressure of  
50 mmHg18 during 8 heart cycles, with a 
10-heart cycles interval between the venous 
occlusions. For further description of  this 
method see.15 During the 30° HUT cuff  
pressure was adjusted to the hydrostatic 
pressure, i.e. to 75 mmHg.19
A 30° HUT was chosen since this position 
results in signifi cant cardiovascular effects 
20-22 with a signifi cant increase in peroneal 
muscle sympathetic nerve activity,23 without 
fainting of  the subjects. In HUT position, 
calf  blood fl ow measured with venous 
occlusion plethysmography correlates well 
with superfi cial femoral artery blood fl ow 
measured with Doppler ultrasound, and 
can be measured reproducibly during HUT 
up to 30º.19 Besides, using 30° HUT the 
hydrostatic pressure column, that represents 
venous  pressure, is ~25 mmHg (vertical 
distance right atrium to strain gauge at the 
upper leg). At this venous pressure the 
venous system is still at its steep compliant 
part of  the venous pressure-compliance 
curve, which indicates that venous occlusion 
plethysmography represents arterial infl ow 
and is not affected by venous compliance.
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HUT-protocol
For a schematic presentation and time-
table of  the protocol see . Measurements 
started after complete instrumentation 
and at least 30 minutes after cannulation. 
During the experiment leg blood fl ow 
measurements were performed during three 
subsequent HUT-sessions. Each session 
consisted of  5 minutes of  supine blood 
fl ow measurements. Measurements were 
continued during the subsequent 5 minutes 
with the subject in 30° HUT position.
During the fi rst session NaCl 0.9% 
was infused continuously to measure 
the effect of  HUT on leg blood fl ow 
under baseline conditions. The HUT-
session was repeated during complete 
blockade of  the α-adrenergic receptor 
by continuous infusion of  phentolamine 
in a dose of  12 μg/min/dl upper leg 
volume. Propranolol was coinfused with 
phentolamine at a dose of  2 μg/min/
dl to prevent unopposed β-adrenergic 
vasodilatation during α-adrenergic 
blockade. At this dose propranolol does 
not affect the haemodynamic parameters.15, 
24 Phentolamine will increase baseline 
blood fl ow and this in itself  may affect 
the leg vasoconstrictor response to HUT, 
since there is a large vasomotor reserve 
available for vasoconstriction. This has 
been referred to as the vasoconstrictor 
reserve.25, 26 Therefore, an additional HUT 
was performed to control for this by 
increasing supine blood fl ow values during 
infusion of  sodium nitroprusside (SNP) 
in a dose of  0.2 μg/min/dl. So, SNP was 
infused in order to serve as a vasodilator 
control for phentolamine. Moreover, it was 
used to distinguish between the effect of  
specifi c α-adrenergic receptor blockade 
by phentolamine versus the non-specifi c 
effect of  an altered baseline blood fl ow by 
vasodilatation. 
During the experiment NaCl 0.9% was 
infused during the fi rst HUT session. The 
second HUT was always performed in 
the presence of  SNP. The third and fi nal 
HUT was performed during infusion of  
phentolamine-propranolol. This fi xed 
Infusion of NaCl 0.9%  
SNP infusion (0.02 μg/100m l/min)
Phentolamine (12 μg/100ml /min) coinfused with  propranolol (2 μg/100ml /min)
HUT  HUT  HUT  
-30      
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Schematic representation of the experimental protocol. HUT: 30Figure 1. ° head-up tilt
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sequence was chosen to prevent carry 
over effects because the time to wash out 
for SNP is shorter than for phentolamine-
propranolol. To ensure return of  blood 
fl ow to baseline values each HUT-session 
was preceded by measurements of  supine 
leg blood fl ow measurements with infusion 
of  NaCl 0.9% during 5 minutes. During the 
whole protocol, infusion rate was kept at 
20 μl/min/dl.
Cold pressor test
Ten minutes after completing the last 
HUT a cold pressor test was performed in 
six of  the control individuals to confi rm 
that phentolamine was able to block 
the α-adrenergic receptors completely. 
Phentolamine in a dose of  12 μg/min/dl 
was coinfused in the femoral artery with 
propranolol (2 μg/min/dl) during 5 minutes 
to perform baseline measurements. After 
that the hand was immersed into water of  
4°C for 3 minutes Bilateral leg blood fl ow 
measurements continued and heart rate and 
intra-arterial blood pressure were recorded 
continuously.
Time-control experiment
In another group of  six healthy normotensive 
individuals (age: 29 ± 6 years; 4 men, 2 
women) a time-control experiment was 
performed. The same protocol as described 
above (three subsequent HUT-sessions), 
without intra-arterial cannulation and drug 
infusion, was used to examine the effect of  
time and three repetitive HUT-sessions.
Drugs and solutions
Phentolamine (Regitine®, 10 mg/ml, 
Novartis Pharma BV, Arnhem, The 
Netherlands), and propranolol (Inderal®, 
1 mg/ml, Zeneca Farma BV, Ridderkerk, 
The Netherlands) were dissolved in NaCl 
0.9% at the beginning of  each experiment. 
Sodium nitroprusside (department of  
Clinical Pharmacy, Radboud University 
Nijmegen Medical Centre) was dissolved in 
glucose 5% and protected against light.
Data analysis
Upper leg blood fl ow (LBF) in ml/min/dl 
was calculated as the slope of  the volume 
change curve. Because of  a cuff  infl ation 
artifact during the fi rst second, the slope 
from 2 – 6 seconds after cuff  infl ation was 
used. LBF values obtained during the last 2 
minutes in supine position and during the 
last 2 minutes of  HUT were averaged to 
represent LBF at baseline and during HUT, 
respectively. To calculate steady state heart 
rate and mean arterial pressure in response 
to HUT, values obtained during the last 2 
minutes of  HUT were averaged.
Upper leg vascular resistance (LVR) was 
calculated as mean arterial pressure (MAP) 
in mmHg divided by LBF in ml/min/dl and 
expressed in arbitrary units (AU). For these 
measurements we used mean arterial blood 
pressure measurements of  the portapres 
device, because these were adjusted to 
hydrostatic pressure during HUT, assuming 
no net change in perfusion pressure when 
the leg is in dependent position27, 28.
During the cold pressor test the mean of  the 
three highest values of  LVR in the infused 
and non-infused leg was used to calculate 
the percent change in LVR from baseline. 
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Statistics
Results are expressed as the mean ± SEM. 
Baseline leg blood fl ow values were not 
normally distributed across the SCI group. 
Therefore, possible differences in baseline 
measurements of  leg blood fl ow (LBF) and 
leg vascular resistance (LVR) between SCI 
and controls were assessed by means of  a 
Mann-Whitney U-test.
Because HUT-induced vasoconstriction, 
defi ned as the absolute increase in LVR, 
were normally distributed for both groups, 
parametric tests were used to test for 
differences in vasoconstrictor responses. 
Possible differences between the groups 
were identifi ed by an unpaired t-test. A 
paired Student’s t-test was used to test for 
different HUT-induced vasoconstriction 
within the groups between SNP, saline 
and phentolamine infusion. Hemodynamic 
effects in response to HUT for each HUT-
session and each group, separately, were 
tested using a paired t-test.
The effect of  time on hemodynamics and 
responses to HUT in the non-infused leg 
of  controls and during the time-control 
experiment were tested using a one-way 
repeated measures ANOVA. Because LVR 
in response to the cold pressor test was 
not normally distributed, especially for the 
non-infused leg, possible change in LVR 
in response to the cold pressor test for the 
infused and non-infused leg, separately, were 
identifi ed using a Wilcoxon’s signed rank 
test. (Statistical Package for Social Sciences 
(SPSS) 14.0). Statistical signifi cance level 
was set at 5% (two sided).
Results
Baseline characteristics
Baseline supine leg blood fl ow (LBF) and leg 
vascular resistance (LVR) of  the infused leg 
did not differ between the groups (Table 2).
α-adrenergic contribution to HUT-
induced vasoconstriction (Figure 2)
Controls 
The HUT-induced vasoconstriction was 
12 ± 2 AU (62 ± 13%) during infusion of  
saline. During infusion of  the non-selective 
α-blocking agent, phentolamine, HUT still 
caused  vasoconstriction (10 ± 2 AU; 66 ± 
13%), and this response did not differ from 
HUT-induced vasoconstriction during saline 
infusion (Figure 1).
Because supine LVR was lower during 
infusion of  phentolamine compared to saline 
a more pronounced response to HUT during 
infusion of  phentolamine can be expected 
(see method section). To further analyse this 
confounding effect of  differences in baseline 
LVR between saline and phentolamine 
infusion an increase in baseline supine blood 
fl ow was induced by sodium nitroprusside 
(SNP) infusion prior to HUT. Supine LVR 
during infusion of  SNP decreased to 12 ± 
2 AU, which signifi cantly differed from the 
values obtained during both saline (23 ± 4 
AU; P=0.002) and phentolamine infusion 
(16 ± 3 AU; P=0.019). The HUT-induced 
vasoconstriction during infusion of  SNP (18 
± 2 AU; 165 ± 21%; P=0.002 and P=0.04, 
respectively) was signifi cantly higher than 
during infusion of  phentolamine and saline.
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Spinal cord-injured individuals
The HUT-induced vasoconstriction during 
infusion of  SNP or phentolamine did not 
differ, but tended to be signifi cantly lower 
during saline infusion within SCI subjects 
(P=0.055 and P=0.065 for comparison 
saline-phentolamine, and saline-SNP, 
respectively) (Figure 2). Like in controls 
supine LVR was signifi cantly lower during 
phentolamine and SNP infusion than 
during saline infusion. During infusion of  
phentolamine supine LVR did not differ 
between the groups. The vasoconstrictor 
responses upon HUT during saline, SNP 
and phentolamine infusion did not differ 
between the groups (saline: SCI: 7 ± 3 AU 
(n=8), controls: 12 ± 2 AU; SNP: SCI: 16 
± 2 AU, controls 18 ± 2 AU; phentolamine: 
SCI: 15 ± 3 AU, controls: 10 ± 2 AU)
Blood pressure and heart rate in res-
ponse to HUT
In controls, MAP increased in all HUT 
sessions, but in SCI a HUT-induced 
increase in MAP was only observed during 
saline infusion (Table 2). In controls heart 
rate did not increase from supine to HUT 
Leg vascular resistance (AU)
0
10
20
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40
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60
Controls
SCI
SNP Saline PhentolamineSaline Saline
Leg vascular resistance in arbitrary units (AU) ± SEM in the infused leg of controls and spinal Figure 2. 
cord-injured individuals (SCI). This fi gure clearly demonstrates that during infusion of phentolamine 
head-up tilt still caused vasoconstriction, and the vasoconstriction during infusion of phentolamine was 
independent of intact sympathetic barorefl ex control since head-up tilt-induced vasoconstriction in SCI 
was comparable with controls.
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during saline, but showed an increase in 
response to HUT during infusion of  SNP 
and phentolamine (4.6% ± 0.9, P=0.001; 
and, 10.2 % ± 1.2, P<0.001, respectively). In 
SCI, heart rate tended to increase in response 
to HUT during saline and phentolamine 
infusion (7.8% ± 3.8, P=0.073, and 10.6% 
± 6.2, P= 0.099, respectively), but did not 
increase during infusion of  SNP.
Non-infused leg in controls and time-
control experiment
Throughout the experiment supine LBF 
during saline infusion did not change. In 
Mean absolute values ± SEM for all parameters.Table 2. 
Controls
Dose of drugs
LBF MAP LVR HR
Infused Non-infused Infused Non-infused
Saline
Supine 4.2 ± 0.5 4.1 ± 0.6 83 ± 4 23 ± 4 24 ± 3 58 ± 2
HUT 2.7 ± 0.2 2.5 ± 0.3 88 ± 5 34 ± 2 39 ± 4 58 ± 2
Saline Supine 3.8 ± 0.5 3.7 ± 0.5 91 ± 4 28 ± 3 32 ± 6 56 ± 2
SNP
Supine 8.2 ± 1.0 3.1 ± 0.5* 87 ± 3 12 ± 2 33 ± 5* 59 ± 1
HUT 3.4 ± 0.3 2.1 ± 0.3* 93 ± 4 30 ± 3 54 ± 8* 62 ± 2
Saline Supine 3.8 ± 0.4 3.5 ± 0.4* 98 ± 4 30 ± 4 33 ± 5* 55 ± 1
Phent
Supine 6.2 ± 0.5 3.4 ± 0.6* 94 ± 4 16 ± 3 34 ± 5* 62 ± 2
HUT 4.1 ± 0.3 2.4 ± 0.2* 102 ± 5 26 ± 2 47 ± 6* 68 ± 2
Spinal cord-injured individuals
Dose of drugs
LBF MAP LVR HR
Infused Non-infused‡ Infused Non-infused‡
Saline
Supine 3.4 ± 0.6 3.0 ± 0.8 95 ± 5 35 ± 4 47 ± 10 57 ± 3
HUT 2.5 ± 0.3‡ 2.1 ± 0.5 101 ± 6 45 ± 5‡ 60 ± 8 61 ± 3
Saline Supine 3.4 ± 0.5 3.0 ± 0.7 102 ± 7 33 ± 3 41 ± 5 58 ± 3
SNP
Supine 7.9 ± 1.0 3.7 ± 0.9 92 ± 6 13 ± 2 30 ± 4 67 ± 4
HUT 3.6 ± 0.5 3.4 ± 0.5 96 ± 6 29 ± 2 50 ± 7 71 ± 7
Saline Supine 3.5 ± 0.6 3.2 ± 0.8 99 ± 4 32 ± 4 39 ± 6 56 ± 4
Phent
Supine 5.3 ± 0.9 3.7 ± 0.7 97 ± 4 22 ± 3 30 ± 4 62 ± 3
HUT 2.9 ± 0.4 2.5 ± 0.5 98 ± 5 37 ± 4 43 ± 4 68 ± 3
* n=9          ‡ n=8
Phent = phentolamine; SNP = sodium nitroprusside; HUT = 30º head-up tilt; LBF = leg blood fl ow in ml/
min per dl; MAP = mean arterial pressure in mmHg; LVR = leg vascular resistance; HR = heart rate in beats 
per minute.
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supine position LVR, in both the infused and 
non-infused leg, and mean arterial pressure 
increased throughout the whole experiment 
(Table 2). These results are consistent with 
the time-control experiments (data not 
shown).
In the time-control experiment absolute 
changes in LVR in response to HUT 
became signifi cantly less with subsequent 
HUT-manoeuvres (1st: 19 ± 5 AU, 2nd: 17 
± 3 AU, 3rd: 10 ± 3 AU; P=0.014) In the 
non-infused leg of  the control subjects 
absolute changes in response to HUT did 
not decrease throughout the experiment 
(LVR: saline: 16 ± 3 AU, SNP: 21 ± 5 AU, 
phentolamine: 14 ± 4 AU).
Confi rmation of complete 
α-adrenergic blockade by the cold 
pressor test (n=6)
Complete α-adrenergic blockade was 
confi rmed by a cold pressor test. In the 
phentolamine infused leg a slight, but 
irrelevant, increase in LVR was observed 
(phentolamine: 19 ± 3 AU; phentolamine 
and cold pressor test: 20 ± 2; P=0.046), 
while in the non-infused leg the cold pressor 
test induced an increase in LVR from 31 ± 
6 AU to 53 ± 12 AU (P=0.026).
Discussion
In the present study the α-adrenergic 
contribution to head-up tilt induced 
vasoconstriction in the leg was assessed 
by infusing an α-adrenergic blocking agent 
– phentolamine – into the femoral artery 
in supine and head-up tilt position. The 
major fi nding is that after pharmacological 
blockade of  the α-adrenergic receptor, leg-
vasoconstrictor responses are still present 
upon head-up tilt (HUT) in humans, 
irrespective of  an intact sympathetic 
barorefl ex. Other mechanisms, such as the 
myogenic response, and stimulation of  
non-adrenergic receptors by sympathetic 
neurotransmitters that are co-released 
with norepinephrine, possibly contribute 
to leg vasoconstriction during postural 
stress. This study reveals that redundant 
mechanisms compensate for the absence 
of  α-adrenergic vasoconstriction in the leg 
of  healthy volunteers during postural stress. 
In spinal cord-injured individuals these 
redundant mechanisms do not depend on 
an intact barorefl ex. 
Phentolamine, a non-selective 
α-adrenoceptor blocker, was infused 
into the femoral artery to block the 
α-adrenergic receptor. Nevertheless, 
HUT still induced leg vasoconstriction 
comparable to that during saline infusion. 
Could incomplete α-adrenoceptor blockade 
explain this preserved HUT-induced leg 
vasoconstriction? Using a similar dose, 
a maximal and comparable vasodilator 
effect was achieved in previous studies, 
for both controls and spinal cord-injured 
individuals (SCI), indicating complete 
α-adrenoceptor blockade in the leg vascular 
bed.15, 24 Moreover, during an endogenous 
sympathetic stimulus (the cold pressor 
test) vasoconstriction was abolished in the 
phentolamine infused leg as compared to 
the non-infused leg. This confi rms that 
intra-arterial infusion of  phentolamine 
achieved effective intrasynaptic drug 
concentrations. 
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A possible inhibiting effect of  phentolamine 
on leg vasoconstriction could have 
been masked by phentolamine-induced 
vasodilatation prior to HUT. Therefore, 
HUT was also performed under SNP 
infusion. Supine vasodilatation induced by 
phentolamine was less than during SNP, 
and the HUT-induced vasoconstriction 
was smaller during phentolamine than 
during SNP. Although a small confounding 
effect of  differences in supine leg vascular 
resistance cannot be ruled out, this does not 
explain the preserved leg vasoconstriction 
during HUT under phentolamine infusion. 
In addition, the time-control experiment 
demonstrated that during consecutive HUT 
procedures leg vascular responses subside. 
Therefore, the lack of  difference in HUT-
induced vasoconstriction during infusion 
of  phentolamine (third) and saline (fi rst) 
only strengthens our conclusion that HUT-
induced vasoconstriction is to a large extent 
preserved during α-adrenergic blockade.
Spinal cord-injured individuals exhibited 
a similar HUT-induced vasoconstriction 
compared with controls during infusion of  
SNP, when supine blood fl ow values were 
comparable between the groups. Former 
observations where leg vasoconstriction, 
in either skin or muscle vasculature, in 
response to postural change was hardly 
infl uenced by central sympathetic blockade2 
(epidural29 or proximal nerve blockade,4 
acute sympathectomy2 or in spinal cord-
injured individuals5-7, 30) suggested that 
the venoarteriolar refl ex is responsible 
for the observed vasoconstriction. The 
venoarteriolar refl ex involves α-adrenergic 
sympathetic nerves.9, 29 However, the present 
study shows that in SCI, where HUT-
induced vasoconstriction relies on local 
mechanisms solely, leg vasoconstriction is 
not affected by local α-adrenergic blockade. 
This observation questions the importance 
of  the venoarteriolar refl exes in HUT-
induced vasoconstriction or, alternatively, 
makes the α-adrenergic origin of  the 
venoarteriolar refl ex  uncertain.31
Besides α-adrenergic neurotransmitters, 
other neurotransmitters, such as ATP 
and neuropeptide Y, are released 
simultaneously with norepinephrine by 
the sympathetic nerve endings and can 
cause vasoconstriction by activating P2x 
receptors and Y1 receptors, respectively, 
as has been assessed in animal research.32 
When the sympathetic nervous system 
is stimulated by Lower Body Negative 
Pressure (LBNP) in humans, blockade of  
the α-adrenoceptor did not abolish, but 
reduced, vasoconstriction in the forearm 
arterioles.11 Complete elimination of  
vasoconstriction with bretylium revealed 
the presence of  a certain amount of  non-
adrenergic sympathetic vasoconstriction 
in humans. In the forearm these non-
adrenergic sympathetic mechanisms could 
not fully compensate for the absence of  
α-adrenergic vasoconstriction, whereas the 
present study showed that in the leg the 
HUT-induced vasoconstrictor response 
was completely compensated during 
α-adrenoceptor blockade. This discrepancy 
may be related to the HUT-induced change 
in transmural pressure in the leg, eliciting 
the myogenic response, which is absent in 
the forearm during LBNP.
The co-release of  other neurotransmitters 
in spinal cord-injured individuals is not 
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likely, since they have no central control 
of  barorefl ex activity which is confi rmed 
by the lack of  a rise in levels of  plasma 
noradrenaline upon HUT.33, 34 Non-
adrenergic sympathetic mechanisms can, 
therefore, not explain the observed leg 
vasoconstriction during HUT in SCI. 
Most likely, the observed vasoconstriction 
during α-adrenoceptor blockade upon 
HUT in SCI, can be explained by myogenic 
vasoconstriction in arterioles in response 
to the increase in lower limb transmural 
pressure.35 Sympathoexcitation may 
facilitate myogenic responses to changes 
in transmural pressure.36 The present 
study, however, showed that even when the 
sympathetic α-adrenergic contribution to 
vascular tone is blocked, and in individuals 
who lack supraspinal sympathetic control, 
HUT-induced leg vasoconstriction is still 
largely preserved. This suggests that when 
normal sympathetic regulatory mechanisms 
fail, like in SCI, the myogenic response 
comes into play.13
Questions may arise about the involvement 
of  humoral vasoconstrictor factors, like 
renin-angiotensin, vasopressin, aldosterone, 
and epinephrine. No changes of  these 
hormones have been found within 10 
minutes of  HUT in healthy controls and 
paraplegics, whereas a slight increase was 
observed in quadriplegics.21, 37, 38 Since in 
the present study HUT only lasted for 5 
minutes and all, but one, were paraplegic 
individuals humoral mechanisms will not 
explain the observed vasoconstriction. 
Conclusions could only be drawn on the 
vasoconstriction in the leg vascular bed 
and not on other vascular beds, i.e. the 
splanchnic area, which also plays a role 
in restoring blood pressure upon HUT. 
SCI maintained, but did not enhance 
blood pressure as observed in controls 
in response to HUT during infusion 
of  phentolamine and SNP. This is in 
accordance with former observations 
in SCI, 7where both blood pressure and 
total peripheral vascular resistance did not 
increase. In most of  our SCI subjects (6 
to 8 out of  9) the splanchnic area is not 
under barorefl ex control. Therefore, HUT-
induced increase in splanchnic vascular 
tone may be blunted, since it is not known 
whether compensatory mechanisms, like 
for example myogenic responses, may also 
play a role in the splanchnic area.
Limitations
Thirty degrees HUT provokes mild 
orthostatic stress and it may be considered 
to what extent the sympathetic outfl ow 
to the leg is increased by unloading the 
baroreceptors. Although sympathetic 
nervous activity was not measured, 30° 
HUT causes a signifi cant increase in muscle 
sympathetic nerve activity,23 and results 
in signifi cant cardiovascular effects.20-23 
Although in controls heart rate did not 
show a statistically signifi cant increase 
upon HUT during infusion of  saline in the 
steady state situation (the average over the 
last 2 min. of  each HUT session), heart rate 
initially increased upon HUT (from 59 ± 2 
beats/min just before HUT to 63 ± 2 beats/
min during the fi rst minute into HUT), 
indicating autonomic changes compatible 
with barorefl ex activation. Moreover, a more 
pronounced HUT-induced increase in heart 
rate was observed during infusion of  both 
SNP and phentolamine supporting that the 
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orthostatic challenge is not reduced during 
subsequent head-up tilts and suffi cient to 
alter autonomic outfl ow. In addition, the 
most profound changes in leg blood fl ow 
as measured by echo Doppler and venous 
occlusion plethysmography were observed 
from supine to 30° HUT and did not 
further change when HUT continued to 
45° and 70°.19
This study shows that in humans under 
conditions of  effective α-adrenergic 
blockade, leg vasoconstriction upon 
head-up tilt is still preserved, regardless 
of  an intact barorefl ex control of  the leg 
vascular bed. Thus, in humans redundant 
mechanisms compensate for the absence 
of  α-adrenergic vasoconstriction in the leg 
vascular bed that is subject to orthostatic 
changes. In humans with intact barorefl ex 
control of  the leg vascular bed stimulation 
of  non-adrenergic receptors and myogenic 
mechanisms may come into play, whereas 
in spinal cord-injured individuals, who lack 
barorefl ex control of  the leg vascular bed, 
head-up tilt-induced vasoconstriction relies 
most likely on the myogenic response.
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Abstract 
Background – Local vasoconstriction plays an 
important role in maintaining blood pressure in spinal 
cord-injured individuals (SCI). We aimed to unravel the 
mechanisms of local vasoconstriction (venoarteriolar 
refl ex (VAR) and myogenic response) using both limb 
dependency and cuff  infl ation in SCI and compare 
these with control subjects.
Methods – Limb blood fl ow was measured in 11 male 
SCI (age: 24-55 year) and 9 male controls (age: 23-
56 year) using venous occlusion plethysmography 
in forearm and calf during three levels of (1) limb 
dependency, and (2) cuff  infl ation. During limb 
dependency vasoconstriction relies on both the VAR 
and the myogenic response. During cuff  infl ation 
the decrease in blood fl ow is caused by the VAR and 
by a decrease in arterio-venous pressure diff erence, 
whereas the myogenic response does not play a role.
Results – At the highest level of leg dependency 
the percent increase in calf vascular resistance 
(mean arterial pressure/calf blood fl ow) was more 
pronounced in SCI than in controls (SCI: 186 ± 53% 
and controls: 51 ± 17% (P=0.032)). In contrast, during 
cuff  infl ation no diff erences were found between SCI 
and controls (SCI: 17 ± 17% and controls: 14 ± 10%). 
Percent changes in forearm vascular resistance in 
response to either forearm dependency or forearm 
cuff  infl ation were equal in both groups.
Conclusion – Local vasoconstriction during 
dependency of the paralyzed leg in SCI is enhanced. 
The contribution of the VAR to local vasoconstriction 
does not diff er between the groups, since no 
diff erences between groups existed for cuff  infl ation. 
Therefore, the augmented local vasoconstriction in 
SCI during leg dependency relies, most likely, on the 
myogenic response.
Local vasoconstriction in humansTable 1. 
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Introduction
In individuals with a spinal cord injury 
(SCI), sympathetic brainstem control of  the 
vascular bed below the level of  the spinal 
cord lesion is defi cient. Despite the absence 
of  central sympathetic control,1 these patients 
show a remarkable orthostatic tolerance 
during postural stress and, in particular 
the paraplegic individuals, maintain blood 
pressure during orthostatic challenges.2 
Moreover, preservation of  tilt-induced leg 
vasoconstriction in these individuals has 
been reported.3-5
Local mechanisms have to play an important 
role in the tilt-induced increase in leg vascular 
tone in SCI. The myogenic response, which 
is triggered when transmural pressure 
across an arteriole is increased, seems to 
be partly responsible for the increase in 
leg vascular resistance in healthy able-
bodied individuals upon head-up tilt6 but 
could also explain vasoconstriction in SCI 
individuals. Former research suggests that 
the local venoarteriolar refl ex (VAR),7-10 
which is elicited when venous transmural 
pressure exceeds 25 mmHg, contributes to 
the observed tilt-induced vasoconstriction 
in the leg muscle of  SCI.4, 5 Originally the 
VAR was thought to be mediated via a 
sympathetic α-adrenergic mechanism, but 
recent evidence suggests a non-adrenergic 
mechanism.11
The mechanisms of  local vasoconstriction, 
i.e. VAR and myogenic response, have been 
evaluated during venous congestion by cuff  
infl ation, and by lowering the limb below 
heart level (limb dependency).12-15 During cuff  
infl ation the reduction in blood fl ow may 
not be solely due to the VAR. A decrease 
in local perfusion pressure between arteries 
and veins may also reduce blood fl ow upon 
Characteristics of the spinal cord-injured individuals.Table 1. 
Subject Age,
Years
Level 
of 
spinal 
lesion
Complete-
ness of 
lesion
(ASIA score)
Time 
since 
injury,
Years
Spastic 
paresis
Sweating 
below 
spinal 
lesion
Smoking Medication
1 24 T5 A 4 + - - -
2 44 T5 A 22 + + - -
3 46 T10 A 6 + - + Antibiotic
4 33 T11 A 6 - - + -
5 46 T8 A 11 + - - -
6 42 T12 A 20 - + - Furadantine 50mg
7 37 T4 A 9 + - - Detrusitol, Microlax
8 54 T9 A 15 + + - -
9 43 T9 B 21 + - - Bisoprofumaraat 20mg
10 51 C6 B 21 + - - -
11 44 T10 B 3 + - - Oxybutynine HCL5, 
Sirdalud 2mg, Baclofen
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cuff  infl ation. It was previously found that 
upon lowering the hand or foot below heart 
level venous as well as arterial pressure rise 
equally in the hand and foot, respectively.16, 
17 So, assuming that limb dependency 
does not affect perfusion pressure, the 
consequent reduction in blood fl ow 
may not be solely due to the VAR via an 
increase in venous transmural pressure, but 
may also be due to the myogenic response, 
which is elicited when arteriolar transmural 
pressure increases (Figure 1). By use of  
limb dependency and cuff  infl ation of  the 
leg, Okazaki et al calculated that in healthy 
men the VAR and the myogenic response 
contribute 55% and 45%, respectively, to 
local postural skin vasoconstriction.12
Because of  the lack of  sympathetic 
barorefl ex control below the level of  the 
spinal cord lesion, SCI individuals depend 
more on local vasoconstriction mechanisms 
during orthostatic challenges. Therefore, in 
this study we aimed to unravel the different 
local vasoconstriction mechanisms 
in SCI individuals by comparing the 
vasoconstriction in SCI individuals with 
able-bodied control subjects in response to 
both limb dependency and cuff  infl ation 
above (forearm) and below (calf) the level 
of  the spinal lesion. Based on previous 
research,18 demonstrating the highest initial 
decrease in cutaneous blood fl ow upon 
leg dependency in SCI individuals, we 
hypothesize that the vasoconstriction to 
both limb dependency and cuff  infl ation 
is more pronounced in SCI individuals 
than in controls because of  enhancement 
of  both myogenic and venoarteriolar 
vasoconstriction.
Baseline characteristics.Table 2. 
SCI (n=11) C (n=9) P-value
Age, y 42 ± 2 38 ± 1 0.384
Body mass, kg 82 ± 4 80 ± 3 0.712
Height, m 1.83 ± 0.02 1.83 ± 0.01 0.785
SBP, mmHg 119 ± 2 126 ± 3 0.04
DBP, mmHg 77 ± 3 82 ± 2 0.122
MAP, mmHg 91 ± 2 96 ± 2 0.06
CBF, ml·100ml-1·min-1 (*) 3.0 ± 0.5 2.0 ± 0.2 0.086
CVR, AU (*) 38 ± 6 44 ± 6 0.446
FBF, ml·100ml-1·min-1 (*) 4.4 ± 0.8 5.2 ± 0.8 0.467
FVR, AU (*) 30 ± 6 20 ± 3 0.138
Exercise, h/wk 1.8 ± 2.2 1.8 ± 1.6 0.964
Values are mean ± SEM. (*) Mean of two baseline values; SCI, spinal cord-injured individuals; 
C, controls; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial 
pressure; CBF, calf blood fl ow; CVR, calf vascular resistance; FBF, forearm blood fl ow; FVR, 
forearm vascular resistance.
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Methods
Subjects
Eleven spinal cord-injured individuals 
(SCI) and nine able-bodied controls (all 
men) volunteered to participate in this 
study. Individual baseline characteristics of  
the SCI are shown in Table 1, and baseline 
characteristics of  both groups are presented 
in Table 2. 
The SCI continued their medication 
throughout the study. The study was 
carried out according to the principles of  
the Declaration of  Helsinki. All subjects 
gave their written informed consent before 
participation and the study was approved 
by the Hospital Ethics Committee. 
Measurements
Calf  and forearm blood fl ow were measured 
by electrocardiography-triggered venous 
occlusion plethysmography using mercury-
in-silastic strain gauges (E-4 Hokanson, 
Hokanson, Bellevue, WA.). The electrically 
calibrated gauges were stretched around 
the thickest part of  the right forearm and 
calf  and connected to the plethysmograph 
(Loosco, Amsterdam, The Netherlands). 
The “plethysmography” cuff  was wrapped 
around the right upper leg and arm (10-cm 
width) and connected to an adjustable air 
pressure source (E-20 Hokanson Rapid 
Cuff  Infl ator and AG-101 Cuff  Infl ator 
Pressure source, Hokanson). A double 
occlusion cuff  arrangement was used to 
measure limb blood fl ow during increases 
of  local venous pressure. We, therefore, 
placed a second cuff  (=congesting cuff) 
proximal to the “plethysmography” cuff, 
that was connected to a manometer to 
raise local venous pressure during “cuff  
infl ation” (see Figure 1 for set-up). A fi nger 
cuff  was attached to the middle phalanx of  
the left third fi nger, which was kept at heart 
level, in order to measure fi nger arterial 
blood pressure using Portapres (TNO, The 
Netherlands). Data were collected beat to 
beat during the experiment at a sampling 
rate of  200 Hz. A built in expert system, 
physiocal, was in operation to establish and 
adjust a proper volume clamp setpoint. 
Heart rate was recorded, beat-to-beat, from 
a 3-lead ECG.
Protocol
Subjects were asked to refrain from 
drinking coffee, tea, cola or alcohol in the 
18 hours before testing, and not to eat 2 
hours before testing. All individuals had 
emptied their bladder 1.5 hours prior to 
testing to minimize the possibility of  any 
refl ex sympathetic activity from bladder 
fi lling on vascular tone.
All tests were performed in the afternoon 
with the subjects in supine position in a 
quiet temperature-controlled room.
Each experiment consisted of  four 
measurements: forearm blood fl ow as well 
as calf  blood fl ow were measured during 
both cuff  infl ation and limb dependency. 
The order of  the measuring site (forearm 
or calf) and the order of  the condition 
(limb dependency or cuff  infl ation) were 
randomized among the subjects.
Cuff  inflation (Figure 1)
Calf  and forearm blood fl ow were measured 
during an increase in supine local venous 
pressure by infl ating a cuff  (=congesting 
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cuff) proximal to the “plethysmography” 
cuff. Congesting cuff  pressure was set at 
different levels: baseline, 15 mmHg, and 25 
mmHg for the arm; and baseline, 15, and 30 
mmHg for the leg. Calf  or forearm blood 
fl ow were fi rst measured in supine position 
without increasing local venous pressure, 
with the limb just above heart level, for 
four minutes with the “plethysmography” 
pressurized intermittently to 40 mmHg.19 To 
increase local venous pressure, the proximal 
congesting cuff  at the arm and thigh were 
infl ated to 15 mmHg for four minutes, 
which increases local venous pressure to 
a similar magnitude.20-22 Blood fl ow was 
measured with the “plethysmography” cuff  
pressure adjusted to local venous pressure 
and was set at 55 mmHg. After four 
minutes, local venous pressure was raised to 
25 mmHg and 30 mmHg for the forearm 
and calf, respectively, and blood fl ow was 
measured with the “plethysmography” 
cuff  pressurized to 65, and 70 mmHg, 
respectively. For all individuals, diastolic 
blood pressure was more than 70 mmHg, so 
blood fl ow measured by venous occlusion 
plethysmography was not affected.19
A. Limb dependency
1. Pv ↑ (VAR)
2. Pa ↓(Myogenic)
3. ΔPa-v=
Levels of limb dependency
1. SG: Heart level
2. SG: 19 cm below heart level
3. SG: 32/39 cm below heart level
 “Plethysmography” cuff 
Strain gauge (SG) 
Figure 1A. During limb dependency venous 
(transmural) pressure (Pv) and arteriolar 
(transmural) pressure (Pa) rise equally due to 
an increase in hydrostatic pressure. Therefore, 
the arterio-venous pressure difference does 
not change. So, limb blood fl ow decreases 
by eliciting the venoarteriolar refl ex (VAR) via 
an increase in Pv and the arteriolar myogenic 
response via an increase in Pa.
B. Cuff  infl ation
1. Pv ↑ (VAR)
2. Pa =
3. ΔPa-v↓
Levels of cuff  infl ation
1. Heart level
2. 15 mmHg cuff  pressure
3. 25/30 mmHg cuff  pressure
 “Plethysmography” cuff 
Strain gauge (SG) 
Figure 1B. Limb cuff  infl ation impedes venous 
return resulting in venous congestion. 
Subsequently Pv rises whereas infl ation of the 
cuff minimally affects Pa. Therefore, arterio-
venous pressure difference (ΔPa-v) is decreased, 
resulting in a decrease in driving pressure. 
Since Pa is minimally affected, the arteriolar 
myogenic response is not likely to be activated. 
So, during cuff infl ation limb blood fl ow 
decreases by a decrease in driving pressure 
(ΔPa-v) and by eliciting the VAR via an increase 
in Pv independently of the arteriolar myogenic 
response.
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Limb dependency (Figure 1)
 In order to match the increase in local 
venous pressure during limb dependency 
with cuff  infl ation, the limb was lowered 
such that the strain gauge was 0, 19, and 
32 cm below heart level for the forearm 
and 0, 19, and 39 cm below heart level for 
the calf. The hydrostatic pressure column 
in mmHg was calculated with the formula: 
0.776*hydrostatic pressure in cm blood. 
Calf  or forearm blood fl ow were fi rst 
measured in supine position. Thereafter the 
limb was lowered such that the strain gauge 
was 19 cm below heart level and blood fl ow 
measurements continued for four minutes. 
Subsequently, blood fl ow was measured 
with the forearm and calf  lowered to 32 cm 
and 39 cm below heart level, respectively. 
Cuff  pressure for blood fl ow measurements 
was adjusted to the hydrostatic pressure 
column when the “plethysmography” 
cuff  was below heart level. Due to a hip 
contracture or an increase in spasm in two 
SCI individuals, the limb was lowered to 32 
and 36 cm, respectively.
With limb dependency, transmural pressure 
in the arterioles increases in accordance 
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A typical plethysmographic tracing of the blood fl ow measurements during leg dependency Figure 2. 
of one control individual. The arrows indicate the levels of leg dependency. Notice that calf volume 
increases with increasing levels of leg dependency. Besides, looking at a typical plethysmographic 
tracing at 39 cm leg dependency, the increase in venous volume is linear during the fi rst 5 seconds 
of cuff infl ation, indicating that blood fl ow measurements using venous occlusion plethysmography 
during leg dependency are not compromised by a decrease in venous compliance.
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with the hydrostatic pressure gradient 
between the heart and the limb.16 Initially, 
the venous valves restrict the backward 
fl ow preventing limb venous pressure to 
increase to the same hydrostatic pressure. 
However, as blood continues to fl ow from 
the arteries into the dependent veins, they 
are fi lled with blood and the valves are 
forced open in a heart ward progression 
until there is an uninterrupted hydrostatic 
column between the central circulation 
and the limbs.16 Thus, once all venous 
valves are open, the limb venous pressure 
is the sum of  the dynamic pressure and 
the hydrostatic pressure.16 Therefore, the 
premise of  this study is that there is no net 
change in perfusion pressure during limb 
dependency. 
When local venous pressure is 30 mmHg 
the venous system is still at its steep 
compliant part of  the curve, which indicates 
that venous occlusion plethysmography 
represents arterial infl ow and is not affected 
by venous compliance.23 This is illustrated 
in Figure 2 where upon the highest level 
of  leg dependency the increase in leg 
volume is linear during the fi rst 5 seconds 
of  cuff  infl ation, indicating that blood 
fl ow measurements using venous occlusion 
plethysmography during leg dependency 
are not compromised by a decrease in 
venous compliance.
Data analysis
Data were digitalized with a sample 
frequency of  100 Hz (MIDAC, 
Instrumentation Department, Radboud 
University Nijmegen Medical Centre, 
The Netherlands) and analyzed by a 
customized computer program (Matlab 6.1; 
Mathworks, Natick, MA, USA). Blood fl ow 
was calculated as the slope of  the volume 
change over a 4-seconds interval. An 
initial steep rise, previously observed and 
attributed to a cuff  infl ation artifact,24 was 
skipped. Registrations with artifacts, due 
to movements, were excluded. The blood 
fl ow values over the last 2 minutes in each 
stage of  cuff  infl ation or limb dependency 
(12-17 slopes) were averaged and represent 
arterial infl ow in ml·100ml-1·min-1. 
Baseline vascular resistance was calculated 
by dividing [(arterial pressure, Pa) – (local 
venous pressure, Pv)]/arterial infl ow. Pa was 
assumed to be equal to MAP. For supine Pv 
5 mmHg was used since pilot experiments 
and previous literature20 demonstrates that 
when the limb is above heart level resting 
venous pressure varies between 0 and 7 
mmHg. During cuff  infl ation vascular 
resistance was estimated from [(arterial 
pressure, Pa) – (local venous pressure, 
Pv)]/arterial infl ow. Pa was assumed to 
be equal to MAP and Pv was equal to 
the cuff  infl ation pressure. Experiments 
in our laboratory, where venous pressure 
upon venous congestion was measured in 
the vena saphena magna at the ankle in a 
group of  three healthy volunteers, have 
demonstrated that cuff  pressure is a good 
index for local venous pressure (a cuff  
pressure of  30 mmHg corresponds with a 
venous pressure of  27 ± 2 mmHg). This 
is also in line with previous literature.20-22 
During limb dependency Pa and Pv were 
assumed to increase similarly with no 
change in perfusion pressure.16, 17 In three 
volunteers, we verifi ed the increase in venous 
pressure during limb dependency: local 
venous pressure during limb dependency, 
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measured invasively, with the ankle ranging 
from 39-54 cm below heart level, increased 
up to 40 mmHg, which corresponds with 
the calculated increase in venous pressure 
based on the height difference between 
ankle and heart.
Vasoconstriction was quantifi ed by 
normalizing blood fl ow and vascular 
resistance during cuff  infl ation and limb 
dependency to baseline values and was 
presented as percent change from baseline.
Hemodynamic responses during cuff  infl ation and limb dependency in the forearm and calf.Table 3. 
   Limb dependency
Spinal cord-injured individuals (n=11) Control (n=9)
Cm below 
heart level
0 19 F32/C39 max % D 0 19 F32/C39 max % D
Calf
BF 3.0 ± 0.5 1.7 ± 0.2 1.3 ± 0.2 -44 ± 9 1.9 ± 0.2 1.7 ± 0.2 1.5 ± 0.2 (*‡) -18 ± 8
VR 39 ± 8 67 ± 14 95 ± 22 186 ± 53 45 ± 6 58 ± 7 67 ± 9 (*) 51 ± 17 (†)
HR 64 ± 3 63 ± 3 62 ± 3 61 ± 2 61 ± 3 61 ± 3
MAP 85 ± 3 88 ± 4 91 ± 4 84 ± 3 87 ± 3 87 ± 3 (*)
Forearm
BF 4.8 ± 1.0 2.3 ± 0.2 1.7 ± 0.2 -54 ± 7 5.3 ± 0.8 3.2 ± 0.4 2.5 ± 0.3 (*) -45 ± 8
VR 30 ± 7 48 ± 8 70 ± 12 248 ± 94 19 ± 4 31 ± 4 39 ± 4 (*) 163 ± 57
HR 66 ± 3 66 ± 4 64 ± 4 61 ± 2 60 ± 2 60 ± 3
MAP 89 ± 5 89 ± 4 93 ± 4 83 ± 3 84 ± 3 85 ± 3 (*)
Cuff  infl ation
Spinal cord-injured individuals (n=11) Control (n=9)
Infl ation 
pressure 
(mmHg)
0 15 F25/C30 max % D 0 15 F25/C30 max % D
Calf
BF 3.0 ± 0.5 2.7 ± 0.4 1.9 ± 0.2 -29 ± 8 2.1 ± 0.3 1.8 ± 0.2 1.3 ± 0.1(*) -34 ± 4
VR 37 ± 7 34 ± 5 37 ± 6 17 ± 17 43 ± 5 43 ± 4 47 ± 4 14 ± 10
HR 63 ± 4 66 ± 3 62 ± 3 61 ± 3 60 ± 3 62 ± 3 (‡)
MAP 85 ± 3 86 ± 3 86 ± 3 86 ± 4 86 ± 4 88 ± 4
Forearm
BF 4.0 ± 0.7 3.3 ± 0.6 2.6 ± 0.4 -34 ± 5 5.2 ± 0.9 4.4 ± 0.6 3.5 ± 0.4(*) -30 ± 4
VR 28 ± 4 31 ± 5 35 ± 7 18 ± 7 20 ± 3 19 ± 3 21 ± 3 9 ± 6
HR 64 ± 3 63 ± 3 63 ± 3 61 ± 3 61 ± 3 62 ± 2
MAP 87 ± 3 88 ± 3 89 ± 3 87 ± 4 87 ± 3 87 ± 4
Values are mean ± SEM. BF, blood fl ow (ml·100ml-1·min-1); VR, vascular resistance (AU); HR, 
heart rate (min-1); MAP, mean arterial pressure (mmHg); F, forearm; C, calf; max % D, maximal 
percent change from baseline (= 0); (*) statistically signifi cant (P<0.05) cuff or limb dependency 
(=pressure) effect; (†) statistically signifi cant (P<0.05) between the SCI and C group. (‡) statistically 
signifi cant (P<0.05) group * pressure interaction.
Local vasoconstriction in humans
119
Statistical analysis
All values are reported as means ± SEM, 
unless otherwise indicated. Baseline 
characteristics were tested using Student’s 
t-test. Differences between the groups 
were analyzed by means of  two way 
repeated measures ANOVA, with the 
pressure (levels of  limb dependency or 
cuff  infl ation) as within subject factor and 
the presence of  a SCI as between subject 
factor. The pressure factor represents the 
overall effect of  limb dependency or cuff  
infl ation. The pressure by group factor 
was used to test for differences of  limb 
dependency or cuff  infl ation between the 
groups. Statistically signifi cant differences 
were further analyzed by unpaired t-tests 
at the highest level of  limb dependency or 
cuff  infl ation. Statistically signifi cance level 
was set at P<0.05.
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individuals (SCI) and controls (C). Data are presented as means ± SEM. The brackets respresent the results 
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for the group by pressure interaction).
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Results
Baseline characteristics
The two groups did not differ with respect 
to age, body mass, height, diastolic blood 
pressure, mean arterial pressure (MAP), 
and hours exercise per week. Systolic blood 
pressure was signifi cantly lower in SCI 
than in control subjects. Baseline calf  and 
forearm blood fl ow and vascular resistance 
did not differ between the groups (Table 2).
Calf: SCI versus controls
Cuff  inflation
During cuff  infl ation, calf  blood fl ow 
decreased with increasing cuff  pressure in 
both groups (Table 3; Figure 3C). However, 
calf  vascular resistance did not change with 
increasing cuff  pressure (Table 3; Figure 
3D). The responses in both calf  blood 
fl ow and calf  vascular resistance during 
cuff  infl ation did not differ between the 
groups.
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Limb dependency
During leg dependency, calf  blood fl ow 
decreased and calf  vascular resistance 
increased in both groups (Table 3; Figure 
3A). During the levels of  leg dependency 
the percent decrease in blood fl ow tended 
to be higher in SCI (two-way repeated 
measures ANOVA; group*pressure 
interaction: P=0.11).
During leg dependency calf  vascular 
resistance increased with increasing level 
of  dependency (Table 3; Figure 3B). The 
relative increase in calf  vascular resistance at 
the different levels of  leg dependency was 
signifi cantly higher in SCI than in controls 
(two-way repeated measures ANOVA; 
group*pressure interaction: P=0.04). With 
the calf  39 cm below heart level the percent 
increase in calf  vascular resistance was 186 
± 53% in SCI, which was signifi cantly higher 
than the 51 ± 17% increase in controls 
(Student’s t-test: P=0.032).
Forearm: SCI versus controls
During arm dependency, forearm blood 
fl ow decreased signifi cantly and forearm 
vascular resistance increased signifi cantly 
in both groups. Changes in forearm blood 
fl ow and resistance did not differ between 
both groups (Table 3, Figure 4). During cuff  
infl ation, forearm blood fl ow decreased 
and forearm vascular resistance increased 
statistically signifi cant in both groups. 
Heart rate and MAP
Heart rate did not change during limb 
dependency nor during cuff  infl ation. 
During forearm and leg cuff  infl ation, 
MAP did not change in both groups. 
During both arm and leg dependency MAP 
increased in both groups (P=0.012 for arm, 
and P<0.001 for leg) (Table 3).
Discussion
The results of  this study show that 
vasoconstriction below the level of  the 
spinal cord lesion in response to depending 
the leg is more pronounced in spinal cord-
injured (SCI) individuals than in controls. 
In contrast, no differences in forearm 
vascular responses between the groups, i.e. 
above the level of  the spinal cord lesion, 
were observed upon arm dependency. 
When the forearm as well as the calf  were 
subjected to an increase in venous pressure 
during cuff  infl ation blood fl ow decreased 
equally in both groups, whereas in both 
groups the increase in vascular resistance 
was less marked.
Venous congestion by cuff  infl ation
Limb blood fl ow in response to venous 
congestion by cuff  infl ation decreased. 
Interestingly, the increase in limb vascular 
resistance upon cuff  infl ation was less 
marked; in the forearm an increase in 
vascular resistance was observed, whereas 
in the calf  the increase in vascular resistance 
did not reach statistical signifi cance. The 
consistency of  this fi nding is underlined 
since it was found in both controls and 
SCI individuals. It was previously described 
that the reduction in blood fl ow within 
human skeletal muscle when subjected 
to venous congestion was attributed to 
a local vasoconstrictor mechanism, the 
venoarteriolar refl ex (VAR), which is elicited 
when venous transmural pressure exceeds 
25 mmHg.9 To assess vasoconstriction upon 
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venous congestion, in the present and former 
studies12, 15, 25 changes in perfusion pressure 
have been taken into account to calculate 
limb vascular resistance. The observations 
are ambiguous. In the cutaneous circulation 
of  the human fi nger, vascular tone did not 
change upon venous congestion indicating 
that a venoarteriolar refl ex mechanism is not 
operative in that specifi c region.15 However, 
this is in contrast to an increase in vascular 
resistance upon venous congestion in the 
human forearm and calf  skin.12 There are 
several reasons for this striking difference. 
First, regulation of  blood fl ow in the fi nger 
(apical skin) and forearm (nonapical skin) 
is different; sympathetic tone in the apical 
skin in a thermoneutral environment at rest 
is substantial, whereas nonapical skin at rest 
demonstrates little vasoconstrictor activity. 
So, the vasoconstrictor effect of  the VAR 
in the preconstricted fi nger skin vascular 
bed may be marginal. Second, calculation 
of  perfusion pressure differed between 
the studies. To calculate perfusion pressure 
Richardson et al 15 used capillary pressure, 
which is higher than venous pressure that 
was used in the present study and the 
study by Okazaki et al.12 The consequent 
underestimation of  vascular resistance 
may explain the lack of  increase in vascular 
tone upon venous congestion in the study 
by Richardson et al.15 However, calculation 
of  vascular resistance in the present study, 
which is similar to that used by Okazaki et 
al,12 can not explain the attenuated increase in 
vascular resistance upon venous congestion. 
Using venous occlusion plethysmography 
to measure blood fl ow a previous study 
described that a venous congestion of  40 
mmHg caused an increase in calf  vascular 
resistance of  25%.13 Although a venous 
pressure of  25-30 mmHg used in the 
present study exceeds the threshold to elicit 
the VAR, it may explain the less marked 
increase in vascular resistance upon venous 
congestion. So, up to a venous congestion 
pressure of  30 mmHg the present study 
casts doubt on a leading role of  an active 
venoarteriolar vasoconstriction mechanism 
in the arm or leg vascular bed. In other 
words, the reduction in limb blood fl ow 
upon venous congestion up to 30 mmHg 
seems to be mostly a passive effect caused 
by a reduced arterio-venous pressure 
difference with a minor role of  additional 
active vasoconstriction mechanism. 
Limb dependency
Upon forearm and calf  dependency limb 
blood fl ow decreased in both groups. 
In contrast to the observations during 
cuff  infl ation, limb dependency resulted 
in a marked increase in limb vascular 
resistance. Upon limb dependency the 
increase in vascular tone is elicited by (i) 
the myogenic response via an increase in 
arteriolar pressure, and it was assumed 
that (ii) the increase in venous pressure 
will activate the VAR. However, taking into 
account the vascular responses during cuff  
infl ation, one may question to what extent 
the venoarteriolar response contributes 
to the increase in limb vascular resistance 
upon depending a limb, since local venous 
pressure upon cuff  infl ation matches local 
venous pressure upon limb dependency 
and results in a local venous pressure of  25-
30 mmHg. Hence, the increase in vascular 
resistance upon limb dependency in the 
present study seems to be predominantly 
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due to arterial myogenic vasoconstriction, 
which has been suggested before.11
Leg cuff  infl ation induced similar changes 
in calf  vascular tone in SCI and controls. 
However, upon leg dependency, SCI 
showed a more pronounced increase in calf  
vascular resistance than controls, where no 
differences in forearm vascular responses 
were observed between the groups upon 
arm dependency. Since calf  blood fl ow 
tended to be higher in the SCI group, a larger 
vasoconstrictor reserve in the SCI than in 
the control group could have infl uenced the 
results of  the study. Therefore, results of  
matched supine blood fl ows of  a subgroup 
of  5 SCI individuals and 5 control subjects 
are presented in Figure 5. Using these 
subgroups of  subjects the trend towards 
an enhanced vasoconstriction during leg 
dependency in SCI is evident. In addition, 
the decrease in calf  blood fl ow upon venous 
congestion in the subgroup of  subjects 
is equal in both groups. This underlines 
our conclusion that local vasoconstriction 
upon leg dependency is enhanced in spinal 
cord-injured individuals. So, an exaggerated 
myogenic response, below the level of  the 
spinal lesion, could explain the disparity in 
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vascular responses found in the calf  upon 
leg dependency between SCI and controls. 
The myogenic response is inherent to 
vascular smooth muscle. It is considered 
to be attributable to an increase in 
smooth muscle intracellular free calcium 
concentration, after depolarization of  
the smooth muscle cell. The myogenic 
response seems to be independent of  
metabolic, hormonal or neural infl uences.26 
However, recently it has been suggested 
that vascular sensory fi bers are involved 
in mediating the myogenic response in rat 
mesenteric arteries.27 C-fi bre nerves are 
depolarized, via arachidonate metabolites 
generated by an increase in transmural 
pressure, and release vasoactive sensory 
neuropeptides. This could explain that 
lidocaine treatment abolished cutaneous 
vasoconstriction during limb dependency.11, 
12 The myogenic response is affected by 
chronic changes in transmural pressure. 
After rat hindlimb unloading, causing a 
decrease in transmural pressure in the 
hindlimbs and an increase of  transmural 
pressure in the forelimbs, myogenic tone 
is attenuated in both arterioles of  fast 
twitch fi bers in the gastrocnemius muscle28 
and in mesenteric resistance arteries.29 In 
contrast to hindlimb unloading, the calf  
muscles of  the wheelchair bound SCI 
individuals are always dependent with a 
constantly high transmural pressure across 
the vessels due to the absence of  the 
calf  muscle pump and an invariable high 
hydrostatic pressure gradient. It has been 
suggested that elevation of  transmural 
pressure, as in small cerebral arteries in rats 
subjected to hindlimb unloading30 and in 
spontaneously hypertensive rats myogenic 
tone is enhanced.31 So, the constantly high 
transmural pressure in calf  muscles of  SCI 
could increase myogenic responsiveness, 
which may contribute to the increase in 
peripheral vascular tone and maintaining 
blood pressure during orthostatic stress, 
and may explain the observations in the 
present study. The mechanisms whereby 
the myogenic response may be increased 
could involve alterations in components that 
transduces changes of  transmural pressure 
into myogenic tone, by increasing the calcium 
content within the smooth muscle cell, such 
as for example stretch activated channels or 
voltage dependent Ca2+ channels.32
Clinical relevance
In SCI individuals, the importance of  local 
vasoconstriction in withstanding orthostatic 
tolerance has been emphasized by former 
research.3-5, 18, 33 The uniqueness of  the 
present study is that mechanisms of  local 
vasoconstriction were investigated without 
interference of  barorefl ex-mediated 
vasoconstriction by limb dependency 
and during venous congestion above and 
below the level of  the spinal lesion. No 
differences between the groups were found 
in changes of  calf  blood fl ow and calf  
vascular resistance upon venous congestion, 
indicating that the reduction in blood fl ow 
upon venous congestion relies on a change 
in perfusion pressure and to a minor extent 
on the VAR, which are equal in both groups. 
Upon leg dependency, however, changes in 
calf  blood fl ow and calf  vascular resistance 
were more pronounced in the SCI group. 
This supports the idea that the enhanced 
local vasoconstriction in the paralyzed legs 
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of  SCI individuals is most likely due to the 
myogenic mechanisms.
Limitations
The mechanisms of  local vasoconstriction 
are investigated by both limb dependency 
and cuff  infl ation. This approach is based 
on several assumptions. We do not exactly 
know how arteriolar pressure is changed 
upon cuff  infl ation and limb dependency. 
Nonetheless, it may be possible for these 
two models to demonstrate differences that 
may reasonably be attributed to different 
mechanisms. For example, upon cuff  
infl ation back pressure from the increased 
local venous pressure does exert some 
unknown infl uence on arteriolar pressure. 
These unknown mechanisms, however, do 
not differ between the control and spinal 
cord-injured group, and do, therefore, not 
infl uence the observations in the present 
study. In order to verify the assumptions 
made in the present study leg venous 
pressure under different conditions was 
measured invasively by cannulation of  the 
vena saphena magna at the ankle in a group 
of  three healthy volunteers. Like previous 
studies,20, 22 where venous pressure was 
measured invasively, these experiments 
demonstrated that cuff  pressure is a good 
index for local venous pressure (a cuff  
pressure of  30 mmHg corresponds with a 
venous pressure of  27 ± 2 mmHg).
We did not measure arterial pressure 
during venous congestion and assumed 
that arterial pressure remained similar to 
the period just prior to venous congestion. 
So, perfusion pressure is calculated as 
mean arterial pressure minus cuff  pressure. 
As confi rmed in three volunteers with 
invasive venous pressure measurements, leg 
dependency results in an increase in local 
venous pressure that corresponds with the 
calculated hydrostatic pressure gradient 
(see method section). We assumed that the 
hydrostatic pressure gradient causes a similar 
increase in the arteries16 and that, therefore, 
perfusion pressure was not affected by limb 
dependency. This is confi rmed in a study 
where arterial and venous pressure, both 
measured in the depending limb, changed 
linearly with the height of  the column of  
blood.17
In conclusion, upon arm dependency, 
above the level of  the spinal lesion, both 
groups exhibited similar vasoconstriction 
responses. However, upon leg dependency 
vasoconstriction was more pronounced 
in the paralyzed legs of  SCI than in the 
legs of  controls. No differences between 
the groups were observed upon cuff  
infl ation, where the myogenic response is 
not involved. So, most likely the myogenic 
response is responsible for the augmented 
vasoconstriction upon leg dependency in 
SCI. Therefore, the myogenic response 
may play a pivotal role in the orthostatic 
tolerance in SCI, where sympathetic 
barorefl ex control over the leg vasculature 
is absent.
Chapter 7
126
Acknowledgements
The contribution of  G.A. Rongen has 
been made possible by a fellowship of  the 
Royal Netherlands Academy of  Arts and 
Sciences.
References
1. Houtman S, Oeseburg B, Hughson RL, et 
al. Sympathetic nervous system activity and 
cardiovascular homeostatis during head-up 
tilt in patients with spinal cord injuries. Clin 
Auton Res. 2000;10(4):207-212.
2. Grimm DR, De Meersman RE, Almenoff  
PL, et al. Sympathovagal balance of  the 
heart in subjects with spinal cord injury. Am 
J Physiol. 1997;272(2 Pt 2):H835-842.
3. Groothuis JT, Boot CR, Houtman S, et al. 
Leg vascular resistance increases during 
head-up tilt in paraplegics. Eur J Appl Physiol. 
2005;94(4):408-414.
4. Andersen EB, Boesen F, Henriksen O, et al. 
Blood fl ow in skeletal muscle of  tetraplegic 
man during postural changes. Clin Sci (Lond). 
1986;70(4):321-325.
5. Skagen K, Jensen K, Henriksen O, et al. 
Sympathetic refl ex control of  subcutaneous 
blood fl ow in tetraplegic man during postural 
changes. Clin Sci (Lond). 1982;62(6):605-
609.
6. Imadojemu VA, Lott ME, Gleeson K, et 
al. Contribution of  perfusion pressure 
to vascular resistance response during 
head-up tilt. Am J Physiol Heart Circ Physiol. 
2001;281(1):H371-375.
7. Henriksen O. Local refl ex in microcirculation 
in human subcutaneous tissue. Acta Physiol 
Scand. 1976;97(4):447-456.
8. Hassan AA, Tooke JE. Mechanism of  the 
postural vasoconstrictor response in the 
human foot. Clin Sci (Lond). 1988;75(4):379-
387.
9. Henriksen O, Sejrsen P. Local refl ex in 
microcirculation in human skeletal muscle. 
Acta Physiol Scand. 1977;99(1):19-26.
10. Vissing SF, Secher NH, Victor RG. 
Mechanisms of  cutaneous vasoconstriction 
during upright posture. Acta Physiol Scand. 
1997;159(2):131-138.
11. Crandall CG, Shibasaki M, Yen TC. Evidence 
that the human cutaneous venoarteriolar 
response is not mediated by adrenergic 
mechanisms. J Physiol. 2002;538(Pt 2):599-
605.
12. Okazaki K, Fu Q, Martini ER, et 
al. Vasoconstriction during venous 
congestion: effects of  venoarteriolar 
response, myogenic refl exes, and 
hemodynamics of  changing perfusion 
pressure. Am J Physiol Regul Integr Comp 
Physiol. 2005;289(5):R1354-1359.
13. Stewart JM, Medow MS, Montgomery 
LD. Local vascular responses affecting 
blood fl ow in postural tachycardia 
syndrome. Am J Physiol Heart Circ Physiol. 
2003;285(6):H2749-2756.
14. Bishop GD, Brown MD. Cutaneous 
postural vasoconstriction is modifi ed by 
exogenous but not endogenous female 
hormones in young women. Clinical 
Autonomic Research. 2007.
15. Richardson DR, Shepherd S. Separate 
effects of  gravity and venous pressure 
on regional and capillary blood fl ows in 
the human fi nger. Microcirc Endothelium 
Lymphatics. 1989;5(6):417-433.
16. Rowell LB. Passive effects of  gravity. 
Human cardiovascular control. New York: 
Oxford University Press; 1993:3-36.
17. Levick JR, Michel CC. The effects of  
position and skin temperature on the 
capillary pressures in the fi ngers and toes. 
J Physiol. 1978;274:97-109.
18. Theisen D, Vanlandewijck Y, Sturbois 
X, et al. Blood distribution adaptations 
in paraplegics during posture changes: 
peripheral and central refl ex responses. 
Eur J Appl Physiol. 2000;81(6):463-469.
19. Groothuis JT, Van Vliet L, Kooijman M, et 
al. Venous cuff  pressures from 30 mmHg 
to diastolic pressure are recommended to 
measure arterial infl ow by plethysmography. 
J Appl Physiol. 2003;95(1):342-347.
Local vasoconstriction in humans
127
20. Halliwill JR, Minson CT, Joyner MJ. 
Measurement of  limb venous compliance 
in humans: technical considerations and 
physiological fi ndings. J Appl Physiol. 
1999;87(4):1555-1563.
21. Gamble J, Christ F, Gartside IB. Human 
calf  precapillary resistance decreases in 
response to small cumulative increases 
in venous congestion pressure. J Physiol. 
1998;507(Pt 2):611-617.
22. Christ F, Gamble J, Baschnegger H, et al. 
Relationship between venous pressure and 
tissue volume during venous congestion 
plethysmography in man. J Physiol. 1997;503 
( Pt 2):463-467.
23. Kooijman M, Poelkens F, Rongen GA, et al. 
Leg blood fl ow measurements using venous 
occlusion plethysmography during head-up 
tilt. Clin Auton Res. 2007;17(2):106-111.
24. Brakkee AJ, Kuiper JP. Plethysmographic 
measurement of  venous fl ow resistance in 
man. Vasa. 1982;11(3):166-167.
25. Oldfi eld MA, Brown MD. Evaluation of  the 
time course of  vascular responses to venous 
congestion in the human lower limb. J Vasc 
Res. 2006;43(2):166-174.
26. Davis MJ, Hill MA. Signaling Mechanisms 
Underlying the Vascular Myogenic 
Response. Physiol. Rev. 1999;79(2):387-423.
27. Scotland RS, Chauhan S, Davis C, et 
al. Vanilloid Receptor TRPV1, Sensory 
C-Fibers, and Vascular Autoregulation: A 
Novel Mechanism Involved in Myogenic 
Constriction. Circ Res. 2004;95(10):1027-
1034.
28. Delp MD. Myogenic and vasoconstrictor 
responsiveness of  skeletal muscle arterioles 
is diminished by hindlimb unloading. J Appl 
Physiol. 1999;86(4):1178-1184.
29. Looft-Wilson RC, Gisolfi  CV. Rat small 
mesenteric artery function after hindlimb 
suspension. J Appl Physiol. 2000;88(4):1199-
1206.
30. Geary GG, Krause DN, Purdy RE, et al. 
Simulated microgravity increases myogenic 
tone in rat cerebral arteries. J Appl Physiol. 
1998;85(5):1615-1621.
31. Izzard AS, Bund SJ, Heagerty AM. 
Myogenic tone in mesenteric arteries from 
spontaneously hypertensive rats. Am J 
Physiol. 1996;270(1 Pt 2):H1-6.
32. D’Angelo G, Meininger GA. Transduction 
mechanisms involved in the regulation of  
myogenic activity. Hypertension. 1994;23(6 Pt 
2):1096-1105.
33. Groothuis JT, Boot CR, Houtman S, et al. 
Does peripheral nerve degeneration affect 
circulatory responses to head-up tilt in 
spinal cord-injured individuals? Clin Auton 
Res. 2005;15(2):99-106.

Chapter 8
General discussion and 
future implications
General discussionTable 1. 
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A spinal cord injury leads to numerous 
vascular adaptations below the level of  the 
spinal lesion. Since supraspinal sympathetic 
control of  the leg vascular bed is lost in 
spinal cord-injured (SCI) individuals, one 
might expect that blood fl ow in the legs is 
increased and that leg vascular resistance is 
decreased. However, the opposite is true; 
leg blood fl ow is decreased and leg vascular 
resistance is increased in SCI individuals. 
These vascular changes likely contribute to 
increased risk of  secondary complications 
in SCI individuals, such as pressure ulcers 
and impaired wound healing in the paralyzed 
and therefore inactive lower part of  the 
body. The mechanisms responsible for the 
increase in leg vascular resistance in SCI 
individuals are not completely understood. 
The studies described in this thesis aimed 
to elucidate the role of  the α-adrenergic 
receptor and endothelial nitric oxide (NO) 
in the regulation of  baseline vascular tone 
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Calf vascular resistance (CVR) in response to a cold pressor test of the hand (A) and the foot (B) Figure 1. 
in control subjects and SCI individuals. The cold pressor test lasted for 2 minutes and is marked in grey. 
In response to the cold pressor test of the hand in controls, CVR increased, whereas in SCI, CVR did not 
change, that confi rms disruption of supraspinal sympathetic control in SCI. When immersing the foot in ice 
water in both controls and SCI with a spastic paresis, CVR increased, whereas in SCI with a fl accid paresis 
and without spinal sympathetic activity, CVR did not change. (Data derived from this thesis, Chapter 2)
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in SCI individuals. The results of  those 
studies will be discussed in the fi rst part of  
this chapter.
Although leg vasculature of  SCI individuals 
is not under supraspinal barorefl ex control, 
an orthostatic challenge will increase leg 
vascular resistance, a vascular response 
that is widely regarded to be regulated 
solely via the sympathetic nervous system. 
Accordingly, the second part of  this chapter 
will discuss the potential mechanisms 
responsible for this observation.
Regulation of vascular tone 
in SCI individuals: resistance 
arteries
Preserved sympathetic α-adrenergic 
tone
In SCI individuals, the leg vascular bed 
is not under supraspinal control (Figure 
1A), which is confi rmed by the absence 
of  baroreceptor related sympathetic nerve 
activity and very low baseline leg sympathetic 
nerve activity in these individuals.1, 2 
Therefore, the observations in Chapter 
2, describing a preserved sympathetic 
α-adrenergic tone of  the leg skeletal muscle 
vascular bed in SCI individuals, were 
surprising. In theory, several mechanisms 
may be responsible for the preserved 
α-adrenergic contribution to basal vascular 
tone in SCI individuals. First, the spinal 
cord injury may have been incomplete or 
supraspinal control of  sympathetic outfl ow 
to the leg may have been restored. However, 
a cold pressor test, that drives sympathetic 
activity, did not result in an increase in 
leg vascular resistance below the spinal 
lesion level in SCI individuals as is shown 
in Figure 1A. This confi rms a complete 
disruption of  supraspinal sympathetic 
control. Although supraspinal sympathetic 
control is lost, spinal sympathetic refl ex 
activity may be intact and could contribute 
to the preservation of  α-adrenergic tone in 
SCI individuals. Figure 1B shows that in 
individuals with a fl accid pareses, stimulation 
of  the sympathetic nervous system (cold 
pressor test of  the foot) below the level of  
the spinal lesion does not evoke a change 
in calf  vascular resistance. Therefore, in 
individuals with a fl accid pareses spinal 
sympathetic refl ex activity is unlikely to 
contribute to the preserved α-adrenergic 
vascular tone. However, individuals with 
a spastic pareses demonstrate an increase 
in vascular resistance during a similar 
sympathetic stimulus. This indicates that 
spinal sympathetic refl exes are intact and 
may contribute to basal vascular tone. 
Although previous research1, 2 showed 
very low leg sympathetic nerve activity in 
SCI individuals, one may hypothesize that 
infl ation of  a cuff  to 50 mmHg during 
blood fl ow measurements by venous 
occlusion plethysmography act as a 
stimulus to trigger leg spinal sympathetic 
nerve activity. Since we did not measure 
muscle sympathetic nerve activity below 
the level of  the spinal lesion, we can only 
speculate on this. Nonetheless, intra-
arterial blood pressure can be used as 
derivative of  sympathetic nerve activity. 
In all SCI individuals, regardless the level 
or type of  the spinal lesion, blood fl ow 
measurements did hardly infl uence blood 
pressure. Therefore, the role of  spinal 
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sympathetic refl exes in the regulation of  
basal vascular tone is probably not affected 
by our experimental procedures.
Finally, local release of  noradrenaline in 
SCI individuals is reduced, which may 
induce a compensatory increase in either 
the sensitivity or number of  α-adrenergic 
receptors or the effi cacy of  post-receptor 
signaling, leading to preservation of  
basal α-adrenergic tone.3-5 Although there 
is hardly any scientifi c evidence, this 
explanation can be verifi ed by observations 
in disease states in which the sympathetic 
control of  the leg vascular bed is impacted, 
such as in patients with primary autonomic 
failure. Although leg vascular resistance 
is reported to be slightly decreased in 
autonomic failure patients,6 suggestive for 
a reduced sympathetic vasoconstrictor 
tone, ~50% of  these individuals suffer 
from supine hypertension.7, 8 Interestingly, 
in patients with multiple system atrophy, 
residual sympathetic activity drives supine 
hypertension; both blockade of  autonomic 
ganglia as well as administration of  
phentolamine reduced blood pressure not 
only by a decrease in cardiac output but 
also by infl uencing peripheral vascular 
tone.7 Although α-adrenergic peripheral 
vascular tone is not quantifi ed in autonomic 
failure patients, these results suggest 
that in autonomic failure patients supine 
hypertension refl ects a state of  increased 
postganglionic sympathetic neurovascular 
tone and, like in SCI individuals, the 
sympathetic nervous system still contributes 
to peripheral vascular tone. Since the 
preservation of  α-adrenergic tone cannot 
be explained by an increase in noradrenaline 
release in both autonomic failure patients 
and SCI individuals, the sensitivity to 
endogenously-released noradrenaline must 
be increased. 
In summary, in contrast to our hypothesis 
baseline α-adrenergic vascular tone is 
preserved in SCI individuals. The increased 
responsiveness of  the α-adrenergic receptor 
to noradrenaline, released systemically or 
locally by the sympathetic nerve, seems 
to be most likely to explain our results. 
However, the role of  spinal sympathetic 
refl exes can not be completely ruled out.
The role of the endothelium in the 
regulation of baseline vascular tone in 
SCI individuals
Nitric oxide (NO) is an important anti-
atherogenic molecule. Therefore, decreased 
endothelial function, characterized by a 
reduced bioavailability of  NO, has been 
proposed as an important early event in 
the pathogenesis of  atherosclerosis.9 Since 
physical inactivity is an important and 
independent risk factor for atherosclerosis, 
we hypothesized that the NO availability 
is reduced in the inactive legs of  SCI 
individuals. Previous animal data suggested 
that physical inactivity can reduce vascular 
expression of  endothelial nitric oxide 
synthase (eNOS) and consequently lead 
to a reduction of  NO bio-availability.10 
By use of  intra-arterial administration of  
NG-monomethyl-L-arginine (L-NMMA), a 
blocker of  eNOS, NO availability and the 
contribution of  NO to baseline vascular 
tone can be assessed. In contrast to our 
hypothesis, the results presented in Chapter 
3 indicate that the contribution of  NO to 
baseline vascular tone is not impaired in the 
inactive legs of  SCI individuals. Therefore, 
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a reduction in NO availability can not 
explain the increase in leg vascular tone in 
chronic SCI subjects.
The likely physiological stimulus to 
endothelial NO production has been 
identifi ed as increased fl ow through the 
vessel lumen with acute NO-mediated 
vasodilatation tending to normalize shear 
stress. Changes in shear stress, as a result 
of  exercise training or physical inactivity, 
may, respectively, improve or reduce the 
bioavailability of  NO. Four weeks of  
cycling exercise caused an increase in basal 
NO production in the forearm vascular 
bed.11 In contrast, baseline NO production 
in endurance trained athletes did not 
differ from controls, which suggests that 
long-term training does not affect NO 
production in the forearm vascular bed. In 
mice, physical inactivity leads to an initial 
decrease in baseline NO production in 
response to a low-fl ow state.12 However, 
after 14 days of  physical inactivity, baseline 
NO production was partly normalized while 
the decrease in arterial diameter has become 
mostly structural. So, short-term functional 
endothelial adaptations to normalize shear 
stress, lead to arterial remodelling and 
structural normalization of  shear stress. 
Subsequently, endothelial function and NO 
availability return towards baseline levels.13 
In SCI individuals, structural vascular 
adaptations are accomplished with weeks.14 
Collectively, it may be possible that chronic 
SCI would have demonstrated an initial 
reduction in NO bioavailability in the acute 
phase after the spinal cord injury, but that 
after normalization of  shear the contribution 
of  NO to baseline vascular tone is not 
affected as described in Chapter 3.
Since the increase in basal vascular 
resistance in chronic SCI individuals 
is unlikely to be explained by the NO 
pathway, other endothelial factors may be 
involved. The role of  the other endothelial 
vasodilating substances, i.e. prostacyclin 
and EDHF, have never been investigated 
in SCI individuals. Recently it has been 
demonstrated that the contribution of  
vasoconstrictive agent endothelin-1 (ET-
1) to baseline leg vascular tone in SCI 
individuals is increased,15 suggesting that 
ET-1 could be a regulator of  changes in 
vascular tone during deconditioning.
Vascular adaptations in 
conduit arteries in SCI 
individuals: the role of NO
Endothelial function at conduit artery 
level can be assessed using fl ow-mediated 
dilatation (FMD), which represents the 
conduit artery dilatation that occurs in 
response to a 5-minute distal arterial 
occlusion. Our fi ndings described in 
Chapter 4 demonstrate an enhanced FMD 
response in SCI individuals, when FMD is 
expressed as change of  baseline diameter, 
which is in accordance with a study by De 
Groot et al.16 FMD is strongly dependent 
on arterial size,17-19 as is shown in Figure 2. 
Therefore, larger relative FMD responses 
can be expected in SCI subjects, who have 
smaller baseline superfi cial femoral arteries, 
than in able-bodied controls. This strong 
link is suggested to result from differences 
in the level of  shear rate during reactive 
hyperaemia, which is regarded as the eliciting 
stimulus of  the FMD. It is proposed that 
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smaller arteries, exposed by virtue of  their 
size to a great shear stress stimulus, exhibit 
enhanced dilator responses compared to 
arteries of  larger dimension. Therefore, it 
has been proposed that the FMD response 
should be corrected for the eliciting 
stimulus by taking the post-occlusive area-
under-the-curve of  the mean wall shear 
rate.20 After correcting FMD data in this 
manner, FMD is similar in controls and 
SCI subjects, indicating that FMD seems 
not to be affected by deconditioning.
To gain better insight into the mechanisms 
responsible for the preserved FMD in the 
deconditioned legs of  SCI individuals, 
experiments described in Chapter 4 were 
performed. First, we aimed to assess 
whether the FMD response of  the 
superfi cial femoral artery in SCI individuals 
is mediated exclusively by NO. The 
dilatation during the FMD response may 
be affected by vasodilators other than 
NO, such as prostacyclin or endothelium-
derived hyperpolarizing factor, which could 
be co-released in response to an increase in 
shear stress after 5 minutes of  ischaemia. 
Second, smooth muscle cell responsiveness 
to NO could be increased in response to 
deconditioning.16, 21, 22
For brachial and radial arteries it is known 
that, using a 5-minute ischemic period distal 
from the imaging site, FMD in healthy 
young subjects is mediated by endothelial-
derived NO.23, 24 However, the role of  NO 
in the superfi cial femoral artery FMD is 
not known, neither in healthy subjects 
nor in SCI individuals. One cannot simply 
extrapolate the fi ndings in upper limb 
conduit arteries to the superfi cial femoral 
artery, since leg and arm vasculature 
beds have been demonstrated to respond 
differently to endothelium-dependent 
and -independent vasodilator agents.25 In 
Chapter 4, it was described that superfi cial 
femoral artery FMD in healthy men, after a 
brief  episode of  an increase in shear stress, 
was almost completely abolished during 
infusion of  L-NMMA. In accordance 
with data in the upper limbs, these results 
demonstrate that the FMD response of  the 
superfi cial femoral artery in healthy men, 
using 5 minutes of  distal ischemia, refl ects 
a NO-mediated endothelium-dependent 
vasodilatation. In SCI individuals, the 
FMD response during blockade of  NO 
production by L-NMMA was similarly 
attenuated as in the able-bodied controls. 
Since NO-blockade could not completely 
block dilatation after cuff  release, the 
contribution of  other vasodilating agents 
to FMD in SCI individuals can not 
completely be ruled out. Nonetheless, the 
FMD of  the superfi cial femoral artery in 
the deconditioned legs of  SCI individuals 
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Relation between resting superfi cial Figure 2. 
artery diameter and fl ow-mediated dilatation in 
SCI individuals,16 older men, and young control 
subjects. (Pearson correlation coeffi  cient (r) = 0.696, 
P<0.001)
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is predominantly NO-mediated.
Hindlimb unweighting in rats indicates 
that deconditioning can lead to a down-
regulation of  endothelial NO-synthase 
expression.26 Accordingly, one explanation 
for the preserved FMD in the legs of  SCI 
subjects relates to the possibility that smooth 
muscle cell sensitivity to NO is enhanced 
in response to deconditioning. Previous 
studies16, 21, 22 concluded that deconditioning 
induced an increase in smooth muscle cell 
responsiveness of  conduit arteries to NO. 
However, this is usually assessed using a 
single dose of  sublingual administration of  
a NO donor, rather than by construction of  
a dose-response curve. In resistance arteries 
we already showed, as is described in Chapter 
3, that deconditioning, as a result of  a 
spinal cord injury or due to unilateral lower 
limb suspension, does not affect smooth 
muscle cell responsiveness. Recently, we 
published a study that demonstrates that 
superfi cial femoral artery dilatation to 
intra-arterial administration of  three doses 
of  SNP is not affected by deconditioning 
due to a spinal cord injury.27 This suggests 
that NO sensitivity of  the smooth muscle 
cells of  conduit arteries in SCI individuals 
is not elevated. Furthermore, both resting 
diameter and maximal conduit artery 
vasodilator responses were less in SCI 
individuals, which demonstrates an inward 
remodelling of  the superfi cial femoral 
artery in SCI individuals. In conclusion, 
conduit arteries supplying chronically 
deconditioned limbs seem to undergo 
structural changes, while vascular function 
of  the same artery is normalized.
 
Baseline blood fl ow and 
vascular resistance in SCI 
individuals
In this thesis, different methods to measure 
blood fl ow have been used. In Table 1 
pooled data from studies of  blood fl ow 
measurements using venous occlusion 
plethysmography and Doppler ultrasound, 
conducted at the department of  Physiology, 
Radboud University Nijmegen Medical 
Centre, are presented. Venous occlusion 
plethysmography primarily refl ects muscle 
blood fl ow normalized for leg volume. 
Doppler ultrasound refl ects blood fl ow 
within a specifi c conduit artery vessel and 
detects functional as well as structural 
vascular adaptations. Although Doppler 
ultrasound does not actually measure 
blood fl ow within the muscles, it may be 
expected that altered muscle blood fl ow 
will ultimately lead to changes in blood 
fl ow at conduit arteries level. Maximal post-
occlusive reactive hyperaemia, as measured 
by Doppler ultrasound or venous occlusion 
plethysmography, has been proposed as 
a measure of  structural changes in the 
microvasculature, such as capillaries.
Interestingly, using Doppler ultrasound 
superfi cial femoral artery blood fl ow as 
well as artery dimensions do not differ 
between SCI individuals and able-bodied 
subjects after correction for leg volume 
(Table 1).28, 29 This fi nding suggests that in 
chronic SCI individuals, structural vascular 
adaptations and muscular atrophy have 
changed in a similar degree, and seem 
to have a strong functional link. From 
a physiological perspective, it would be 
interesting to examine whether vascular 
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structural adaptations precede changes 
in muscle volume, or vice versa or 
simultaneously, during the initial stage of  
deconditioning. Pooled blood fl ow data by 
venous occlusion plethysmography show 
discrepancies between thigh and calf  blood 
fl ow in SCI individuals; thigh blood fl ow 
and vascular resistance are decreased and 
increased, respectively, whereas, in contrast 
to prior observations30 no differences in 
calf  blood fl ow and vascular resistance 
were found between SCI individuals and 
able-bodied subjects.
Based on these blood fl ow data, one may 
question whether the increase in leg vascular 
resistance refl ects a structural (i.e. a decrease 
in number of  arterioles and capillaries and/
or a decrease in the diameter of  the vessels) 
or functional adaptation (endothelium-
derived factors, circulating humoral factors 
and/or sympathetic vascular regulation). 
As demonstrated in this thesis (Chapter 
2 and 3), endothelium derived NO and 
α-adrenergic stimulation do not contribute 
to the increase in upper leg vascular 
resistance. Although the contribution of  
endothelin-1 to baseline vascular tone in 
SCI individuals is increased,15 the increase 
in vascular resistance can also be explained 
by structural adaptations of  the muscle 
vascular bed. The latter is supported by the 
fact that sympathectomy in rats results in 
an increase in vascular resistance, which 
is due to a decrease in density of  the 
vascular network.31 Moreover, a reduction 
in maximal vasodilatation during post-
Pooled blood fl ow data using venous occlusion plethysmography and Doppler ultrasound.Table 1. 
SCI Controls
Venous occlusion plethysmography
  ULBF (ml·100ml-1·min-1) 2.7 ± 1.2 (n=26) 3.7 ± 1.4 (n=42) ↓
  ULVR (AU) 41 ± 18 (n=26) 27 ± 8 (n=40) ↑
  CBF (ml·100ml-1·min-1) 2.9 ± 1.5 (n=21) 2.2 ± 0.7 (n=58) =
  CVR (AU) 42 ± 19 (n=21) 44 ± 19 (n=50) =
Doppler Ultrasound
  CFA blood fl ow (ml·min-1) 238 ± 133 (n=56) 265 ± 106 (n=38) =
  CFA diameter (cm) 0.69 ± 0.11 (n=56) 0.97 ± 0.11 (n=38) ↓
  SFA blood fl ow (ml·min-1) 109 ± 72 (n=39) 96 ± 39 (n=50) =
  SFA diameter (cm) 0.54 ± 0.06 (n=39) 0.76 ± 0.08 (n=50) ↓
After correction for total leg volume
  CFA blood fl ow (ml·min-1·L-1) 34 ± 17 (n=19) 25 ± 10 (n=8) =/↑
  CFA diameter (cm·L-1) 0.10 ± 0.02 (n=19) 0.12 ± 0.01 (n=8) =
  SFA blood fl ow (ml·min-1·L-1) 15.5 ± 8.0 (n=16) 8.5 ± 3.5 (n=16) =/↑
  SFA diameter (cm·L-1) 0.08 ± 0.02 (n=16) 0.08 ± 0.01 (n=16) =
ULBF, upper leg blood fl ow; ULVR, upper leg vascular resistance; CBF, calf blood fl ow; CVR, calf vascular 
resistance; CFA, common femoral artery; SFA, superfi cial femoral artery.
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ischemic hypaeremia in SCI individuals, as 
is shown in Chapter 2 and Chapter 4, supports 
structural vascular changes. So, the increase 
in vascular resistance in SCI individuals 
can therefore be explained by a decrease in 
capillary density, and in part by functional 
changes at resistance artery level.
Denervation and deconditioning seem to 
inconsistently affect the decrease in capillary 
density in the legs of  SCI individuals, since 
thigh vascular resistance is more increased 
than vascular resistance in the calf  (Table 1). 
Variability of  changes in muscle fi bre type 
and associated changes in capillarisation may 
explain this apparent difference between 
areas of  the lower limbs. Within a group 
of  SCI individuals, the percentage slow, 
well capillarised, fi bres in the vastus lateral 
muscle may vary between 0 and 62%.32 Even 
within SCI individuals, fi bre types can vary 
from the exclusively slow twitch fi bres in 
the tibial anterior muscle to predominantly 
fast twitch fi bres in the vastus lateralis.33 
Although speculative, changes in muscle 
fi bre composition to merely fast twitch low 
oxidative fi bres could explain the increase 
in thigh vascular resistance, whereas in our 
population of  SCI individuals muscle fi bre 
type in the calf  seems to be less deteriorated. 
Variability in muscle fi bre types could also 
explain the large variation found in calf  as 
well as thigh blood fl ow within the group 
of  SCI individuals.
Regulation of vascular tone 
in response to orthostatic 
challenges
The prompt increase in peripheral vascular 
resistance is the key event in blood pressure 
control during postural stress.34 It was 
suggested that this response is primarily 
mediated by barorefl ex sympathetic 
activation with subsequent α-adrenergic 
stimulation. However, in Chapter 6, we 
found that after pharmacological blockade 
of  the α-adrenergic receptor in both 
healthy young men and SCI individuals, 
who lack barorefl ex control of  the leg 
vascular bed, leg-vasoconstrictor responses 
are still present in a similar magnitude 
upon head-up tilt in humans, irrespective 
of  the presence of  an intact sympathetic 
barorefl ex. Apart from α-adrenoceptor 
stimulation, non-adrenergic mechanisms, 
such as purinoceptor stimulation by ATP 
and release of  neuropeptide Y acting on 
Y1 receptors, seem to contribute to the 
vasoconstrictor response after sympathetic 
stimulation.35-37 However, this does not 
explain the preserved vasoconstriction 
upon postural change in SCI individuals,38 
where supraspinal sympathetic activation is 
lost. In these individuals other, presumably 
local, vasoconstriction mechanisms may 
compensate for the lack of  supraspinal 
sympathetic control.
Local vasoconstriction mechanisms
It has been suggested that in able-bodied 
individuals during orthostasis as much as 
~45% of  the increase in systemic vascular 
tone is due to the venoarteriolar refl ex 
(VAR).39 Accordingly, the VAR potentially 
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contributes to the increase in vascular 
tone in SCI individuals during orthostatic 
challenge. However, from the results 
presented in Chapter 7, the contribution 
of  the VAR to leg vasoconstriction upon 
postural changes seems to be minimal. It 
has been suggested that the VAR runs via 
a sympathetic axon where the receptors 
are presumably stretch receptors placed in 
the small veins and the effector site are the 
arterioles.40 However, research to confi rm 
a venoarteriolar axon by histobiochemical 
techniques is sparse. Only one study41 
showed that sporadic fi bres from the 
dense plexus of  sympathetic fi bres around 
arterioles innervate the venules directly and 
return from the venule back to the arteriolar 
network. In light of  the results of  Chapter 7, 
where the VAR seems to play a minor role 
in local arteriolar vasoconstriction upon 
orthostatic challenges, the existence of  a 
venoarteriolar axon should be questioned.
As was suggested in Chapter 7, other 
local vasoconstriction mechanisms such 
as the myogenic response could also 
explain vasoconstriction upon orthostatic 
challenges in SCI individuals.42 In human 
in vivo research, local vasoconstriction upon 
orthostatic challenges is mostly examined 
by lowering the limb.43-45 Apart from an 
increase in venous transmural pressure, 
this manoeuvre also increases transmural 
pressure on the arteriolar level. An increase 
in arteriolar transmural pressure causes a 
myogenic response. The mechanisms that 
sense the increase in arteriolar transmural 
pressure resulting in myogenic arteriolar 
vasoconstriction are not known. In theory, 
nerve endings in the adventitia, that are 
exposed to the infl uence of  transmural 
pressure, can be the sensor element that 
detects the change in vessel wall tension and 
initiates the myogenic response. Human in 
vivo research suggested a neurally mediated 
response in the microcirculation of  the 
skin since application of  local anaesthetics 
abolished skin vasoconstriction upon 
lowering of  the limb.39, 40, 45-49 This is in 
contrast with an equal reduction in blood 
fl ow in response to limb dependency 
in normal innervated and denervated 
skin fl aps.50 Also in SCI individuals 
with a fl accid pareses, where nerves are 
completely atrophied, vasoconstriction 
upon lowering the leg was preserved 
(Chapter 7). Moreover, in vitro research 
showed that after elimination of  a tonic 
nervous infl uence on the vessel by blocking 
nerve endings in the adventitia no alteration 
of  the myogenic response was observed,51 
suggesting no neural involvement in the 
initiation of  the myogenic response. On 
the other hand, neural infl uences, especially 
from adrenergic nerves, may modulate 
the myogenic response by increasing the 
strength of  the myogenic response.51 So, it 
is still of  debate what role nerves play in the 
initiation or modulation of  the myogenic 
response.
In conclusion, based on the results presented 
in Chapter 7, myogenic mechanisms are 
most likely responsible for the preserved 
vasoconstriction in SCI individuals upon 
postural changes. Although venoarteriolar 
refl exes seem not to initiate arteriolar 
vasoconstriction upon changes in vascular 
transmural pressure, the role of  neurally 
mediated mechanisms via initiating or 
infl uencing the myogenic response can not 
be ruled out.
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Redundancy
Blood fl ow upon orthostatic stress is 
tightly regulated and depends on many 
different mechanisms, that interact and can 
compensate when one of  the regulatory 
mechanisms fail. Such a process is often 
referred to as redundancy, which refl ects 
the versatility of  blood fl ow regulation 
mechanisms. Research in the fi eld of  
exercise physiology is being faced with this 
phenomenon; it is hard to fi nd clear evidence 
for a dominant vasodilatating factor or 
factors that link muscle metabolism to 
exercise hyperaemia.52, 53 In these studies, it 
is found that when one of  the key pathways 
is blocked others can compensate and evoke 
a normal rise in blood fl ow during exercise. 
To our opinion, the study described in 
Chapter 6 is the fi rst that suggests redundant 
mechanisms in the regulation of  peripheral 
vascular tone upon orthostatic challenges. 
In this perspective, it is of  interest whether 
peripheral vasoconstriction is preserved in 
different groups of  patients who suffer from 
various causes of  orthostatic intolerance. 
Currently, most research to elucidate 
the mechanisms that cause orthostatic 
intolerance focuses on central regulatory 
mechanisms and barorefl ex function. 
However, based on our fi ndings in Chapter 
6, peripheral vascular responses may be 
underexposed and play an important role 
in compensating barorefl ex dysfunction. 
A better knowledge of  these peripheral 
vascular mechanisms of  vasoconstriction 
in response to orthostatic challenge may 
provide new targets for intervention to 
improve orthostatic tolerance of  patients 
with barorefl ex failure. 
Implications of the studies 
and future directions
The studies presented in this thesis 
importantly contributed to the 
understanding of  the regulation of  leg 
vascular resistance in spinal cord-injured 
individuals. The contribution of  nitric 
oxide to leg vascular tone is preserved in 
SCI individuals. Whilst, the sympathetic 
nervous system still contributes to basal 
vascular tone in SCI individuals, we 
demonstrated that the α-adrenergic tone is 
not increased in SCI individuals compared 
with able-bodied counterparts. Based on 
these results, we question whether other 
mechanisms contribute to the increased 
vascular resistance found in SCI individuals. 
Atrophy of  skeletal muscles as a result of  
paralyses of  the legs of  SCI individuals 
coincide with vascular atrophy, not only of  
conduit arteries, but also of  the muscular 
vascular bed. Functional vascular changes 
may precede the structural vascular 
changes. To support this view, in the 
chronic phase of  a spinal cord injury, we 
found that endothelial function as well as 
smooth muscle cell function have returned 
to normal. Accordingly, we hypothesize 
that the increase in vascular resistance is 
merely caused by structural changes of  
the vascular bed, although the effect of  
endothelin-1 and angiotensin II on baseline 
vascular tone may not be ruled out. 
While recent data demonstrate a role for 
endothelin-1 to contribute to the increased 
vascular resistance in SCI subjects, the role 
of  angiotensin II on baseline vascular tone, 
especially in SCI individuals with cervical or 
high thoracic spinal lesions where the renin-
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angiotensin-aldosteron system is affected, 
should be topic for further research.
How can we explain these results in light 
of  the spinal cord-injured individual 
complaining of  cold legs or confronted 
with pressure sores and poor wound 
healing? The development of  pressure 
sores is strongly dependent on skin tissue 
oxygenation, which is signifi cantly lower in 
individuals with SCI than in controls.54 An 
increase in arteriovenous shunting in SCI 
individuals55 could explain the impaired skin 
tissue oxygenation. Arteriovenous shunting 
is hypothesized to increase susceptibility 
to local ischemia with prolonged pressure 
and subsequently increasing the risk 
of  skin ulceration. Venous occlusion 
plethysmography or Doppler ultrasound 
are unable to examine the arteriovenous 
shunting since it measures total limb blood 
fl ow, which can be unaffected despite 
an increase in arteriovenous shunting 
with subsequent impairment of  tissue 
oxygenation.
The occurrence of  cold legs and impaired 
wound healing could also be explained by 
the lack of  variation of  leg blood fl ow due 
to inactivity. Furthermore, wound healing 
is negatively infl uenced in subjects who 
are frequently suffering from autonomic 
dysrefl exia, i.e. increases sympathetic 
vascular tone and decreases blood fl ow. 
Finally, sitting in a wheelchair, the legs of  
SCI subjects are continuously in dependent 
position. The increase in transmural pressure 
while sitting will engage the myogenic 
response that decreases both muscle and 
skin blood fl ow. In theory, the increase in 
myogenic tone can result in a decrease in 
blood fl ow resulting in a decrease in tissue 
oxygenation of  the leg skin and muscles 
in SCI individuals while sitting,56 and 
can therefore be a primary factor in the 
causation and poor healing of  pressure 
sores and wounds in SCI individuals. 
Taken together, even when vascular tone 
is not increased in SCI individuals, tissue 
oxygenation can be compromised by 
atrophy of  the vascular bed resulting in an 
increase in vascular resistance, and/or by 
arteriovenous shunting. 
The protective behaviours and risk factors 
associated with the development of  
pressure sores and poor wound healing 
in SCI individuals have been identifi ed 
in several studies.57-59 A healthy life style 
appears to be strongly associated with 
avoiding pressure sores. Moreover, 
previous cross-sectional and longitudinal 
studies of  subjects with SCI showed that 
the prevalence of  pressure ulcers increased 
as time since injury increased.60, 61 Chronic 
denervated skin with long-term structural 
and physiologic (vascular) changes may 
play an important role in the development 
of  pressure sores among subjects with 
longstanding spinal cord injury. So, future 
research could focus more on changes in 
skin blood fl ow (regulation) and skin tissue 
oxygenation in relation to the occurrence 
of  pressure sores in recently injured SCI 
individuals and SCI individuals aged with 
a spinal cord injury. The pathophysiology 
behind the changes in skin blood fl ow can 
be unravelled by elucidating the role of  
autonomic dysregulation and other factors 
that could importantly infl uence skin 
vascular tone, like endothelial and myogenic 
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factors. Moreover, the effect of  pressure 
and friction on skin blood fl ow and the 
recovery of  skin blood fl ow after pressure 
is removed would be an interesting topic for 
further research. After the understanding 
of  the changes in skin blood fl ow regulation 
and skin tissue oxygenation has improved, 
the effect of  therapeutic interventions (i.e. 
functional electrical stimulation (FES), 
that can improve blood fl ow but also can 
infl uence the effect of  pressure on skin 
blood fl ow by reducing muscular atrophy, 
or pharmacological interventions) on 
reducing secondary complications, like 
pressure sores or impaired wound healing, 
can be evaluated.
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Individuals with a complete spinal cord 
injury (SCI) lack sympathetic barorefl ex 
control of  the leg vascular bed. However, 
despite sympathetic denervation in the 
paralyzed legs, (1) leg vascular tone is almost 
twice as high as compared with able-bodied 
subjects, and (2) SCI individuals show 
head-up tilt induced increase in leg vascular 
tone to withstand orthostatic stress. The 
aim of  the present thesis is to elucidate the 
role of  the sympathetic nervous system 
and endothelial derived substances, in 
particular NO, in the regulation of  baseline 
vascular tone in SCI individuals and able-
bodied subjects. Furthermore, we tried 
to unravel the regulation mechanisms 
behind the preserved head-up tilt induced 
vasoconstriction in SCI individuals. 
Chapter 2 focuses on the contribution of  
the sympathetic nervous system to baseline 
leg vascular tone in SCI individuals and 
controls. Upper leg vascular resistance 
responses to local infusion of  incremental 
doses of  phentolamine (a competitive 
antagonist of  the α-adrenoceptor) into 
the femoral artery were determined in 
a group of  SCI individuals and control 
subjects during local β-adrenergic receptor 
blockade with propranolol. In contrast to 
our hypothesis the phentolamine induced 
decrease in leg vascular resistance did 
not differ between SCI individuals and 
the control group. This indicates that the 
α-adrenoceptor-mediated vascular tone in 
the leg is preserved in SCI individuals, who 
lack sympathetic supraspinal control.
Decreased endothelial function, 
characterized by a reduced bioavailability 
of  nitric oxide (NO), has been proposed 
as an important early event in the 
pathogenesis of  atherosclerosis, since NO 
is an important anti-atherogenic molecule. 
Whether the increase in leg vascular tone 
due to deconditioning as a result of  SCI 
can be explained by an attenuated release 
of  endothelium derived NO is not known. 
Therefore, the study described in Chapter 
3 was designed to assess baseline NO 
availability in the leg vascular bed after 
extreme, long-term deconditioning (SCI 
individuals) as well as after moderate, short-
term deconditioning (4 weeks of  unilateral 
lower limb suspension, ULLS). The NO 
production was blocked by infusion of  
NG-monomethyl-L-arginine (L-NMMA) in 
fi ve incremental dosages into the femoral 
artery. Sodium nitroprusside (SNP) was 
infused to test the vascular responsiveness 
to NO. Deconditioning did neither alter 
the vasoconstrictor response to L-NMMA, 
nor the vascular responsiveness to NO. 
Therefore, it can be concluded that two 
human in vivo models of  deconditioning 
show a preserved baseline NO availability 
in the leg skeletal muscle vascular bed.
Apart from the preserved baseline NO 
availability in SCI individuals at resistance 
artery level, the FMD, which is an non-
invasive tool to assess endothelial function, 
in the paralyzed and thus inactive legs 
of  SCI individuals is preserved as well. 
Therefore, in Chapter 4, we examined 
whether superfi cial femoral artery FMD 
in healthy subjects and in SCI individuals 
is NO-mediated. 5-minute FMD response 
in the superfi cial femoral artery both 
during infusion of  saline and during 
infusion of  the NO-synthase-blocker NG-
monomethyl-L-arginine (L-NMMA) was 
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assessed in a group of  SCI individuals and 
control subjects. In controls, the FMD 
response was almost completely abolished 
during L-NMMA infusion. L-NMMA also 
signifi cantly decreased the FMD response 
in SCI individuals. The effect of  L-NMMA 
on FMD persisted in both groups after 
correction for the shear stress stimulus. So, 
superfi cial femoral artery FMD in response 
to distal arterial occlusion for a period of  
5 minutes is predominantly mediated by 
NO in healthy men and in the extremely 
deconditioned legs of  SCI individuals.
Venous occlusion plethysmography is a 
well-established method to measure limb 
blood fl ow in humans. However, its use for 
leg blood fl ow measurements during head-
up tilt (HUT) is questionable, since the leg 
venous system is not empty and venous 
pressure exceeds zero. For that reason, in 
Chapter 5, the accuracy and reproducibility 
of  venous occlusion plethysmography for 
measuring calf  blood fl ow was assessed 
during different angles of  head-up tilt. 
Calf  blood fl ow measured with venous 
occlusion plethysmography was compared 
with superfi cial femoral artery blood 
fl ow as measured by Doppler ultrasound. 
Measurements of  both methods correlated 
well and reproducibility of  venous occlusion 
plethysmography was fair in supine position 
and 30° HUT. This indicates that venous 
occlusion plethysmography is an applicable 
tool to measure leg blood fl ow especially 
up to 30° HUT.
The prompt increase in peripheral vascular 
resistance, mediated by sympathetic 
α-adrenergic stimulation is the key event 
in blood pressure control during postural 
stress. Interestingly, this orthostatic leg 
vasoconstriction is preserved in SCI 
individuals, despite the fact that they lack 
barorefl ex sympathetic control of  the leg 
vasculature. This suggests that α-adrenergic 
mechanisms are not obligate in maintaining 
blood pressure during postural stress. 
So, in Chapter 6, the contribution of  both 
central and local sympathetic α-adrenergic 
leg vasoconstriction to head-up tilt was 
assessed by including healthy individuals 
and individuals who lack barorefl ex control 
over the leg vascular bed, due to a spinal cord 
injury. Upper leg blood fl ow was measured 
before and during 30° HUT throughout 
intra-arterial infusion of  saline or the non-
selective α-adrenergic receptor antagonist 
phentolamine, respectively. Interestingly, 
during infusion of  phentolamine, HUT still 
caused vasoconstriction in controls as well as 
in the SCI group. So, effective α-adrenergic 
blockade, which was confi rmed by a cold 
pressor test, did not reduce HUT-induced 
vasoconstriction, regardless of  intact 
barorefl ex control of  the leg vasculature. 
Apparently, redundant mechanisms 
compensate for the absence of  sympathetic 
α-adrenoceptor leg vasoconstriction in 
response to postural stress.
In Chapter 7, we aimed to unravel these 
redundant mechanisms, in particular the 
local mechanisms of  vasoconstriction 
(venoarteriolar refl ex (VAR) and myogenic 
response) using both limb dependency 
and venous stasis by cuff  infl ation in SCI 
individuals and compare responses with 
those in control subjects. Limb blood fl ow 
was measured in the forearm and calf  during 
three levels of  (1) limb dependency, and (2) 
cuff  infl ation. During limb dependency 
vasoconstriction relies on both the VAR 
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and the myogenic response. During cuff  
infl ation the decrease in blood fl ow is 
caused by the VAR and by a decrease in 
arterio-venous pressure difference, whereas 
the myogenic response does not play a role. 
At the highest level of  leg dependency, the 
percent increase in calf  vascular resistance 
was more pronounced in SCI individuals 
than in controls. In contrast, during cuff  
infl ation no differences were found between 
SCI individuals and controls. In the forearm, 
where the vascular bed is not infl uenced by 
the spinal cord injury, responses in vascular 
resistance were equal in both groups in 
response to both forearm dependency as 
well as forearm cuff  infl ation. Thus, local 
vasoconstriction during dependency of  the 
paralyzed leg in SCI individuals is enhanced. 
The contribution of  the VAR to local 
vasoconstriction does not differ between 
the groups, since no differences between 
groups existed for cuff  infl ation. Therefore, 
the augmented local vasoconstriction in SCI 
individuals during leg dependency relies, 
most likely, on the myogenic response.
In Chapter 8, the mechanisms responsible 
for the increase in basal leg vascular 
resistance, and the increase in leg vascular 
resistance upon orthostatic challenges in 
SCI individuals are discussed. Furthermore 
suggestions for future research are given. 
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Het sympathisch zenuwstelsel is een deel 
van het autonome of  onwillekeurige 
zenuwstelsel. Het speelt een grote rol in 
het reguleren van de doorbloeding in het 
menselijk lichaam. Bij een intact sympathisch 
zenuwstelsel resulteert toename van 
sympathische activiteit vanuit de hersenstam 
in een afname van doorbloeding. In 
“rust” is er een basale beïnvloeding van 
de bloedvaten door het sympathisch 
zenuwstelsel; als het sympathisch 
zenuwstelsel ter hoogte van de bloedvaten 
geblokkeerd wordt neemt, de doorbloeding 
toe. In rechtopgaande houding neemt de 
activiteit van het sympathisch zenuwstelsel 
toe. Dit leidt onder andere tot vermindering 
van doorbloeding en verhoging van de 
hartslag om een daling van de bloeddruk, 
orthostatische hypotensie genoemd, te 
voorkomen.
Bij mensen met een complete dwarslaesie is 
door het ruggenmergletsel het sympathisch 
zenuwstelsel onderbroken. De hersenstam 
kan dan via het sympathisch zenuwstelsel 
de bloedvaten onder het niveau van de 
dwarslaesie niet meer beïnvloeden. Door 
het niet goed meer functioneren van het 
sympathisch zenuwstelsel verwacht je een 
toename van de doorbloeding onder het 
niveau van het ruggenmergletsel. Echter 
bij mensen met een dwarslaesie blijkt het 
tegenovergestelde waar: de doorbloeding 
in de verlamde en daardoor inactieve 
benen is fors verminderd. De verminderde 
doorbloeding speelt een rol in het ontstaan 
van allerlei complicaties, zoals vertraagde 
wondgenezing en doorligwonden.
Opmerkelijk is dat mensen met een 
dwarslaesie, met name in de chronische 
fase, goed in staat  zijn een rechtopgaande 
houding aan te nemen zonder fl auw te 
vallen. Dit wordt orthostatische tolerantie 
genoemd. Ondanks dat het sympathisch 
zenuwstelsel niet meer onder controle 
van de hersenstam staat, vernauwen de 
bloedvaten in de benen nog wel bij mensen 
met een dwarslaesie die een rechtopgaande 
houding aannemen. Deze vaatvernauwing 
is mogelijk één van de mechanismen die 
de opvallende orthostatische tolerantie bij 
deze groep mensen kan verklaren.
Tot nu toe is nog niet bekend welke 
factoren bijdragen aan de verminderde 
doorbloeding in de benen in rust bij 
mensen met een dwarslaesie. Ook de 
mechanismen verantwoordelijk voor de 
afname van de doorbloeding in de benen 
tijdens rechtopgaande houding zijn nog 
grotendeels onbekend. Daarom is het doel 
van het huidig promotie-onderzoek de 
regulatie van de doorbloeding bij mensen 
met een dwarslaesie te ontrafelen, zowel 
in rust als tijdens een rechtopgaande 
houding.
In Hoofdstuk 1 wordt een globaal overzicht 
gegeven van de factoren die betrokken 
zijn bij de regulatie van de doorbloeding 
onder normale omstandigheden. Daarnaast 
komen verschillende mechanismen aan bod 
die mogelijk de verminderde doorbloeding 
bij mensen met een dwarslaesie kunnen 
verklaren. Niet alleen de rol van het 
sympathisch zenuwstelsel in de regulatie 
van de doorbloeding wordt belicht. Aan 
de hand van verschillende proefdier en 
humane modellen wordt ook het effect 
van fysieke inactiviteit op de functie van 
de bloedvatwand beschreven. Met name 
het endotheel, dat de binnenwand van het 
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bloedvat bekleedt, is van belang vanwege de 
productie van verschillende vaatverwijdende 
stoffen, waaronder stikstofmonoxide, en 
vaatvernauwende stoffen. De regulatie van 
de doorbloeding tijdens het recht op gaan 
staan en de mogelijke mechanismen die 
verantwoordelijk zijn voor de vernauwing 
van de bloedvaten in de benen van de 
mensen met een dwarslaesie  worden 
eveneens besproken. 
De bijdrage van het sympathisch 
zenuwstelsel aan de doorbloeding van de 
benen van zowel mensen met een dwarslaesie 
als controle personen is in Hoofdstuk 2 
onderzocht. Fentolamine, een middel dat 
de sympathische zenuwoverdracht in de 
bloedvaten van de spieren blokkeert, werd 
in oplopende doseringen via de liesslagader 
toegediend en het effect op de doorbloeding 
werd gemeten. Onze hypothese was dat 
blokkeren van het sympathisch zenuwstelsel 
bij mensen met een dwarslaesie geen effect 
zou hebben op de doorbloeding. Echter 
tijdens het toedienen van fentolamine 
nam de doorbloeding niet alleen in de 
controle groep, maar ook bij de personen 
met een dwarslaesie toe. Heel verrassend 
blijkt bij mensen met een dwarslaesie 
het sympathisch zenuwstelsel, ondanks 
dat het niet meer onder controle van de 
hersenstam staat, nog wel bij te dragen aan 
de doorbloeding van de benen. Omdat de 
bijdrage van het sympathisch zenuwstelsel 
aan de doorbloeding niet verschilt tussen de 
beide groepen kan dit niet de verminderde 
doorbloeding van de benen verklaren bij 
mensen met een dwarslaesie.
Verminderde functie van het endotheel, 
dat wordt gekarakteriseerd door een 
verminderde stikstofmonoxide productie, 
speelt een belangrijke rol in de pathogenese 
van hart- en vaatziekten. Een belangrijke 
onafhankelijke risicofactor voor hart- 
en vaatziekten is lichamelijk inactiviteit. 
Of  de verminderde doorbloeding in de 
verlamde en dus inactieve benen van 
mensen met een dwarslaesie verklaard 
wordt door een verminderde productie 
van stikstofmonoxide werd onderzocht 
in Hoofdstuk 3. De bijdrage van 
stikstofmonoxide aan de doorbloeding in de 
benen na langdurige fysieke inactiviteit als 
gevolg van een dwarslaesie was behouden. 
Dit zelfde geldt wanneer een “gezond” 
been gedurende korte tijd niet gebruikt 
wordt. Fysieke inactiviteit had geen effect 
op de vermindering van doorbloeding 
na remmen van de productie van 
stikstofmonoxide. Ook de vaatverwijding 
nadat stikstofmonoxide was toegediend 
was niet veranderd. Fysieke inactiviteit blijkt 
tevens de mogelijkheid van het bloedvat 
om te vernauwen niet te beïnvloeden, zoals 
blijkt na toedienen van een vaatvernauwend 
middel (angiotensine II). Concluderend 
kan dus, evenmin als het sympathisch 
zenuwstelsel, ook een verminderde 
productie van stikstofmonoxide de 
verminderde doorbloeding in de benen van 
mensen met een dwarslaesie niet verklaren.
Naast het bepalen van de bijdrage van 
stikstofmonoxide aan de doorbloeding van 
de spieren om endotheelfunctie te bepalen, 
wordt FMD (Flow Mediated Dilatation) 
gebruikt om de endotheelfunctie van 
een groot bloedvat (bijvoorbeeld de 
liesslagader) te meten. De FMD wordt 
uitgedrukt als de procentuele toename van 
het bloedvat na een snelle toename van de 
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bloedstroom in het bloedvat; hoe groter de 
bloedvatverwijding, hoe beter de functie 
van het endotheel. Uit eerder onderzoek 
blijkt dat fysieke inactiviteit als gevolg van 
een dwarslaesie de endotheelfunctie van de 
grote bloedvaten in het been, uitgedrukt als 
FMD, behouden blijft. Hoewel er vanuit 
gegaan wordt dat de FMD veroorzaakt 
wordt door het vrijkomen van stikstofoxide, 
is dit echter in de grote beenvaten nooit 
onderzocht. Ook is niet bekend of  de 
behouden FMD na inactiviteit volledig door 
stikstofoxide wordt veroorzaakt. Daarom is 
in Hoofdstuk 4 de FMD uitgevoerd zonder 
en met remming van de productie van 
stikstofmonoxide in een groep mensen met 
een dwarslaesie en in een controle groep. 
In beide groepen was na remming van de 
productie van stikstofmonoxide de FMD 
fors verminderd tot nagenoeg afwezig. 
Dus, zowel in controle personen als bij 
mensen met een dwarslaesie wordt de 
FMD veroorzaakt door stikstofmonoxide. 
De behouden FMD bij mensen met 
een dwarslaesie lijkt dus een behouden 
endotheelfunctie te weerspiegelen.   
Veneuze occlusie plethysmografi e is een 
veel gebruikte methode om doorbloeding 
in de armen of  benen te meten. Echter, 
één van de voorwaarden voor het gebruik 
van deze methode is dat de venen (aderen) 
leeg zijn. Daarom was het gebruik van deze 
methode tijdens het staan voor het meten 
van de doorbloeding in de benen, wanneer 
de venen gevuld zijn met bloed, discutabel. 
In Hoofdstuk 5 is de toepasbaarheid en 
reproduceerbaarheid van veneuze occlusie 
plethysmografi e om de doorbloeding van de 
kuit tijdens het gaan staan gemeten. Daartoe 
werd middels een kanteltafel verschillende 
posen aangenomen tussen liggen en staan 
(met een kantelhoek variërend van 0°-70°). 
Doorbloeding gemeten met veneuze occlusie 
plethysmografi e werd vergeleken met de 
doorbloeding van een bovenbeenslagader 
gemeten met echo Doppler. De correlatie 
tussen beide methoden was goed en de 
reproduceerbaarheid van veneuze occlusie 
plethysmografi e was redelijk tot goed in 
liggende positie en in 30º kanteling. Dus, 
veneuze occlusie plethysmografi e kan 
toegepast worden voor het meten van de 
doorbloeding in het been tot een kantelhoek 
van 30º.
Tijdens het gaan staan is de vaatvernauwing 
door activatie van het sympathisch 
zenuwstelsel, en als gevolg daarvan de 
afname van doorbloeding in de benen en 
de buik van groot belang voor het op peil 
houden van de bloeddruk. Ondanks dat het 
sympathische zenuwstelsel bij personen met 
een dwarslaesie niet meer onder controle 
staat van de hersenstam, vernauwen de 
bloedvaten in de benen wel tijdens het gaan 
staan. Dit suggereert dat een goed werkend 
sympathisch zenuwstelsel niet cruciaal is 
voor het handhaven van de bloeddruk 
tijdens het gaan staan. In Hoofdstuk 6 
wordt de bijdrage van het sympathisch 
zenuwstelsel aan de vaatvernauwing tijdens 
het gaan staan onder een kantelhoek van 30º 
bepaald in zowel personen met een intact 
sympathisch zenuwstelsel, als in personen 
met een dwarslaesie. De zenuwoverdracht 
van het sympathisch zenuwstelsel in het 
bloedvat van het been werd wederom 
geblokkeerd door fentolamine. Blokkade 
van de sympathische zenuwoverdracht had 
geen effect op  de vaatvernauwing tijdens 
Samenvatting
153
het gaan staan, niet alleen bij de mensen 
met een dwarslaesie, maar ook niet bij de 
controle personen. Blijkbaar zijn andere 
mechanismen, bij het tekortschieten van 
het sympathisch zenuwstelsel, in staat de 
vaatvernauwing volledig te compenseren.
In Hoofdstuk 7 worden locale 
mechanismen in het been onderzocht 
die mogelijk verantwoordelijk zijn voor 
de vaatvernauwing tijdens het staan bij 
mensen met een dwarslaesie. Deze locale 
mechanismen zijn: 1) de venoarteriolare 
refl ex die actief  wordt wanneer de druk in 
de aderen toeneemt en via een sympathische 
zenuw een vaatvernauwing veroorzaakt; 
2) de myogene respons: druktoename 
in het bloedvat doet gladde spiercellen 
samentrekken dat vaatvernauwing 
veroorzaakt. Bij de mensen met een 
dwarslaesie is de locale vaatvernauwing 
groter dan bij de controle personen. De 
bijdrage van de venoarteriolaire refl ex aan 
de locale vaatvernauwing verschilt niet 
tussen de beide groepen. Dit wijst erop dat 
de toename van locale vaatvernauwing bij 
mensen met een dwarslaesie voor een groot 
deel is toe te schrijven aan de myogene 
response. Dit suggereert dat de myogene 
respons een rol speelt in de vaatvernauwing 
tijdens het gaan staan bij mensen met een 
dwarslaesie.
Hoofdstuk 8 bevat een algemene discussie 
over de regulatie van de doorbloeding bij 
mensen met een dwarslaesie en over de 
kennis die dit proefschrift daarover heeft 
bijgedragen. 
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Dankwoord
Het is af!
Zonder de mensen die zich soms meerdere keren lieten verleiden om als proefpersonen aan het 
onderzoek mee te werken, was dit boekje niet tot stand gekomen. Aan hen dus veel dank.
Eén van mijn eerste wetenschappelijke schreden zette ik tijdens mijn afstudeerstage, onder begeleiding 
van onder andere Maria Hopman. Toen is de basis gelegd wat heeft geleid tot dit promotie-traject. 
Maria, jij wist de rode draad van het onderzoek te bewaken, wanneer ik teveel verzandde in details. 
Jouw doortastendheid, optimisme, creativiteit en soms verstrooidheid (sleutels kwijt zijn, is voor 
mij zeer herkenbaar ;)), naast jouw belangstelling voor de mens achter de onderzoeker maakte het 
samenwerken met jou prettig.
Paul (Smits), het feit dat de beide afdelingen boven elkaar gehuisvest zijn maakt dat jij van “bottom 
up” heel laagdrempelig bereikbaar was voor vragen. Dank voor jouw analytische en kritische blik 
op zowel de onderzoeksvoorstellen, de onderzoeksresultaten, en de uiteindelijke “producten”: de 
artikelen. Zowel inhoudelijk als qua vormgeving zette je (soms letterlijk) de puntjes op de “i”. 
Bij de ontwikkeling van het “geperfundeerde bovenbeenmodel” is Gerard Rongen een belangrijke 
spil geweest. Dat jij, Gerard, tijdens het douchen bedacht dat de snelheid van infusie moest worden 
aangepast, kenmerkt jouw enthousiasme en betrokken- en gedrevenheid. Ik heb veel geleerd van 
jouw kennis op zowel fysiologisch als farmacologisch gebied en hoe je een boodschap goed kunt 
verwoorden en overbrengen in een artikel. Daarnaast dank voor de snelheid waarmee je de stukken 
corrigeert.
Het vertrouwen, de medewerking en fl exibiliteit van de supervisoren en opleiders 
revalidatiegeneeskunde, in het bijzonder Dirk van Kuppevelt en Sander Geurts, maakte dit 
AIOSKO traject (voorheen AGIKO) mogelijk. Hoewel aan de zijlijn betrokken voelde ik me zeer 
door jullie gesteund. Dirk, naast AIOSKO en ZAIOS (zwangere AIOS) doet een combinatie van 
beide (ZAIOSKO) wel een beroep op jouw “puzzelvaardigheden”. In goed overleg is het steeds 
weer gelukt het opleidingsschema aan te passen, waar ik je erg dankbaar voor ben.
Met veel plezier kijk ik terug op de tijd die ik heb doorgebracht op de afdeling Fysiologie. Patricia, 
hoewel onze wegen zich scheidden is het voor mij vanzelfsprekend dat je één van mijn paranimfen 
bent! Goede en warme herinneringen koester ik aan de tijd dat ik met jou een kamer deelde 
op de Fysiologie. Naast kennis over onderzoek-gerelateerde zaken hebben wij lief  en leed met 
elkaar gedeeld. Dank voor de positieve en relativerende kijk op het leven (elbee-tje)! Dat jouw 
(idealistische) hart bij het onderzoek ligt, blijkt wel uit je “come-back”. Succes! Dick, jou waardeer 
ik enorm om enerzijds je rustige uitstraling en anderzijds jouw slagvaardigheid en gedrevenheid 
waarmee je jouw wetenschappelijke aspiraties verwezenlijkt. Mede door jouw inspanningen is het 
NO-FMD stuk gepubliceerd. Dank! Op plezierige wijze hebben wij, Michiel, samengewerkt om 
onze beider NO-onderzoeken op poten te zetten. Dat jouw kennis zich niet alleen tot het onderzoek 
en de medische wetenschap beperkt, blijkt wel uit de felle discussie die in de koffi e-kamer werden 
gevoerd! Bregina, dank voor je hulp bij de experimenten en je goedlachsheid! Jouw veelzijdigheid 
en creativiteit blijkt wel uit de (weer) prachtige afbeelding die de voorkant van dit boekje siert. Dank 
hiervoor! Jos, bedankt voor jouw helpende hand, die verder reikt dan alleen die extra hand tijdens de 
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experimenten. Voor het kunnen gebruiken van de meetopstelling op de afdeling Fysiologie ben ik 
Jan Mensen veel dank verschuldigd. Ook de anderen personen op de afdeling Fysiologie, Annelies, 
Louis, Piet, Maarten, Heleen, en de mensen van de “toren”, in het bijzonder René, wil ik bedanken 
voor de fi jne tijd. Diverse studenten hebben aangehaakt bij één van de onderzoeken (“vele handen 
maken licht werk”), waarvan een aantal namen nog terug te vinden zijn in dit boekje. Bedankt voor 
jullie inzet! De andere promovendi, Noortje, Jan, Fleur, Thijs en Madelijn: succes met het afronden 
van jullie promotie-traject!
Veel heb ik gehad aan de kritische blik op de onderzoeksresultaten en de nuttige adviezen tijdens 
de wekelijks AGIKO-bespreking met de andere onderzoekers die zich met vasculair onderzoek 
bezig houden. Het is fi jn om naast de resultaten ook andere “promotie-perikelen” te kunnen 
uitwisselen. 
Voor het inbrengen van de arteriële lijn kon ik altijd terugvallen op Arie van Dijk en Peter P(r)
ickers. Voor statistische back-up kon ik terecht bij de afdeling Statistiek. De laboratoria Chemische 
Endocrinologie en Klinische Chemie dank ik voor de bepalingen en het in bewaring houden van 
de vele buisjes bloed. 
Een goede werksfeer verhoogt het werkplezier en daar hebben jullie, collega AIOS, zeker aan 
bijgedragen! Bedankt voor jullie collegialiteit, samenwerking en gezelligheid tijdens de vele cursussen, 
maar ook “buiten kantooruren”, met of  zonder mannen ; ) 
Inspannen gaat alleen samen met ontspannen! Lieve vrienden, bedankt dat jullie mij dat hebben 
kunnen bieden! Nathalie, ook dit boekje is door jou kritisch van de puntjes op de i voorzien. Meeke, 
ook ìk ben vereerd dat jij mij ter zijde wil staan!
Agnes, bedankt voor je “ad hoc” oppas- en zwemuurtjes. Leo, de reis vanuit Friesland is jou nooit 
te ver. Bedankt voor alle kleine en grote klussen die je voor ons hebt gedaan. Vincent, Maaike en 
kleine Frits, jullie bedank ik voor alle ongedwongen- en gezelligheid!
Lieve Jo, bewondering heb ik voor de manier waarop je jezelf  ontwikkelt, waarbij je jouw idealen 
duidelijk voor ogen houdt. Jouw creativiteit heeft al tot veel mooie dingen geleid. Dank je wel voor 
wie je bent! Liefde kent geen grenzen, heb jij, Arjan, zelf  mogen ervaren. Ondanks de afstand is het 
contact nu intensiever. Jammer dat je er niet bij bent. Ik kijk uit naar december om jou, Lorraine en 
Luuc weer te zien!
Papa en mama, dat jullie liefde onvoorwaardelijk is bewijzen jullie steeds keer op keer! Jullie altijd 
luisterende oor; jullie steun in de door mij gemaakte keuzes;  jouw, papa, ongezouten maar zeer 
oprechte en relativerende mening; jouw, mama, opgewekte en “opgeruimde” karakter. Door jullie 
kan ik zijn wie ik ben. Bedankt… voor alles!
Lieve dametjes, Isa en Suze, wat is het toch geweldig om jullie ontdekkingsreis en jullie oprechte 
verbazing over dingen die zo vanzelfsprekend lijken van dichtbij mee te maken. 
Lieve Tommy, het leven is met jou, en door jou, mooi!
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Curriculum Vitae 
Miriam Kooijman werd geboren op 11 mei 1973 in Werkhoven, gemeente Bunnik. Na het 
behalen van het VWO diploma aan het St Bonifatiuscollege in Utrecht begon zij aan de studie 
Gezondheidswetenschappen (momenteel Biomedische Wetenschappen) aan de Katholieke 
Universiteit Nijmegen (momenteel Radboud Universiteit Nijmegen). Zij stroomde door in het 
verkorte doctoraal programma van de studie Geneeskunde aan dezelfde universiteit na het behalen 
van haar doctoraal Gezondheidswetenschappen.
Tijdens haar studie Gezondheidswetenschappen deed zij onderzoek naar de anatomische “pitfalls” 
van triple osteotomie van het bekken op de afdeling Anatomie-Embryologie van de Radboud 
Universiteit in samenwerking met de afdeling Orthopaedie van de Sint Maartenskliniek in Nijmegen. 
Ook heeft zij stage gelopen op de afdeling Fysiologie, alwaar zij onderzoek deed naar het gebruik 
van Near Infrared Spectroscopy om doorbloeding te meten bij patiënten met “etalage”- benen. 
Daar werden de eerste schreden gezet naar het onderzoek dat geleid heeft tot het in dit proefschrift 
beschreven promotie-onderzoek.
Voor de afronding van haar medische opleiding heeft Miriam 3 maanden co-schap gelopen in 
Biharamulo Hospital, Tanzania. In 1999 behaalde zij het arts-examen, waarna zij eerst als poortarts 
in het Bernhoven Ziekenhuis in Veghel heeft gewerkt. In 2000 startte zij met de opleiding tot 
revalidatiearts in de Sint Maartenskliniek (opleiders: drs. HJM van Kuppevelt en prof. dr. ACH Geurts). 
Sindsdien heeft zij haar klinische opleiding afgewisseld met het doen van promotieonderzoek op de 
afdeling Fysiologie in samenwerking met de afdeling Farmacologie-Toxicologie onder begeleiding 
van prof. dr. MTE Hopman, prof. dr. P Smits en dr. GA Rongen. Bij de Trans European Scientifi c 
Contest, gehouden tijdens het twee-jaarlijkse congres van ’European Society of  Physical and 
Rehabilitation Medicine’ in 2004, ontving zij de tweede prijs voor haar mondelinge voordracht.
Op dit moment is Miriam bezig met de laatste fase van haar opleiding tot revalidatiearts. Na het 
afronden van haar opleiding gaat zij als revalidatiearts werken in revalidatiecentrum de Vogellanden 
in Zwolle waarbij haar interesse uitgaat naar de kinderrevalidatie.
Miriam is getrouwd met Tommy Visscher. Zij hebben twee kinderen, Isa en Suze.

